,Catalog No.,Product Name,Clinical Research Yes/NO,FDA Approved Yes/No,M.w.,CAS Number,Form,Targets,Information,Smiles,Max Solubility in DMSO,URL,Pathway,Compound ID,Well,Rack,Barcode,CID
0,S8050,ETP-46464,,,470.52,1345675-02-6,free base,"mTOR,ATM/ATR",ETP-46464 is a potent and selective inhibitor of ATR with IC50 of 25 nM.,C1=CC(=CC2=C1N=CC3=C2N(C(OC3)=O)C4=CC=C(C=C4)C(C#N)(C)C)C5=CN=C6C(=C5)C=CC=C6,12,http://www.selleckchem.com/products/etp-46464.html,PI3K/Akt/mTOR,K06474a,A1,L1200-1,0187170645,72199292
1,S1134,AT9283,Yes,,381.43,896466-04-9,free base,"JAK,Aurora Kinase,Bcr-Abl","AT9283 is a potent JAK2/3 inhibitor with IC50 of 1.2 nM/1.1 nM; also potent to Aurora A/B, Abl(T315I). Phase 1/2.",N(C(=O)NC1C(=NNC=1)C2NC3C(N=2)=CC(=CC=3)CN4CCOCC4)C5CC5,199,http://www.selleckchem.com/products/AT9283.html,JAK/STAT,K04272c,A10,L1200-1,0187172246,135398495
2,S1164,Lenvatinib (E7080),Yes,,426.85,417716-92-8,free base,VEGFR,"E7080 (Lenvatinib) is a multi-target inhibitor, mostly for VEGFR2(KDR)/VEGFR3(Flt-4) with IC50 of 4 nM/5.2 nM, less potent against VEGFR1/Flt-1, ~10-fold more selective for VEGFR2/3 against FGFR1, PDGFRα/β. Phase 3.",C1(=C(C=C2C(=C1)C(=CC=N2)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl)OC)C(N)=O,93,http://www.selleckchem.com/products/E7080.html,Protein Tyrosine Kinase,K04371c,A11,L1200-1,0187172245,9823820
3,S1017,Cediranib (AZD2171),Yes,,450.51,288383-20-0,free base,VEGFR,"Cediranib (AZD2171) is a highly potent VEGFR(KDR) inhibitor with IC50 of <1 nM, also inhibits Flt1/4 with IC50 of 5 nM/≤3 nM, similar activity against c-Kit and PDGFRβ, 36-, 110-fold and >1000-fold selective more for VEGFR than PDGFR-α, CSF-1R and Flt3, Phase 2/3.",C1(=C(C=C2C(=C1)C(=NC=N2)OC3=C(C4=C(C=C3)NC(=C4)C)F)OCCCN5CCCC5)OC,199,http://www.selleckchem.com/products/Cediranib.html,Protein Tyrosine Kinase,K04295c,A2,L1200-1,0187172254,9933475
4,S1026,Imatinib Mesylate (STI571),Yes,Yes,589.71,220127-57-1,mesylate,"c-Kit,Bcr-Abl,PDGFR","Imatinib Mesylate (STI571) is an orally bioavailability mesylate salt of Imatinib, which is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM, respectively.",C1(=CC=C(C(=C1)NC2=NC=CC(=N2)C3=CC=CN=C3)C)NC(=O)C4(=CC=C(C=C4)CN5CCN(CC5)C).OS(C)(=O)=O,200,http://www.selleckchem.com/products/Imatinib-Mesylate.html,Protein Tyrosine Kinase,K06336a,A3,L1200-1,0187172253,123596
5,S1039,Rapamycin (Sirolimus),Yes,Yes,914.18,53123-88-9,free base,"Autophagy,mTOR","Rapamycin (Sirolimus, AY-22989, WY-090217) is a specific mTOR inhibitor with IC50 of ~0.1 nM.",[C@@H]1([C@@H](C[C@@H](CC1)C[C@H]([C@@H]2CC([C@@H](/C=C(\C)[C@H]([C@@H](C([C@@H](C[C@@H](/C=C/C=C/C=C(/[C@H](C[C@@H]3CC[C@H]([C@](C(C(N4CCCC[C@@H](C(O2)=O)4)=O)=O)(O3)O)C)OC)C)C)C)=O)OC)O)C)=O)C)OC)O,21,http://www.selleckchem.com/products/Rapamycin.html,PI3K/Akt/mTOR,K06340a,A4,L1200-1,0187172252,5284616
6,S1055,Enzastaurin (LY317615),Yes,,515.61,170364-57-5,free base,PKC,"Enzastaurin (LY317615) is a potent PKCβ selective inhibitor with IC50 of 6 nM, 6- to 20-fold selectivity against PKCα, PKCγ and PKCε. Phase 3.",C1=CC=C2C(=C1)C(=CN2C3CCN(CC3)CC4=NC=CC=C4)C5C(NC(C=5C6C7C(N(C=6)C)=CC=CC=7)=O)=O,58,http://www.selleckchem.com/products/Enzastaurin.html,TGF-beta/Smad,K04282c,A5,L1200-1,0187172251,176167
7,S1075,SB216763,,,371.22,280744-09-4,free base,GSK-3,SB216763 is a potent and selective GSK-3 inhibitor with IC50 of 34.3 nM for GSK-3α and equally effective at inhibiting human GSK-3β.,C1=CC=CC2=C1N(C=C2C3=C(C(NC3=O)=O)C4=CC=C(C=C4Cl)Cl)C,61,http://www.selleckchem.com/products/SB-216763.html,PI3K/Akt/mTOR,K00961b,A6,L1200-1,0187172250,176158
8,S1092,KU-55933 (ATM Kinase Inhibitor),,,395.49,587871-26-9,free base,ATM/ATR,"KU-55933 is a potent and specific ATM inhibitor with IC50/Ki of 12.9 nM/2.2 nM, and is highly selective for ATM as compared to DNA-PK, PI3K/PI4K, ATR and mTOR.",C1=CC=C2C(=C1)SC3=C(S2)C=CC=C3C4=CC(C=C(O4)N5CCOCC5)=O,83,http://www.selleckchem.com/products/KU-55933.html,DNA Damage,K02643b,A7,L1200-1,0187172249,5278396
9,S1105,LY294002,,,307.34,154447-36-6,free base,"Autophagy,PI3K","LY294002 is the first synthetic molecule known to inhibit PI3Kα/δ/β with IC50 of 0.5 μM/0.57 μM/0.97 μM, respectively; more stable in solution than Wortmannin, and also blocks autophagosome formation.",C1=CC(=C2C(=C1)C(C=C(O2)N3CCOCC3)=O)C4=CC=CC=C4,117,http://www.selleckchem.com/products/LY294002.html,PI3K/Akt/mTOR,K00235c,A8,L1200-1,0187172248,3973
10,S1114,JNJ-38877605,Yes,,377.35,943540-75-8,free base,c-Met,"JNJ-38877605 is an ATP-competitive inhibitor of c-Met with IC50 of 4 nM, 600-fold selective for c-Met than 200 other tyrosine and serine-threonine kinases. Phase 1.",N1=CC=CC2=C1C=CC(=C2)C(C3N4C(=NN=3)C=CC(=N4)C5C=NN(C=5)C)(F)F,98,http://www.selleckchem.com/products/JNJ-38877605.html,Protein Tyrosine Kinase,K06348a,A9,L1200-1,0187172247,46911863
11,S1005,Axitinib,Yes,Yes,386.47,319460-85-0,free base,"c-Kit,VEGFR,PDGFR","Axitinib is a multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFRβ and c-Kit with IC50 of 0.1 nM, 0.2 nM, 0.1-0.3 nM, 1.6 nM and 1.7 nM, respectively.",C1(=CC=CC=C1C(=O)NC)SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4,108,http://www.selleckchem.com/products/Axitinib.html,Protein Tyrosine Kinase,K00956d,B1,L1200-1,0187170650,6450551
12,S1138,Brivanib Alaninate (BMS-582664),Yes,,441.46,649735-63-7,alaninate,"VEGFR,FGFR","Brivanib alaninate (BMS-582664) is the prodrug of BMS-540215, an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM.",C12=C(C(=C(C=C1)OC3=NC=NN4C3=C(C(=C4)OC[C@@H](C)OC([C@@H](N)C)=O)C)F)C=C(N2)C,199,http://www.selleckchem.com/products/Brivanib-alaninate.html,Protein Tyrosine Kinase,K06350a,B10,L1200-1,0187172241,11154925
13,S1167,CP-724714,,,469.53,537705-08-1,free base,"EGFR,HER2","CP-724,714 is a potent, selective inhibitor of HER2/ErbB2 with IC50 of 10 nM, >640-fold selectivity against EGFR, InsR, IRG-1R, PDGFR, VEGFR2, Abl, Src, c-Met etc. Phase 2.",C1(=CC=C2C(=C1)C(=NC=N2)NC3=CC=C(C(=C3)C)OC4=CC=C(N=C4)C)/C=C/CNC(COC)=O,200,http://www.selleckchem.com/products/CP-724714.html,Protein Tyrosine Kinase,K06352a,B11,L1200-1,0187172242,None
14,S8057,Pacritinib (SB1518),Yes,,472.58,937272-79-2,free base,JAK,"Pacritinib (SB1518) is a potent and selective inhibitor of Janus Kinase 2 (JAK2) and Fms-Like Tyrosine Kinase-3 (FLT3) with IC50s of 23 and 22 nM, respectively.",C1=CN=C2N=C1C3=CC(=CC=C3)COC/C=C/COCC4=CC(=CC=C4OCCN5CCCC5)N2,23,http://www.selleckchem.com/products/pacritinib-sb1518.html,JAK/STAT,K06484a,B2,L1200-1,0187172233,46216796
15,S1028,Lapatinib (GW-572016) Ditosylate,Yes,Yes,925.46,388082-77-7,ditosylat,"HER2,EGFR","Lapatinib Ditosylate (GW572016, GW2016) is a potent EGFR and ErbB2 inhibitor with IC50 of 10.8 and 9.2 nM, respectively.",C1(=C(C=C2C(=C1)N=CN=C2NC3=CC=C(C(=C3)Cl)OCC4=CC=CC(=C4)F)C5OC(=CC=5)CNCCS(=O)(C)=O).C6(=C(C=CC(=C6)S(O)(=O)=O)C).C7=C(C=CC(=C7)S(O)(=O)=O)C,199,http://www.selleckchem.com/products/Lapatinib-Ditosylate.html,Protein Tyrosine Kinase,K06337a,B3,L1200-1,0187170669,9941095
16,S1040,Sorafenib Tosylate,Yes,Yes,637.03,475207-59-1,tosylate,"PDGFR,Raf,VEGFR","Sorafenib Tosylate (Bay 43-9006) is a multikinase inhibitor of Raf-1, B-Raf and VEGFR-2 with IC50 of 6 nM, 22 nM and 90 nM, respectively.",C1(=CC=C(C=C1C(F)(F)F)NC(NC2=CC=C(C=C2)OC3=CC=NC(=C3)C(NC)=O)=O)Cl.C4=CC(=CC=C4S(O)(=O)=O)C,199,http://www.selleckchem.com/products/Sorafenib-Tosylate.html,MAPK,K06341a,B4,L1200-1,0187172235,406563
17,S1056,AC480 (BMS-599626),Yes,,567.01,714971-09-2,free base,"HER2,EGFR","AC480 (BMS-599626) is a selective and efficacious inhibitor of HER1 and HER2 with IC50 of 20 nM and 30 nM, ~8-fold less potent to HER4, >100-fold to VEGFR2, c-Kit, Lck, MET etc. Phase 1.",C1(CN[C@@H](CO1)COC(NC2=CN3C(=C2C)C(=NC=N3)NC4=CC5=C(C=C4)N(N=C5)CC6=CC(=CC=C6)F)=O).Cl,199,http://www.selleckchem.com/products/BMS-599626.html,Protein Tyrosine Kinase,K06344a,B5,L1200-1,0187172236,10437018
18,S1076,SB203580,,,377.43,152121-47-6,free base,p38 MAPK,"SB203580 is a p38 MAPK inhibitor with IC50 of 0.3-0.5 μM, 10-fold less sensitive to SAPK3(106T) and SAPK4(106T) and blocks PKB phosphorylation with IC50 of 3-5 μM. ",N1=CC=C(C=C1)C2=C(N=C(N2)C3=CC=C(C=C3)S(C)=O)C4=CC=C(C=C4)F,198,http://www.selleckchem.com/products/SB-203580.html,MAPK,K00038c,B6,L1200-1,0187172237,176155
19,S1093,GSK1904529A,,,851.96,1089283-49-7,free base,IGF-1R,"GSK1904529A is a selective inhibitor of IGF-1R and IR with IC50 of 27 nM and 25 nM, >100-fold more selective for IGF-1R/InsR than Akt1/2, Aurora A/B,B-Raf, CDK2, EGFR etc.",C1=C(C(=C(C=C1)F)NC(C2=C(C=CC(=C2)C3=C(N4C(=N3)C=CC=C4)C5=CC=NC(=N5)NC6=C(C=C(C(=C6)CC)N7CCC(CC7)N8CCN(CC8)S(C)(=O)=O)OC)OC)=O)F,145,http://www.selleckchem.com/products/GSK1904529A.html,Protein Tyrosine Kinase,K04356c,B7,L1200-1,0187172238,25124816
20,S1106,OSU-03012 (AR-12),Yes,,460.45,742112-33-0,free base,PDK-1,OSU-03012 is a potent inhibitor of recombinant PDK-1 with IC50 of 5 μM and 2-fold increase in potency over OSU-02067.,C12=C(C=CC3=C1C=CC(=C3)C4=CC(=NN4C5=CC=C(C=C5)NC(CN)=O)C(F)(F)F)C=CC=C2,23,http://www.selleckchem.com/products/OSU-03012.html,PI3K/Akt/mTOR,K06346a,B8,L1200-1,0187172239,10027278
21,S1116,Palbociclib (PD-0332991) HCl,Yes,,483.99,827022-32-2,hydrochloride,CDK,"PD0332991 is a highly selective inhibitor of CDK4/6 with IC50 of 11 nM/16 nM. It shows no activity against CDK1/2/5, EGFR, FGFR, PDGFR, InsR, etc. Phase 2/3.",N1(=C(N=C2C(=C1)C(=C(C(N2C3CCCC3)=O)C(C)=O)C)NC4=NC=C(C=C4)N5CCNCC5).Cl,10,http://www.selleckchem.com/products/PD-0332991.html,Cell Cycle,K04235b,B9,L1200-1,0187172240,11431660
22,S1006,Saracatinib (AZD0530),Yes,,542.03,379231-04-6,free base,"Src,Bcr-Abl","Saracatinib (AZD0530) is a potent Src inhibitor with IC50 of 2.7 nM, and potent to c-Yes, Fyn, Lyn, Blk, Fgr and Lck; less active for Abl and EGFR (L858R and L861Q). Phase 1/2.",C1=C(C=C2C(=C1OC3CCOCC3)C(=NC=N2)NC4=C(C=CC5=C4OCO5)Cl)OCCN6CCN(CC6)C,184,http://www.selleckchem.com/products/AZD0530.html,Angiogenesis,K04284d,C1,L1200-1,0187172231,10302451
23,S1143,AG-490 (Tyrphostin B42),,,294.3,133550-30-8,free base,"JAK,EGFR","AG-490 (Tyrphostin B42) is an inhibitor of EGFR with IC50 of 0.1 μM, 135-fold more selective for EGFR versus ErbB2, also inhibits JAK2 with no activity to Lck, Lyn, Btk, Syk and Src.",C1(=C(C=CC(=C1)/C=C(/C(NCC2=CC=CC=C2)=O)C#N)O)O,200,http://www.selleckchem.com/products/AG-490.html,Protein Tyrosine Kinase,K06351a,C10,L1200-1,0187172222,5328779
24,S1169,TGX-221,,,364.44,663619-89-4,free base,PI3K,"TGX-221 is a p110β-specific inhibitor with IC50 of 5 nM, 1000-fold more selective for p110β than p110α.  ",C1=C(C=C(C2N1C(C=C(N=2)N3CCOCC3)=O)C(C)NC4=CC=CC=C4)C,32,http://www.selleckchem.com/products/TGX-221.html,PI3K/Akt/mTOR,K02697c,C11,L1200-1,0187172221,9907093
25,S1019,Canertinib (CI-1033),Yes,,485.94,267243-28-7,free base,"EGFR,HER2","Canertinib (CI-1033) is a pan-ErbB inhibitor for EGFR and ErbB2 with IC50 of 1.5 nM and 9.0 nM, no activity to PDGFR, FGFR, InsR, PKC, or CDK1/2/4. Phase 3.",C1(=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4)NC(C=C)=O,10,http://www.selleckchem.com/products/CI-1033(Canertinib).html,Protein Tyrosine Kinase,K04281b,C2,L1200-1,0187172230,156414
26,S1032,Motesanib Diphosphate (AMG-706),Yes,,569.44,857876-30-3,diphosphate,"VEGFR,PDGFR,c-Kit","Motesanib Diphosphate (AMG-706) is a potent ATP-competitive inhibitor of VEGFR1/2/3 with IC50 of 2 nM/3 nM/6 nM, respectively; similar activity against Kit, ~10-fold more selective for VEGFR than PDGFR and Ret. Phase 1/2.",C1(=CN=CC=C1CNC2=C(C=CC=N2)C(=O)NC3=CC=C4C(=C3)NCC4(C)C).P(O)(=O)(O)O.P(O)(=O)(O)O,175,http://www.selleckchem.com/products/Motesanib-Diphosphate.html,Protein Tyrosine Kinase,K06338a,C3,L1200-1,0187172229,16097729
27,S1042,Sunitinib Malate,Yes,Yes,532.56,341031-54-7,malate,"VEGFR,PDGFR,c-Kit","Sunitinib Malate is a multi-targeted RTK inhibitor targeting VEGFR2 (Flk-1) and PDGFRβ with IC50 of 80 nM and 2 nM, and also inhibits c-Kit.",C1(=CC=C2C(=C1)/C(C(N2)=O)=C/C3NC(=C(C=3C)C(NCCN(CC)CC)=O)C)F.C(C[C@@H](C(O)=O)O)(O)=O,28,http://www.selleckchem.com/products/Sunitinib-Malate-(Sutent).html,Protein Tyrosine Kinase,K06342a,C4,L1200-1,0187172228,6456015
28,S1064,Masitinib (AB1010),Yes,Yes,498.64,790299-79-5,free base,"PDGFR,c-Kit","Masitinib is a novel inhibitor for Kit and PDGFRα/β with IC50 of 200 nM and 540 nM/800 nM, weak inhibition to ABL and c-Fms. Phase 2/3.",C1(=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CC=CN=C5)C,200,http://www.selleckchem.com/products/Masitinib-(AB1010).html,Protein Tyrosine Kinase,K04286c,C5,L1200-1,0187172227,10074640
29,S1077,SB202190 (FHPI),,,331.34,152121-30-7,free base,p38 MAPK,"SB202190 (FHPI) is a potent p38 MAPK inhibitor targeting p38α/β with IC50 of 50 nM/100 nM, sometimes used instead of SB 203580 to investigate potential roles for SAPK2a/p38 in vivo.",C1=C(C=CC(=C1)C2N=C(NC=2C3=CC=NC=C3)C4=CC=C(C=C4)O)F,199,http://www.selleckchem.com/products/SB-202190.html,MAPK,K00037c,C6,L1200-1,0187172226,5169
30,S1094,PF-04217903,Yes,,372.38,956905-27-4,free base,c-Met,"PF-04217903 is a selective ATP-competitive c-Met inhibitor with IC50 of 4.8 nM, susceptible to oncogenic mutations (no activity to Y1230C mutant). Phase 1.",C12=CC=CN=C1C=CC(=C2)CN3C4=C(N=N3)N=CC(=N4)C5=CN(N=C5)CCO,13,http://www.selleckchem.com/products/PF-04217903.html,Protein Tyrosine Kinase,K06345a,C7,L1200-1,0187172225,17754438
31,S1107,Danusertib (PHA-739358),Yes,,474.55,827318-97-8,free base,"c-RET,FGFR,Bcr-Abl,Aurora Kinase","Danusertib (PHA-739358) is an Aurora kinase inhibitor for Aurora A/B/C with IC50 of 13 nM/79 nM/61 nM, modestly potent to Abl, TrkA, c-RET and FGFR1, and less potent to Lck, VEGFR2/3, c-Kit, CDK2, etc. Phase 2.",C1(=CC=CC=C1)[C@H](C(N2CC3=C(C2)C(=NN3)NC(=O)C4=CC=C(C=C4)N5CCN(CC5)C)=O)OC,200,http://www.selleckchem.com/products/PHA-739358(Danusertib).html,Cell Cycle,K04229c,C8,L1200-1,0187172224,11442891
32,S1117,Triciribine,Yes,,320.3,35943-35-2,free base,Akt,"Triciribine is a DNA synthesis inhibitor, also inhibits Akt and HIV-1 with IC50 of 130 nM and 20 nM, respectively; does not inhibit PI3K/PDK1; 5000-fold less active in cells lacking adenosine kinase. Phase 1/2.",[C@H]1([C@@H]([C@H](O[C@@H]1N2C3=C4C(=C2)C(=NN(C4=NC=N3)C)N)CO)O)O,199,http://www.selleckchem.com/products/Triciribine.html,PI3K/Akt/mTOR,K06242b,C9,L1200-1,0187172223,65399
33,S1008,Selumetinib (AZD6244),Yes,,457.68,606143-52-6,free base,MEK,"Selumetinib (AZD6244) is a potent, highly selective MEK1 inhibitor with IC50 of 14 nM, also inhibits ERK1/2 phosphorylation with IC50 of 10 nM, no inhibition to p38α, MKK6, EGFR, ErbB2, ERK2, B-Raf, etc. Phase 1/2.",C1=C2C(=C(C(=C1C(NOCCO)=O)NC3=CC=C(C=C3Cl)Br)F)N=CN2C,201,http://www.selleckchem.com/products/AZD6244.html,MAPK,K04277b,D1,L1200-1,0187172208,10127622
34,S1145,SNS-032 (BMS-387032),Yes,,380.53,345627-80-7,free base,CDK,"SNS-032 has firstly been described as a selective inhibitor of CDK2 with IC50 of 48 nM and is 10- and 20-fold selective over CDK1/CDK4. It is also found to be sensitive to CDK7/9 with IC50 of 62 nM/4 nM, with little effect on CDK6. Phase 1.",C1(=CN=C(O1)CSC2=CN=C(S2)NC(=O)C3CCNCC3)C(C)(C)C,199,http://www.selleckchem.com/products/SNS-032.html,Cell Cycle,K04278c,D10,L1200-1,0187172217,3025986
35,S1170,WZ3146,,,464.95,1214265-56-1,free base,EGFR,WZ3146 is a mutant-selective irreversible inhibitor of EGFR(L858R) and EGFR(E746_A750) with IC50 of 2 nM and 2 nM; does not inhibit ERBB2 phosphorylation (T798I).,C1(=CC=C(C=C1)NC2=NC=C(C(=N2)OC3=CC(=CC=C3)NC(C=C)=O)Cl)N4CCN(CC4)C,200,http://www.selleckchem.com/products/WZ3146.html,Protein Tyrosine Kinase,K05785b,D11,L1200-1,0187172218,44607360
36,S1020,PD184352 (CI-1040),Yes,,478.67,212631-79-3,free base,MEK,"CI-1040 (PD 184352) is an ATP non-competitive MEK1/2 inhibitor with IC50 of 17 nM, 100-fold more selective for MEK1/2 than MEK5. Phase 2.",C1=C(C(=C(C(=C1)C(NOCC2CC2)=O)NC3=CC=C(C=C3Cl)I)F)F,200,http://www.selleckchem.com/products/CI-1040-(PD184352).html,MAPK,K06333a,D2,L1200-1,0187172209,6918454
37,S1033,Nilotinib (AMN-107),Yes,Yes,529.52,641571-10-0,free base,Bcr-Abl,Nilotinib (AMN-107) is a Bcr-Abl inhibitor with IC50 less than 30 nM.,C1(=CC=C(C(=C1)NC2=NC=CC(=N2)C3=CN=CC=C3)C)C(=O)NC4=CC(=CC(=C4)N5C=C(N=C5)C)C(F)(F)F,50,http://www.selleckchem.com/products/Nilotinib.html,Angiogenesis,K00933d,D3,L1200-1,0187172210,644241
38,S1043,Tandutinib (MLN518),Yes,,562.7,387867-13-2,free base,FLT3,"Tandutinib (MLN518, CT53518) is a potent FLT3 antagonist with IC50 of 0.22 μM, also inhibits PDGFR and c-Kit, 15 to 20-fold higher potency for FLT3 versus CSF-1R and >100-fold selectivity for the same target versus FGFR, EGFR and KDR. Phase 1/2.",C1=C(C(=CC2=C1N=CN=C2N3CCN(CC3)C(NC4=CC=C(C=C4)OC(C)C)=O)OC)OCCCN5CCCCC5,10,http://www.selleckchem.com/products/Tandutinib-(MLN518).html,Angiogenesis,K04302c,D4,L1200-1,0187172211,3038522
39,S1065,GDC-0941,Yes,,513.64,957054-30-7,free base,PI3K,"GDC-0941 is a potent inhibitor of PI3Kα/δ with IC50 of 3 nM, with modest selectivity against p110β (11-fold) and p110γ (25-fold).",C1(=CC=CC2=C1C=NN2)C3=NC(=C4C(=N3)C=C(S4)CN5CCN(CC5)S(=O)(=O)C)N6CCOCC6,85,http://www.selleckchem.com/products/GDC-0941.html,PI3K/Akt/mTOR,K04283c,D5,L1200-1,0187172212,17755052
40,S1078,MK-2206 2HCl,Yes,,480.39,1032350-13-2,dihydrochloride,Akt,"MK-2206 2HCl is a highly selective inhibitor of Akt1/2/3 with IC50 of 8 nM/12 nM/65 nM, respectively; no inhibitory activities against 250 other protein kinases observed. Phase 2.",C1(=CC=CC=C1)C2(=C(N=C3C(=C2)C4N(C=C3)C(NN=4)=O)C5=CC=C(C=C5)C6(CCC6)N).Cl.Cl,29,http://www.selleckchem.com/products/MK-2206.html,PI3K/Akt/mTOR,K04298c,D6,L1200-1,0187172213,46930998
41,S1100,MLN8054,Yes,,476.86,869363-13-3,free base,Aurora Kinase,MLN8054 is a potent and selective inhibitor of Aurora A with IC50 of 4 nM. It is more than 40-fold selective for Aurora A than Aurora B. Phase 1.,C1=C(C=C2C(=C1)C3=C(CN=C2C4=C(C=CC=C4F)F)C=NC(=N3)NC5=CC=C(C=C5)C(=O)O)Cl,199,http://www.selleckchem.com/products/MLN8054.html,Cell Cycle,K04234c,D7,L1200-1,0187172214,11712649
42,S1108,TAE684 (NVP-TAE684),,,614.2,761439-42-3,free base,ALK,"TAE684 is a potent and selective ALK inhibitor with IC50 of 3 nM, 100-fold more sensitive for ALK than InsR.",C1=CC(=CC(=C1NC2=NC=C(C(=N2)NC3=C(C=CC=C3)S(=O)(=O)C(C)C)Cl)OC)N4CCC(CC4)N5CCN(CC5)C,10,http://www.selleckchem.com/products/NVP-TAE684.html,Protein Tyrosine Kinase,K00937f,D8,L1200-1,0187172215,16038120
43,S1118,XL147,Yes,,448.52,956958-53-5,free base,PI3K,"XL147 is a selective and reversible class I PI3K inhibitor for PI3Kα/δ/γ with IC50 of 39 nM/36 nM/23 nM, less potent to PI3Kβ. Phase 1/2.",C1=CC=C2C(=C1)N=C(C(=N2)NS(=O)(=O)C3=CC=C(C=C3)C)NC4=CC5C(C=C4)=NSN=5,10,http://www.selleckchem.com/products/XL147.html,PI3K/Akt/mTOR,K04270b,D9,L1200-1,0187172216,1893730
44,S1009,"BEZ235 (NVP-BEZ235, Dactolisib)",Yes,,469.55,915019-65-7,free base,"PI3K,ATM/ATR,mTOR","BEZ235 (NVP-BEZ235) is a dual ATP-competitive PI3K and mTOR inhibitor for p110α/γ/δ/β and mTOR(p70S6K) with IC50 of 4 nM/5 nM/7 nM/75 nM/6 nM, respectively. Inhibits ATR with IC50 of 21 nM; shown to be poor inhibitory to Akt and PDK1. Phase 1/2.",C12=CN=C3C(=C1N(C(N2C)=O)C4=CC=C(C=C4)C(C#N)(C)C)C=C(C=C3)C5=CC6=C(N=C5)C=CC=C6,10,http://www.selleckchem.com/products/BEZ235.html,PI3K/Akt/mTOR,K04289b,E1,L1200-1,0187172207,11977753
45,S1147,Barasertib (AZD1152-HQPA),,,507.56,722544-51-6,free base,Aurora Kinase,"AZD1152-HQPA (Barasertib) is a highly selective Aurora B inhibitor with IC50 of 0.37 nM, ~100 fold more selective for Aurora B over Aurora A.",C1(=CC=C2C(=C1)N=CN=C2NC3NN=C(C=3)CC(NC4=CC=CC(=C4)F)=O)OCCCN(CCO)CC,200,http://www.selleckchem.com/products/AZD1152-HQPA.html,Cell Cycle,K04228c,E10,L1200-1,0187172198,16007391
46,S1171,CYC116,Yes,,368.46,693228-63-6,free base,"Aurora Kinase,VEGFR","CYC116 is a potent inhibitor of Aurora A/B with Ki of 8.0 nM/9.2 nM, is less potent to VEGFR2 (Ki of 44 nM), with 50-fold greater potency than CDKs, not active against PKA, Akt/PKB, PKC, no effect on GSK-3α/β, CK2, Plk1 and SAPK2A. Phase 1.",C1(=NC=CC(=N1)C2SC(=NC=2C)N)NC3=CC=C(C=C3)N4CCOCC4,65,http://www.selleckchem.com/products/CYC116.html,Cell Cycle,K06353a,E11,L1200-1,0187172197,6420138
47,S1010,Nintedanib (BIBF 1120),Yes,,539.62,656247-17-5,free base,"VEGFR,PDGFR,FGFR","Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and PDGFRα/β with IC50 of 34 nM/13 nM/13 nM, 69 nM/37 nM/108 nM and 59 nM/65 nM. Phase 3.",C1=C(C=C2C(=C1)/C(C(N2)=O)=C(\C3=CC=CC=C3)NC4=CC=C(C=C4)N(C)C(CN5CCN(CC5)C)=O)C(OC)=O,11,http://www.selleckchem.com/products/BIBF1120.html,Protein Tyrosine Kinase,K04315d,E12,L1200-1,No Tube,135423438
48,S1021,Dasatinib,Yes,Yes,488.01,302962-49-8,free base,"Bcr-Abl,c-Kit,Src","Dasatinib is a novel, potent and multi-targeted inhibitor that targets Abl, Src and c-Kit, with IC50 of ＜1 nM, 0.8 nM and 79 nM, respectively.",N1=C(N=C(C=C1NC2=NC=C(S2)C(NC3=C(C=CC=C3C)Cl)=O)N4CCN(CC4)CCO)C,200,http://www.selleckchem.com/products/Dasatinib.html,Angiogenesis,K00617e,E2,L1200-1,0187172206,3062316
49,S1034,NVP-AEW541,,,439.55,475489-16-8,free base,IGF-1R,"NVP-AEW541 is a potent inhibitor of IGF-1R with IC50 of 86 nM, 27-fold greater selectivity for IGF-1R than InsR.",C1=CC(=CC(=C1)OCC2=CC=CC=C2)C3=CN(C4=C3C(=NC=N4)N)[C@@H]5C[C@@H](C5)CN6CCC6,200,http://www.selleckchem.com/products/NVP-AEW541.html,Protein Tyrosine Kinase,K04992b,E3,L1200-1,0187172205,11476171
50,S1044,"Temsirolimus (CCI-779, NSC 683864)",Yes,Yes,1030.29,162635-04-3,free base,mTOR,Temsirolimus (CCI-779) is a specific mTOR inhibitor with IC50 of 1.76 μM.,[C@H]1(C[C@@H](CC[C@@H]1OC(C(CO)(CO)C)=O)C[C@H]([C@@H]2CC([C@@H](/C=C(/[C@H]([C@@H](OC)C([C@@H](C[C@@H](/C=C/C=C/C=C(/[C@H](C[C@]3(CC[C@H]([C@](C(C(N4[C@](C(O2)=O)(CCCC4)[H])=O)=O)(O3)O)C)[H])OC)C)C)C)=O)O)C)C)=O)C)OC,72,http://www.selleckchem.com/products/Temsirolimus.html,PI3K/Akt/mTOR,K06343a,E4,L1200-1,0187172204,6918289
51,S1066,SL-327,,,335.35,305350-87-2,free base,MEK,"SL327 is a selective inhibitor for MEK1/2 with IC50 of 0.18 μM/ 0.22 μM, no activity towards Erk1, MKK3, MKK4, c-JUN, PKC, PKA, or CamKII;capable of transport through the blood-brain barrier.",C1=CC=CC(=C1C(F)(F)F)/C(=C(/SC2=CC=C(C=C2)N)N)C#N,11,http://www.selleckchem.com/products/SL327.html,MAPK,K06453a,E5,L1200-1,0187172203,9549284
52,S1080,SU11274,,,568.09,658084-23-2,free base,c-Met,"SU11274 is a selective Met inhibitor with IC50 of 10 nM, no effects on PGDFRβ, EGFR or Tie2.",C1(=CC=CC(=C1)N(C)S(C2=CC3=C(C=C2)NC(C/3=C/C4NC(=C(C=4C)C(N5CCN(CC5)C)=O)C)=O)(=O)=O)Cl,161,http://www.selleckchem.com/products/SU11274.html,Protein Tyrosine Kinase,K00593c,E6,L1200-1,0187172202,9549297
53,S1101,Vatalanib (PTK787) 2HCl,Yes,,419.73,212141-51-0,dihydrochloride,"c-Kit,VEGFR","Vatalanib (PTK787) is an inhibitor of VEGFR2/KDR with IC50 of 37 nM, less potent against VEGFR1/Flt-1, 18-fold against VEGFR3/Flt-4. Phase 1/2.",C1(=CC=C2C(=C1)C(=NN=C2CC3=CC=NC=C3)NC4=CC=C(C=C4)Cl).Cl.Cl,202,"http://www.selleckchem.com/products/Vatalanib,Dihydrochloride-Salt.html",Protein Tyrosine Kinase,K00618b,E7,L1200-1,0187172201,22386467
54,S1109,BI 2536,Yes,,521.66,755038-02-9,free base,PLK,BI2536 is a potent Plk1 inhibitor with IC50 of 0.83 nM. It shows 4- and 11-fold greater selectivity against Plk2 and Plk3. Phase 2.,C1(=CC=C(C(=C1)OC)NC2=NC=C3C(=N2)N([C@@H](C(N3C)=O)CC)C4CCCC4)C(NC5CCN(CC5)C)=O,40,http://www.selleckchem.com/products/BI-2536.html,Cell Cycle,K03970d,E8,L1200-1,0187172200,11364421
55,S1119,"Cabozantinib (XL184, BMS-907351)",Yes,Yes,501.51,849217-68-1,free base,"FLT3,Tie-2,c-Kit,c-Met,VEGFR,Axl","Cabozantinib (XL184, BMS-907351) is a potent VEGFR2 inhibitor with IC50 of 0.035 nM and also inhibits c-Met, Ret, Kit, Flt-1/3/4, Tie2, and AXL with IC50 of 1.3 nM, 4 nM, 4.6 nM, 12 nM/11.3 nM/6 nM, 14.3 nM and 7 nM, respectively.",C12=C(C(=CC=N1)OC3=CC=C(C=C3)NC(C4(C(NC5=CC=C(C=C5)F)=O)CC4)=O)C=C(C(=C2)OC)OC,199,http://www.selleckchem.com/products/XL184.html,Protein Tyrosine Kinase,K04312c,E9,L1200-1,0187172199,25102847
56,S8058,P276-00,Yes,,438.3,920113-03-7,hydrochloride,CDK,"p276-00 is a novel CDK1, CDK4 and CDK9 inhibitor with IC50 of 79 nM, 63 nM and 20 nM, respectively.",C1(=CC(=C(C=C1)C2=CC(C3=C(O2)C(=C(C=C3O)O)[C@H]4[C@@H](N(CC4)C)CO)=O)Cl).Cl,200,https://www.selleckchem.com/products/p276-00.html,Cell Cycle,K06461a,F1,L1200-1,0187172184,23643975
57,S1152,PLX-4720,,,413.83,918505-84-7,free base,Raf,"PLX4720 is a potent and selective inhibitor of B-RafV600E with IC50 of 13 nM, equally potent to c-Raf-1(Y340D and Y341D mutations), 10-fold selectivity for B-RafV600E than wild-type B-Raf.",C1(=CN=C2C(=C1)C(=CN2)C(=O)C3=C(C(=CC=C3F)NS(=O)(=O)CCC)F)Cl,200,http://www.selleckchem.com/products/PLX-4720.html,MAPK,K05286b,F10,L1200-1,0187172193,24180719
58,S1173,WZ4002,,,494.18,1213269-23-8,free base,EGFR,"WZ4002 is a novel, mutant-selective EGFR inhibitor for EGFR(L858R)/(T790M) with IC50 of 2 nM/8 nM; does not inhibit ERBB2 phosphorylation (T798I).",C1(=CC(=C(C=C1)NC2=NC=C(C(=N2)OC3=CC(=CC=C3)NC(C=C)=O)Cl)OC)N4CCN(CC4)C,26,http://www.selleckchem.com/products/WZ4002.html,Protein Tyrosine Kinase,K05787b,F11,L1200-1,0187172194,44607530
59,S1003,Linifanib (ABT-869),Yes,,375.41,796967-16-3,free base,"CSF-1R,PDGFR,VEGFR","Linifanib (ABT-869) is a novel, potent ATP-competitive VEGFR/PDGFR inhibitor for KDR, CSF-1R, Flt-1/3 and PDGFRβ with IC50 of 4 nM, 3 nM, 3 nM/4 nM and 66 nM respectively, mostly effective in mutant kinase-dependent cancer cells (i.e. FLT3). Phase 3. ",C12=CC=CC(=C1C(=NN2)N)C3=CC=C(C=C3)NC(=O)NC4=C(C=CC(=C4)C)F,199,http://www.selleckchem.com/products/ABT-869.html,Protein Tyrosine Kinase,K04317c,F12,L1200-1,No Tube,11485656
60,S1022,"Ridaforolimus (Deforolimus, MK-8669)",Yes,,990.21,572924-54-0,free base,mTOR,"Ridaforolimus (Deforolimus) is a selective mTOR inhibitor with IC50 of 0.2 nM; while not classified as a prodrug, mTOR inhibition and FKBP12 binding is similar to rapamycin.",[C@H]1(C[C@@H](CC[C@@H]1OP(C)(=O)C)C[C@H]([C@@H]2CC([C@@H](/C=C(/[C@H]([C@@H](OC)C([C@@H](C[C@@H](/C=C/C=C/C=C(/[C@H](C[C@]3(CC[C@H]([C@](C(C(N4[C@](C(O2)=O)(CCCC4)[H])=O)=O)(O3)O)C)[H])OC)C)C)C)=O)O)C)C)=O)C)OC,199,http://www.selleckchem.com/products/Deforolimus.html,PI3K/Akt/mTOR,K06334a,F2,L1200-1,0187172185,11520894
61,S1035,Pazopanib HCl (GW786034 HCl),Yes,Yes,473.98,635702-64-6,hydrochloride,"VEGFR,PDGFR,c-Kit","Pazopanib (GW786034) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms with IC50 of 10 nM, 30 nM, 47 nM, 84 nM, 74 nM, 140 nM and 146 nM, respectively.",C1(=C(C(=CC(=C1)NC2=NC=CC(=N2)N(C3C=CC4C(C=3)=NN(C=4C)C)C)S(=O)(N)=O)C).Cl,35,http://www.selleckchem.com/products/Pazopanib-Hydrochloride.html,Protein Tyrosine Kinase,K06339a,F3,L1200-1,0187172186,11525740
62,S1046,Vandetanib (ZD6474),Yes,Yes,475.35,443913-73-3,free base,VEGFR,Vandetanib (ZD6474) is a potent inhibitor of VEGFR2 with IC50 of 40 nM.,C12=C(C(=NC=N1)NC3=C(C=C(C=C3)Br)F)C=C(C(=C2)OCC4CCN(CC4)C)OC,10,http://www.selleckchem.com/products/Vandetanib.html,Protein Tyrosine Kinase,K00934d,F4,L1200-1,0187172187,3081361
63,S1068,Crizotinib (PF-02341066),Yes,Yes,450.34,877399-52-5,free base,"c-Met,ALK","PF-2341066 (Crizotinib) is a potent inhibitor of c-Met and ALK with IC50 of 11 nM and 24 nM, respectivley.",C1(=CC(=C(N=C1)N)O[C@@H](C2=C(C=CC(=C2Cl)F)Cl)C)C3=CN(N=C3)C4CCNCC4,19,http://www.selleckchem.com/products/PF-2341066.html,Protein Tyrosine Kinase,K02784d,F5,L1200-1,0187172188,11626560
64,S1084,Brivanib (BMS-540215),Yes,,370.38,649735-46-6,free base,"FGFR,VEGFR","Brivanib is an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM, moderate potency against VEGFR-1 and FGFR-1, but >240-fold against PDGFR-β. Phase 3.",C12=C(C(=C(C=C1)OC3=NC=NN4C3=C(C(=C4)OC[C@@H](C)O)C)F)C=C(N2)C,199,http://www.selleckchem.com/products/Brivanib.html,Protein Tyrosine Kinase,K04321b,F6,L1200-1,0187172189,11234052
65,S1102,U0126-EtOH,,,426.56,1173097-76-1,ethanolat,MEK,"U0126-EtOH is a highly selective inhibitor of MEK1/2 with IC50 of 0.07 μM/0.06 μM, 100-fold higher affinity for ΔN3-S218E/S222D MEK than PD098059.",C1(=CC=C(C(=C1)SC(/N)=C(\C(=C(\SC2=C(C=CC=C2)N)N)C#N)C#N)N).CCO,199,http://www.selleckchem.com/products/U0126.html,MAPK,K05710b,F7,L1200-1,0187172190,16220066
66,S1111,Foretinib (GSK1363089),Yes,,632.65,849217-64-7,free base,"VEGFR,c-Met","Foretinib (GSK1363089) is an ATP-competitive inhibitor of HGFR and VEGFR, mostly for Met and KDR with IC50 of 0.4 nM and 0.9 nM. Less potent against Ron, Flt-1/3/4, Kit, PDGFRα/β and Tie-2, and little activity to FGFR1 and EGFR. Phase 2.",C1(=CC=C(C=C1)F)NC(C2(C(NC3=CC(=C(C=C3)OC4C5=C(N=CC=4)C=C(C(=C5)OC)OCCCN6CCOCC6)F)=O)CC2)=O,200,"http://www.selleckchem.com/products/XL880(GSK1363089,EXEL-2880).html",Protein Tyrosine Kinase,K04300c,F8,L1200-1,0187172191,42642645
67,S1120,Everolimus (RAD001),Yes,Yes,958.22,159351-69-6,free base,mTOR,Everolimus (RAD001) is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM.,C(O)CO[C@H]1[C@@H](C[C@@H](CC1)C[C@@H]([C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C([C@]4([C@@H](CC[C@H](O4)C[C@@H](/C(=C/C=C/C=C/[C@H](C[C@H](C([C@@H]([C@@H](O)/C(=C/[C@H](C(C2)=O)C)C)OC)=O)C)C)C)OC)C)O)=O)C)OC,31,http://www.selleckchem.com/products/Everolimus(RAD001).html,PI3K/Akt/mTOR,K06349a,F9,L1200-1,0187172192,6442177
68,S1011,Afatinib (BIBW2992),Yes,Yes,485.94,439081-18-2,free base,"EGFR,HER2","Afatinib (BIBW2992) irreversibly inhibits EGFR/HER2 including EGFR(wt), EGFR(L858R), EGFR(L858R/T790M) and HER2 with IC50 of 0.5 nM, 0.4 nM, 10 nM and 14 nM, respectively; 100-fold more active against Gefitinib-resistant L858R-T790M EGFR mutant. Phase 3.",C1(=C(C=C(C=C1)NC2=NC=NC3=C2C=C(C(=C3)O[C@H]4CCOC4)NC(/C=C/CN(C)C)=O)Cl)F,199,http://www.selleckchem.com/products/BIBW2992.html,Protein Tyrosine Kinase,K04279b,G1,L1200-1,0187172183,10184653
69,S1153,"Roscovitine (Seliciclib,CYC202)",Yes,,354.45,186692-46-6,free base,CDK,"Roscovitine (Seliciclib, CYC202) is a potent and selective CDK inhibitor for Cdc2, CDK2 and CDK5 with IC50 of 0.65 μM, 0.7 μM and 0.16 μM. It shows little effect on CDK4/6. Phase 2.",N1=C2C(=C(N=C1N[C@@H](CO)CC)NCC3=CC=CC=C3)N=CN2C(C)C,200,http://www.selleckchem.com/products/Roscovitine.html,Cell Cycle,K00020e,G10,L1200-1,0187172174,160355
70,S1177,PD98059,,,267.28,167869-21-8,free base,MEK,"PD98059 is a non-ATP competitive MEK inhibitor with IC50 of 2 μM, specifically inhibits MEK-1-mediated activation of MAPK; does not directly inhibit ERK1 or ERK2.",C1=CC=C2C(=C1)C(C=C(O2)C3=CC=CC(=C3N)OC)=O,71,http://www.selleckchem.com/products/PD-98059.html,MAPK,K00023c,G11,L1200-1,0187172173,4713
71,S1018,"Dovitinib (TKI-258, CHIR-258)",Yes,,392.43,405169-16-6,citrate,"FGFR,FLT3,c-Kit,VEGFR,PDGFR","Dovitinib (TKI258, CHIR258) is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit) with IC50 of 1 nM/2 nM, also potent to class IV (FGFR1/3) and class V (VEGFR1-4) RTKs with IC50 of 8-13 nM, less potent to InsR, EGFR, c-Met, EphA2, Tie2, IGF-1R and HER2. Phase 4.",C1=CC=C(C2=C1NC(C(=C2N)C3NC4=C(N=3)C=CC(=C4)N5CCN(CC5)C)=O)F,76,http://www.selleckchem.com/products/CHIR-258.html,Angiogenesis,K00994b,G12,L1200-1,No Tube,135398510
72,S1023,Erlotinib HCl (OSI-744),Yes,Yes,429.9,183319-69-9,hydrochloride,"Autophagy,EGFR","Erlotinib HCl (OSI-744) is an EGFR inhibitor with IC50 of 2 nM, >1000-fold more sensitive for EGFR than human c-Src or v-Abl. Phase 3.",C1(=CC=CC(=C1)C#C)NC2(=NC=NC3=C2C=C(C(=C3)OCCOC)OCCOC)C.Cl,10,http://www.selleckchem.com/products/Erlotinib-Hydrochloride.html,Protein Tyrosine Kinase,K06335a,G2,L1200-1,0187172182,176871
73,S1036,PD0325901,Yes,,482.19,391210-10-9,free base,MEK,"PD0325901 (PD325901) is selective and non ATP-competitive MEK inhibitor with IC50 of 0.33 nM, roughly 500-fold more potent than CI-1040 on phosphorylation of ERK1 and ERK2. Phase 1/2.",C1=CC(=C(C(=C1C(=O)NOC[C@H](O)CO)NC2=CC=C(C=C2F)I)F)F,199,http://www.selleckchem.com/products/PD-0325901.html,MAPK,K05709b,G3,L1200-1,0187172181,9826528
74,S1048,"VX-680 (Tozasertib, MK-0457)",Yes,,464.59,639089-54-6,free base,Aurora Kinase,"VX-680 (Tozasertib, MK-0457) is a pan-Aurora inhibitor, mostly against Aurora A with Kiapp of 0.6 nM, less potent towards Aurora B/Aurora C and 100-fold more selective for Aurora A than 55 other kinases. Phase 2.",C1(=CC(=NC(=N1)SC2=CC=C(C=C2)NC(=O)C3CC3)N4CCN(CC4)C)NC5C=C(NN=5)C,200,http://www.selleckchem.com/products/VX-680(MK-0457).html,Cell Cycle,K00625d,G4,L1200-1,0187172180,5494449
75,S1070,PHA-665752,,,641.61,477575-56-7,free base,c-Met,"PHA-665752 is a potent, selective and ATP-competitive c-Met inhibitor with IC50 of 9 nM,  >50-fold selectivity for c-Met than RTKs or STKs.",C1=CC=C(C(=C1Cl)CS(C2=CC3=C(C=C2)NC(C/3=C/C4=C(C(=C(N4)C)C(N5[C@H](CCC5)CN6CCCC6)=O)C)=O)(=O)=O)Cl,199,http://www.selleckchem.com/products/PHA-665752.html,Protein Tyrosine Kinase,K06413a,G5,L1200-1,0187172179,10461815
76,S1088,NVP-ADW742,,,453.58,475488-23-4,free base,IGF-1R,"NVP-ADW742 is an IGF-1R inhibitor with IC50 of 0.17 μM, >16-fold more potent against IGF-1R than InsR;  little activity to HER2, PDGFR, VEGFR-2, Bcr-Abl and c-Kit.",C12=C(N=CN=C1N)N(C=C2C3=CC(=CC=C3)OCC4=CC=CC=C4)[C@@H]5C[C@H](C5)CN6CCCC6,22,http://www.selleckchem.com/products/NVP-ADW742.html,Protein Tyrosine Kinase,K04993b,G6,L1200-1,0187172178,9825149
77,S1103,ZM 447439,,,513.59,331771-20-1,free base,Aurora Kinase,"ZM 447439 is a selective and ATP-competitive inhibitor for Aurora A and Aurora B with IC50 of 110 nM and 130 nM, respectively. It is more than 8-fold selective for Aurora A/B than MEK1, Src, Lck and has little effect againstCDK1/2/4, Plk1, Chk1, etc.",O1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CN=C3NC4=CC=C(C=C4)NC(=O)C5=CC=CC=C5)OC,200,http://www.selleckchem.com/products/ZM-447439.html,Cell Cycle,K04241b,G7,L1200-1,0187172177,9914412
78,S1112,SGX-523,Yes,,359.41,1022150-57-7,free base,c-Met,"SGX-523 is a selective Met inhibitor with IC50 of 4 nM, no activity to BRAFV599E, c-Raf, Abl and p38α. Phase 1.",C1=C2C(=CC(=C1)SC3N4C(=NN=3)C=CC(=N4)C5C=NN(C=5)C)C=CC=N2,10,http://www.selleckchem.com/products/SGX-523.html,Protein Tyrosine Kinase,K06347a,G8,L1200-1,0187172176,24779724
79,S1124,BMS-754807,Yes,,461.49,1001350-96-4,free base,"IGF-1R,Trk receptor,c-Met","BMS-754807 is a potent and reversible inhibitor of IGF-1R/InsR with IC50 of 1.8 nM/1.7 nM, less potent to Met, Aurora A/B, TrkA/B and Ron, and shows little activity to Flt3, Lck, MK2, PKA, PKC etc. Phase 1/2.",C12N(N=C(N=C1NC3C=C(NN=3)C4CC4)N5CCC[C@]5(C)C(=O)NC6=CC=C(N=C6)F)C=CC=2,199,http://www.selleckchem.com/products/BMS-754807.html,Protein Tyrosine Kinase,K04265c,G9,L1200-1,0187172175,24785538
80,S1014,Bosutinib (SKI-606),Yes,Yes,530.45,380843-75-4,free base,Src,"Bosutinib (SKI-606) is a novel, dual Src/Abl inhibitor with IC50 of 1.2 nM and 1 nM, respectively.",N1=CC(=C(C2=CC(=C(C=C12)OCCCN3CCN(CC3)C)OC)NC4C(=CC(=C(C=4)OC)Cl)Cl)C#N,188,http://www.selleckchem.com/products/Bosutinib.html,Angiogenesis,K00615e,H1,L1200-1,0187172160,5328940
81,S1154,SNS-314 Mesylate,,,527.04,1146618-41-8,mesylate,Aurora Kinase,"SNS-314 Mesylate is a potent and selective inhibitor of Aurora A, Aurora B and Aurora C with IC50 of 9 nM, 31 nM, and 3 nM, respectively. It is less potent to Trk A/B, Flt4, Fms, Axl, c-Raf and DDR2. Phase 1.",C12(=C(N=CN=C1NCCC3SC(=NC=3)NC(NC4=CC(=CC=C4)Cl)=O)C=CS2).CS(=O)(=O)O,199,http://www.selleckchem.com/products/SNS-314.html,Cell Cycle,K04239b,H10,L1200-1,0187172169,24995523
82,S1178,Regorafenib (BAY 73-4506),Yes,Yes,482.82,755037-03-7,free base,"c-RET,VEGFR","Regorafenib (BAY 73-4506) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFRβ, Kit, RET and Raf-1 with IC50 of 13 nM/4.2 nM/46 nM, 22 nM, 7 nM, 1.5 nM and 2.5 nM, respectively.",C1=NC(=CC(=C1)OC2=CC(=C(C=C2)NC(NC3=CC=C(C(=C3)C(F)(F)F)Cl)=O)F)C(=O)NC,200,http://www.selleckchem.com/products/BAY-73-4506.html,Protein Tyrosine Kinase,K04291d,H11,L1200-1,0187172170,11167602
83,S1025,Gefitinib (ZD1839),Yes,Yes,446.9,184475-35-2,free base,EGFR,"Gefitinib (ZD-1839) is an EGFR inhibitor for Tyr1173, Tyr992, Tyr1173 and Tyr992 in the NR6wtEGFR and NR6W cells with IC50 of 37 nM, 37nM, 26 nM and 57 nM, respectively.",C1(=C(C=C2C(=C1)N=CN=C2NC3=CC=C(C(=C3)Cl)F)OCCCN4CCOCC4)OC,199,http://www.selleckchem.com/products/Gefitinib.html,Protein Tyrosine Kinase,K00240c,H2,L1200-1,0187170674,123631
84,S1038,PI-103,,,348.36,371935-74-9,free base,"PI3K,Autophagy,DNA-PK,mTOR","PI-103 is a multi-targeted PI3K inhibitor for p110α/β/δ/γ with IC50 of 2 nM/3 nM/3 nM/15 nM, less potent to mTOR/DNA-PK with IC50 of 30 nM/23 nM.",C12=C(N=C(N=C1N3CCOCC3)C4=CC=CC(=C4)O)C5=C(O2)N=CC=C5,68,http://www.selleckchem.com/products/PI-103.html,PI3K/Akt/mTOR,K00623b,H3,L1200-1,0187172162,9884685
85,S1049,Y-27632 2HCl,,,320.26,129830-38-2,dihydrochloric,"Autophagy,ROCK","Y-27632 2HCl is a selective ROCK1 (p160ROCK) inhibitor with Ki of 140 nM, exhibits >200-fold selectivity over other kinases, including PKC, cAMP-dependent protein kinase, MLCK and PAK.",[C@@H]1(CC[C@@H](CC1)[C@@H](C)N)C(=O)NC2(C=CN=CC=2).Cl.Cl,199,http://www.selleckchem.com/products/Y-27632.html,Cell Cycle,K06241b,H4,L1200-1,0187172163,9901617
86,S1072,ZSTK474,Yes,,417.41,475110-96-4,free base,PI3K,"ZSTK474 inhibits class I PI3Kisoforms with IC50 of 37 nM, mostly PI3Kδ. ",N1=C(N=C(N=C1N2CCOCC2)N3C4=C(N=C3C(F)F)C=CC=C4)N5CCOCC5,50,http://www.selleckchem.com/products/ZSTK474.html,PI3K/Akt/mTOR,K00860d,H5,L1200-1,0187172164,11647372
87,S1091,OSI-906 (Linsitinib),Yes,,421.49,867160-71-2,free base,IGF-1R,"OSI-906 (Linsitinib) is a selective inhibitor of IGF-1R with IC50 of 35 nM; modestly potent to InsR with IC50 of 75 nM, and no activity towards Abl, ALK, BTK, EGFR, FGFR1/2, PKA etc. Phase 3.",C1=C(C=C2C(=C1)C=CC(=N2)C3=CC=CC=C3)C4=C5N(C(=N4)[C@H]6C[C@@](C6)(C)O)C=CN=C5N,199,http://www.selleckchem.com/products/OSI-906.html,Protein Tyrosine Kinase,K04260c,H6,L1200-1,0187172165,11640390
88,S1104,GDC-0879,,,334.37,905281-76-7,free base,Raf,"GDC-0879 is a novel, potent, and selective B-Raf inhibitor with IC50 of 0.13 nM with activity against c-Raf as well; no inhibition known to other protein kinases.",C(CN1N=C(C(=C1)C2=CC=C3C(=C2)CCC/3=N/O)C4C=CN=CC=4)O,200,http://www.selleckchem.com/products/GDC-0879.html,MAPK,K05285b,H7,L1200-1,0187172166,11717001
89,S1113,GSK690693,Yes,,425.48,937174-76-0,free base,Akt,"GSK690693 is a pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 2 nM/13 nM/9 nM, also sensitive to the AGC kinase family: PKA, PrkX and PKC isozymes. Phase 1.",C12=C(C(=CN=C1C#CC(C)(O)C)OC[C@@H]3CNCCC3)N(C(=N2)C4C(=NON=4)N)CC,91,http://www.selleckchem.com/products/GSK690693.html,PI3K/Akt/mTOR,Z01012b,H8,L1200-1,0187172167,16725726
90,S1133,Alisertib (MLN8237),Yes,,518.92,1028486-01-2,free base,Aurora Kinase,Alisertib (MLN8237) is a selective Aurora A inhibitor with IC50 of 1.2 nM. It has >200-fold higher selectivity for Aurora A than Aurora B. Phase 3.,C1=CC=C(C(=C1OC)C2=NCC3=C(C4=C2C=C(C=C4)Cl)N=C(N=C3)NC5=CC(=C(C=C5)C(O)=O)OC)F,52,http://www.selleckchem.com/products/MLN8237.html,Cell Cycle,K04263e,H9,L1200-1,0187172168,24771867
91,S1179,WZ8040,,,481.01,1214265-57-2,free base,EGFR,"WZ8040 is a novel mutant-selective irreversible EGFRT790M inhibitor, does not inhibit ERBB2 phosphorylation (T798I).",C1(=CC=C(C=C1)NC2=NC=C(C(=N2)SC3=CC(=CC=C3)NC(C=C)=O)Cl)N4CCN(CC4)C,199,http://www.selleckchem.com/products/WZ8040.html,Protein Tyrosine Kinase,K06354a,A1,L1200-2,0187170718,44607531
92,S2183,BGJ398 (NVP-BGJ398),Yes,,560.48,872511-34-7,free base,FGFR,"BGJ398 (NVP-BGJ398) is a potent and selective FGFR inhibitor for FGFR1/2/3 with IC50 of 0.9 nM/1.4 nM/1 nM, >40-fold selective for FGFR versus FGFR4 and VEGFR2, and little activity to Abl, Fyn, Kit, Lck, Lyn and Yes. Phase 2.",N(C(=O)NC1C(=C(C=C(C=1Cl)OC)OC)Cl)(C)C2N=CN=C(C=2)NC3C=CC(=CC=3)N4CCN(CC4)CC,10,http://www.selleckchem.com/products/bgj398-nvp-bgj398.html,Angiogenesis,K04345b,A10,L1200-2,0187172822,53235510
93,S2205,OSI-420,,Yes,415.87,183320-51-6,hydrochloride,EGFR,OSI-420 is the active metabolite of Erlotinib (EGFR inhibitor with IC50 of 2 nM).,C1(=C(C=CC=C1NC2=NC=NC3=C2C=C(C(=C3)OCCOC)OCCO)C#C).Cl,199,"http://www.selleckchem.com/products/OSI-420-Desmethyl-Erlotinib,CP-473420.html",Protein Tyrosine Kinase,K06385a,A11,L1200-2,0187172821,18924996
94,S1234,AG-1024 ,,,305.17,65678-07-1,free base,IGF-1R,"AG-1024 (Tyrphostin) inhibits IGF-1R autophosphorylation with IC50 of 7 μM, is less potent to IR with IC50 of 57 μM and specifically distinguishes between InsR and IGF-1R (as compared to other tyrphostins).",C(C(C#N)=CC1C=C(C(=C(C=1)C(C)(C)C)O)Br)#N,199,http://www.selleckchem.com/products/ag-1024-tyrphostin.html,Protein Tyrosine Kinase,K02599c,A2,L1200-2,0187170673,2044
95,S1314,Zoledronic Acid ,Yes,Yes,272.09,118072-93-8,free base,Rac,Zoledronic acid induces apoptosis in osteoclasts by inhibiting enzymes of the mevalonate pathway and preventing the isoprenylation of small GTP-binding proteins such as Ras and Rho.,C1=NC=CN1CC(O)(P(=O)(O)O)P(=O)(O)O,10,http://www.selleckchem.com/products/Zoledronic-Acid.html,Cell Cycle,S00092b,A3,L1200-2,0187172829,68740
96,S1392,Pelitinib (EKB-569),Yes,,467.92,257933-82-7,free base,EGFR,Pelitinib (EKB-569) is a potent irreversible EGFR inhibitor with IC50 of 38.5 nM. Phase2.,C1(=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(/C=C/CN(C)C)=O)OCC,27,http://www.selleckchem.com/products/Pelitinib.html,Protein Tyrosine Kinase,K06364a,A4,L1200-2,0187172828,6445562
97,S1474,GSK429286A,,,432.37,864082-47-3,free base,ROCK,"GSK429286A is a selective inhibitor of ROCK1 and ROCK2 with IC50 of 14 nM and 63 nM, respectively.",C1(CC(C(=C(N1)C)C(NC2=C(C=C3C(=C2)C=NN3)F)=O)C4=CC=C(C=C4)C(F)(F)F)=O,201,http://www.selleckchem.com/products/GSK429286A.html,Cell Cycle,K04854b,A5,L1200-2,0187172827,11373846
98,S1519,CCT129202,,,497.02,942947-93-5,free base,Aurora Kinase,"CCT129202 is an ATP-competitive pan-Aurora inhibitor for Aurora A, Aurora B and Aurora C with IC50 of 0.042 μM, 0.198 μM and 0.227 μM, respectively. It is less potent to FGFR3, GSK3β, PDGFRβ, etc.",C1(=CN=C2C(=C1N3CCN(CC3)CC(NC4SC=CN=4)=O)N=C(N2)C5=CC=C(C=C5)N(C)C)Cl,10,http://www.selleckchem.com/products/CCT129202.html,Cell Cycle,K06370a,A6,L1200-2,0187172826,16202152
99,S1533,R406 (free base),,,470.45,841290-80-0,free base,Syk,"R406 (free base) is a potent Syk inhibitor with IC50 of 41 nM, strongly inhibits Syk but not Lyn, 5-fold less potent to Flt3. Phase 2.",C1(=C(C=C(C=C1OC)NC2=NC(=C(C=N2)F)NC3=NC4=C(C=C3)OC(C(N4)=O)(C)C)OC)OC,44,http://www.selleckchem.com/products/R406(free-base).html,Angiogenesis,K05777b,A7,L1200-2,0187172825,11213558
100,S1570,KU-60019,,,547.67,925701-49-1,free base,ATM/ATR,"KU-60019 is an improved analogue of KU-55933, with IC50 of 6.3 nM for ATM, 270- and 1600-fold more selective for ATM than DNA-PK and ATR,and is a highly effective radiosensitizer.",C1=C(C=CC2=C1CC3=C(S2)C(=CC=C3)C4=CC(C=C(O4)N5CCOCC5)=O)NC(CN6C[C@@H](O[C@@H](C6)C)C)=O,73,http://www.selleckchem.com/products/KU-60019.html,DNA Damage,K06378a,A8,L1200-2,0187172824,15953870
101,S2013,PF-573228,,,491.49,869288-64-2,free base,FAK,"PF-573228 is an ATP-competitive inhibitor of FAK with IC50 of 4 nM, ~50- to 250-fold selective for FAK than Pyk2, CDK1/7 and GSK-3β.",N1C(CCC2C=C(C=CC1=2)NC3N=C(C(=CN=3)C(F)(F)F)NCC4C=C(C=CC=4)S(=O)(=O)C)=O,52,http://www.selleckchem.com/products/pf-573228.html,Angiogenesis,K00964d,A9,L1200-2,0187172823,11612883
102,S1181,ENMD-2076,Yes,,375.47,934353-76-1,tartaric acid,"Aurora Kinase,FLT3,VEGFR","ENMD-2076 has selective activity against Aurora A and Flt3 with IC50 of 14 nM and 1.86 nM, 25-fold selective for Aurora A than over Aurora B and less potent to VEGFR2/KDR and VEGFR3, FGFR1 and FGFR2 and PDGFRα. Phase 2.",C1(N=C(C=C(N=1)N2CCN(CC2)C)NC3=NNC(=C3)C)/C=C/C4C=CC=CC=4,279,http://www.selleckchem.com/products/ENMD-2076.html,Angiogenesis,K06355a,B1,L1200-2,0187172808,16041424
103,S2185,AST-1306,,,621.08,1050500-29-2,mesylate,EGFR,"AST-1306 is a novel irreversible inhibitor of EGFR and ErbB2 with IC50 of 0.5 nM and 3 nM, also effective in mutation EGFR T790M/L858R, more potent to ErbB2-overexpressing cells, 3000-fold selective for ErbB family than other kinases,  ",C(C=C)(=O)NC1(=CC2=C(N=CN=C(C=C1)2)NC3C=C(C(=CC=3)OCC4C=C(C=CC=4)F)Cl).C5=CC(=CC=C5S(O)(=O)=O)C,199,http://www.selleckchem.com/products/ast-1306.html,Protein Tyrosine Kinase,K06430a,B10,L1200-2,0187172817,25027665
104,S2207,PIK-293,,,397.43,900185-01-5,free base,PI3K,"PIK-293 is a PI3K inhibitor, mostly for PI3Kδ with IC50 of 0.24 μM, 500-, 100- and 50-fold less potent to PI3Kα/β/γ, respectively.",C1(N(C(C2=C(N=1)C=CC=C2C)=O)C3=C(C=CC=C3)C)CN4N=CC5=C4N=CN=C5N,201,http://www.selleckchem.com/products/PIK-293.html,PI3K/Akt/mTOR,K06386a,B11,L1200-2,0187172818,53245636
105,S1244,Amuvatinib (MP-470),Yes,,447.51,850879-09-3,free base,"FLT3,c-RET,PDGFR,c-Kit","Amuvatinib (MP-470) is a potent and multi-targeted inhibitor of c-Kit, PDGFRα and Flt3 with IC50 of 10 nM, 40 nM and 81 nM, respectively. Phase 2.",C1=CC=C2C(=C1)C3=C(O2)C(=NC=N3)N4CCN(CC4)C(=S)NCC5=CC=C6C(=C5)OCO6,71,http://www.selleckchem.com/products/MP-470.html,Protein Tyrosine Kinase,K04366b,B2,L1200-2,0187170697,11282283
106,S1342,Genistein,Yes,Yes,270.24,446-72-0,free base,"Topoisomerase,EGFR","Genistein, a phytoestrogen found in soy products, is a highly specific inhibitor of protein tyrosine kinase (PTK)  which blocks the mitogenic effect mediated by EGF on NIH-3T3 cells with IC50 of 12μM or by insulin with IC50 of 19 μM. ",C1(=CC2=C(C(=C1)O)C(C(=CO2)C3=CC=C(C=C3)O)=O)O,199,http://www.selleckchem.com/products/Genistein.html,Protein Tyrosine Kinase,K00046c,B3,L1200-2,0187172810,5280961
107,S1451,Aurora A Inhibitor I,,,588.07,1158838-45-9,free base,Aurora Kinase,"Aurora A Inhibitor I is a novel, potent, and selective inhibitor of Aurora A with IC50 of 3.4 nM. It is 1000-fold more selective for Aurora A than Aurora B.",N1=CC(=C(N=C1NC2=CC=C(C=C2)CC(N3CCN(CC3)CC)=O)NC4=CC=C(C=C4)C(NC5=CC=CC=C5Cl)=O)F,200,http://www.selleckchem.com/products/Aurora-A-Inhibitor-I.html,Cell Cycle,K06365a,B4,L1200-2,0187172811,44139710
108,S1475,Pimasertib (AS-703026),Yes,,431.2,1236699-92-5,free base,MEK,"AS-703026 is a highly selective, potent, ATP non-competitive allosteric inhibitor of MEK1/2 with IC50 of 5 nM-2 μM in MM cell lines. Phase 1/2.",C1=C(C=CC(=C1F)NC2=CN=CC=C2C(NC[C@@H](CO)O)=O)I,199,http://www.selleckchem.com/products/AS703026.html,MAPK,K04271b,B5,L1200-2,0187172812,44187362
109,S1523,SAR245409 (XL765),Yes,,599.66,1349796-36-6,free base,"PI3K,mTOR","SAR245409 (XL765) is a dual inhibitor of mTOR/PI3K, mostly for p110γ with IC50 of 9 nM; also inhibits DNA-PK and mTOR. Phase 1/2.",C12=CC=CC=C1N=C(C(=N2)NC3=CC(=CC(=C3)OC)OC)NS(C4=CC=C(C=C4)NC(=O)C5=CC=C(C(=C5)OC)C)(=O)=O,20,http://www.selleckchem.com/products/XL765(SAR245409).html#,PI3K/Akt/mTOR,K04294b,B6,L1200-2,0187172813,49867926
110,S1536,CP-673451,,,417.5,343787-29-1,free base,PDGFR,"CP 673451 is a selective inhibitor of PDGFRα/β with IC50 of 10 nM/1 nM, exhibits >450-fold selectivity over other angiogenic receptors, has antiangiogenic and antitumor activity.",C1=CC(=C2C(=C1)C=CC(=N2)N3C4=CC=C(C=C4N=C3)OCCOC)N5CCC(CC5)N,100,http://www.selleckchem.com/products/CP-673451.html,Protein Tyrosine Kinase,K06439a,B7,L1200-2,0187172814,10158940
111,S1572,BS-181 HCl,,,416.99,1397219-81-6 ,hydrochloride,CDK,"BS-181 is a highly selective CDK7 inhibitor with IC50 of 21 nM. It is more than 40-fold selective for CDK7 than CDK1, 2, 4, 5, 6, or 9.",C1(=CC(=NC2N1N=CC=2C(C)C)NCCCCCCN)NCC3(=CC=CC=C3).Cl,199,http://www.selleckchem.com/products/BS-181.html,Cell Cycle,K04227b,B8,L1200-2,0187172815,49867928
112,S2014,BMS-265246,,,345.34,582315-72-8,free base,CDK,BMS-265246 is a potent and selective CDK1/2 inhibitor with IC50 of 6 nM/9 nM. It is 25-fold more selective for CDK1/2 than CDK4.,C(=O)(C1C(=CC(=CC=1F)C)F)C2C(=C3C(=NC=2)NN=C3)OCCCC,57,http://www.selleckchem.com/products/bms-265246.html,Cell Cycle,K06431a,B9,L1200-2,0187172816,135402864
113,S1194,CUDC-101,Yes,,434.49,1012054-59-9,free base,"HDAC,HER2,EGFR","CUDC-101 is a potent multi-targeted inhibitor against HDAC, EGFR and HER2 with IC50 of 4.4 nM, 2.4 nM, and 15.7 nM, and inhibits class I/II HDACs, but not class III, Sir-type HDACs. Phase 1.",C12=C(N=CN=C1NC3=CC(=CC=C3)C#C)C=C(C(=C2)OCCCCCCC(NO)=O)OC,46,http://www.selleckchem.com/products/CUDC-101.html,Epigenetics,K04273b,C1,L1200-2,0187172807,24756910
114,S2192,AZD8931 (Sapitinib),Yes,,473.93,848942-61-0,free base,"HER2,EGFR","AZD8931 is a reversible, ATP competitive inhibitor of EGFR, ErbB2 and ErbB3 with IC50 of 4 nM, 3 nM and 4 nM, more potent than Gefitinib or Lapatinib against NSCLC cell, 100-fold more selective for the ErbB family than MNK1 and Flt. Phase 1/2.",C1(=C(C=C2C(=C1)C(=NC=N2)NC3=C(F)C(=CC=C3)Cl)OC)OC4CCN(CC4)CC(NC)=O,84,http://www.selleckchem.com/products/AZD8931.html,Protein Tyrosine Kinase,K06382a,C10,L1200-2,0187172798,11488320
115,S2214,AZ 960,,,354.36,905586-69-8,free base,JAK,"AZ 960 is a novel ATP competitive JAK2 inhibitor with IC50 and Ki of <3 nM and 0.45 nM, 3-fold selectivity of AZ960 for JAK2 over JAK3.",C1=C(C(=NC(=C1F)NC2C=C(NN=2)C)N[C@H](C3=CC=C(C=C3)F)C)C#N,200,http://www.selleckchem.com/products/AZ-960.html,JAK/STAT,K06387a,C11,L1200-2,0187172797,25099184
116,S1249,JNJ-7706621,,,394.36,443797-96-4,free base,"CDK,Aurora Kinase",JNJ-7706621 is pan-CDK inhibitor with the highest potency on CDK1/2 with IC50 of 9 nM/4 nM and showing >6-fold selectivity for CDK1/2 than CDK3/4/6. It also potently inhibits Aurora A/B and has no activity on Plk1 and Wee1.,C1(=CC=C(C=C1)NC2N=C(N(N=2)C(C3=C(C=CC=C3F)F)=O)N)S(N)(=O)=O,200,http://www.selleckchem.com/products/JNJ-7706621.html,Cell Cycle,K00616d,C2,L1200-2,0187172806,5330790
117,S1352,TG100-115,Yes,,346.34,677297-51-7,free base,PI3K,"TG100115 is a PI3Kγ/δ inhibitor with IC50 of 83 nM/235 nM, with little effect on PI3Kα/β. Phase 1/2.",C1(=C(N=C2C(=N1)C(=NC(=N2)N)N)C3=CC=CC(=C3)O)C4=CC(=CC=C4)O,25,http://www.selleckchem.com/products/TG100-115.html,PI3K/Akt/mTOR,K06360a,C3,L1200-2,0187172805,10427712
118,S1454,PHA-680632,,,501.62,398493-79-3,free base,Aurora Kinase,"PHA-680632 is potent inhibitor of Aurora A, Aurora B and Aurora C with IC50 of 27 nM, 135 nM and 120 nM, respectively. It has 10- to 200-fold higher IC50 for FGFR1, FLT3, LCK, PLK1, STLK2, and VEGFR2/3. ",C1(=CC=C(C=C1)C(=O)NC2C3=C(NN=2)CN(C3)C(=O)NC4=C(C=CC=C4CC)CC)N5CCN(CC5)C,199,http://www.selleckchem.com/products/PHA-680632.html,Cell Cycle,K04236b,C4,L1200-2,0187172804,11249084
119,S1485,HMN-214,,,424.47,173529-46-9,free base,PLK,"HMN-214 is a prodrug of HMN-176, which alters the cellular spatial orientation of Plk1.",C1=CC=CC(=C1N(S(C2=CC=C(C=C2)OC)(=O)=O)C(C)=O)/C=C/C3=CC=[N+](C=C3)[O-],28,http://www.selleckchem.com/products/HMN-214.html,Cell Cycle,K06367a,C5,L1200-2,0187172803,9888590
120,S1524,AT7519,Yes,,382.24,844442-38-2,free base,CDK,"AT7519 is a multi-CDK inhibitor for CDK1, 2, 4, 6 and 9 with IC50 of 10-210 nM. It is less potent to CDK3 and little active to CDK7. Phase 1.",C1=C(C(=C(C=C1)Cl)C(NC2=CNN=C2C(=O)NC3CCNCC3)=O)Cl,26,http://www.selleckchem.com/products/AT7519.html,Cell Cycle,K05651b,C6,L1200-2,0187172802,11338033
121,S1555,AZD8055,Yes,,465.54,1009298-09-2,free base,mTOR,"AZD8055 is a novel ATP-competitive mTOR inhibitor with IC50 of 0.8 nM with excellent selectivity (∼1,000-fold) against PI3K isoforms and ATM/DNA-PK. Phase 1.",C1(=C(C=CC(=C1)C2=NC3=C(C=C2)C(=NC(=N3)N4[C@H](COCC4)C)N5[C@H](COCC5)C)OC)CO,199,http://www.selleckchem.com/products/AZD8055.html,PI3K/Akt/mTOR,K04264b,C7,L1200-2,0187172801,25262965
122,S1573,Fasudil (HA-1077) HCl,Yes,,327.83,105628-07-7,hydrochloride,"ROCK,Autophagy","Fasudil (HA-1077) is a potent inhibitor of ROCK-II, PKA,  PKG,  PKC, and MLCK with Ki of 0.33 μM, 1.6 μM, 1.6 μM, 3.3 μM and 36 μM, respectively.  ",C1(=C2C(=C(C=C1)S(N3CCNCCC3)(=O)=O)C=CN=C2).Cl,15,http://www.selleckchem.com/products/Fasudil-HCl(HA-1077).html,Cell Cycle,K05958b,C8,L1200-2,0187172800,163751
123,S2134,AZD8330,Yes,,461.23,869357-68-6,free base,MEK,"AZD8330 is a novel, selective, non-ATP competitive MEK 1/2 inhibitor with IC50 of 7 nM. Phase 1.",C1=C(C=CC(=C1F)NC2N(C(C(=CC=2C(NOCCO)=O)C)=O)C)I,199,http://www.selleckchem.com/products/AZD8330(ARRY-424704).html,MAPK,K04364b,C9,L1200-2,0187172799,16666708
124,S1205,PIK-75,,,488.74,372196-77-5,hydrochloride,"PI3K,DNA-PK","PIK-75 is a p110α inhibitor with IC50 of 5.8 nM (200-fold more potently than p110β), isoform-specific mutants at Ser773, and also potently inhibits DNA-PK with IC50 of 2 nM.",C1(C(=CN2C(C=1)=NC=C2/C=N/N(S(C3=C(C=CC(=C3)[N+](=O)[O-])C)(=O)=O)C)Br).Cl,10,http://www.selleckchem.com/products/PIK-75-Hydrochloride.html,PI3K/Akt/mTOR,K06356a,D1,L1200-2,0187172784,45265864
125,S2193,GSK461364,Yes,,543.6,929095-18-1,free base,PLK,GSK461364 inhibits purified Plk1 with Ki of 2.2 nM. It is more than 1000-fold selective against Plk2/3. Phase 1.,C1N(CCN(C1)CC2=CC3=C(C=C2)N=CN3C4=CC(=C(S4)C(=O)N)O[C@H](C)C5=CC=CC=C5C(F)(F)F)C,18,http://www.selleckchem.com/products/GSK461364.html,Cell Cycle,K04997b,D10,L1200-2,0187172793,15983966
126,S2216,Mubritinib (TAK 165),Yes,,468.47,366017-09-6,free base,HER2,"Mubritinib (TAK-165) is a potent inhibitor of HER2/ErbB2 with IC50 of 6 nM; no activity to EGFR, FGFR, PDGFR, JAK1, Src and Blk.",C1=C(C=CC(=C1)/C=C/C2OC=C(N=2)COC3=CC=C(C=C3)CCCCN4N=NC=C4)C(F)(F)F,27,http://www.selleckchem.com/products/Mubritinib-TAK-165.html,Protein Tyrosine Kinase,K06388a,D11,L1200-2,0187172794,6444692
127,S1264,PD173074,,,523.67,219580-11-7,free base,"VEGFR,FGFR","PD173074 is a potent FGFR1 inhibitor with IC50 of ~25 nM and also inhibits VEGFR2 with IC50 of 100-200 nM, ~1000-fold selective for FGFR1 than PDGFR and c-Src.",N1=C(N=C2C(=C1)C=C(C(=N2)NC(NC(C)(C)C)=O)C3=CC(=CC(=C3)OC)OC)NCCCCN(CC)CC,190,http://www.selleckchem.com/products/PD-173074.html,Angiogenesis,K00747d,D2,L1200-2,0187172785,1401
128,S1360,GSK1059615,Yes,,333.36,958852-01-2,free base,"PI3K,mTOR","GSK1059615 is a dual inhibitor of PI3Kα/β/δ/γ (reversible) and mTOR with IC50 of 0.4 nM/0.6 nM/2 nM/5 nM and 12 nM, respectively. Phase 1.",C1(=CC=C2C(=C1)C(=CC=N2)C3=CC=NC=C3)/C=C4/C(NC(S4)=O)=O,10,http://www.selleckchem.com/products/GSK1059615.html,PI3K/Akt/mTOR,K06361a,D3,L1200-2,0187172786,23582824
129,S1458,VX-745,,,436.26,209410-46-8,free base,p38 MAPK,"VX-745 is a potent and selective inhibitor of p38α with IC50 of 10 nM, 22-fold greater selectivity versus p38β and no inhibition to p38γ.",C1=C(C=CC(=C1F)SC2C=CC3N(N=2)C=NC(C=3C4=C(C=CC=C4Cl)Cl)=O)F,34,http://www.selleckchem.com/products/VX-745.html,MAPK,K06468a,D4,L1200-2,0187172787,3038525
130,S1486,AEE788 (NVP-AEE788),Yes,,440.58,497839-62-0,free base,"HER2,VEGFR,EGFR","AEE788 is a potent inhibitor of EGFR and HER2/ErbB2 with IC50 of 2 nM and 6 nM, less potent to VEGFR2/KDR, c-Abl, c-Src, and Flt-1, does not inhibit Ins-R, IGF-1R, PKCα and CDK1. Phase 1/2.",C1=NC(=C2C(=N1)NC(=C2)C3=CC=C(C=C3)CN4CCN(CC4)CC)N[C@@H](C5=CC=CC=C5)C,199,http://www.selleckchem.com/products/AEE788.html,Protein Tyrosine Kinase,K06368a,D5,L1200-2,0187172788,10297043
131,S1526,Quizartinib (AC220),Yes,,560.67,950769-58-1,free base,FLT3,"Quizartinib (AC220) is a second-generation FLT3 inhibitor for Flt3(ITD/WT) with IC50 of 1.1 nM/4.2 nM, 10-fold more selective for Flt3 than KIT, PDGFRα, PDGFRβ, RET, and CSF-1R. Phase 1/2.",C1=C(C=CC(=C1)C2N=C3N(C=2)C4C(S3)=CC(=CC=4)OCCN5CCOCC5)NC(NC6C=C(ON=6)C(C)(C)C)=O,59,http://www.selleckchem.com/products/AC-220.html,Angiogenesis,K04304b,D6,L1200-2,0187172789,24889392
132,S1556,PHT-427,,,409.61,1191951-57-1,free base,"PDK-1,Akt","PHT-427 is a dual Akt and PDPK1 inhibitor (high affinity binding for the PH domains of Akt and PDPK1) with Ki of 2.7 μM and 5.2 μM, respectively.",C1=C(C=CC(=C1)S(=O)(NC2=NN=CS2)=O)CCCCCCCCCCCC,200,http://www.selleckchem.com/products/PHT-427.html,PI3K/Akt/mTOR,K06374a,D7,L1200-2,0187172790,44240850
133,S1574,BIRB 796 (Doramapimod),Yes,,527.66,285983-48-4,free base,p38 MAPK,"BIRB 796 (Doramapimod) is a highly selective p38α MAPK inhibitor with Kd of 0.1 nM, 330-fold greater selectivity versus JNK2, weak inhibition for c-RAF, Fyn and Lck, insignificant inhibition of ERK-1, SYK, IKK2, ZAP-70, EGFR, HER2, PKA, PKC, PKCα/β/γ.",C1=C(C2=C(C(=C1)OCCN3CCOCC3)C=CC=C2)NC(NC4=CC(=NN4C5=CC=C(C=C5)C)C(C)(C)C)=O,200,http://www.selleckchem.com/products/BIRB-796-(Doramapimod).html,MAPK,K00626d,D8,L1200-2,0187172791,156422
134,S2150,Neratinib (HKI-272),Yes,,557.04,698387-09-6,free base,"HER2,EGFR","Neratinib (HKI-272) is a highly selective HER2 and EGFR inhibitor with IC50 of 59 nM and 92 nM; weakly inhibits KDR and Src, no significant inhibition to Akt, CDK1/2/4, IKK-2, MK-2, PDK1, c-Raf and c-Met. Phase 3.",C1(=C(C=C2C(=C1)N=CC(=C2NC3=CC=C(C(=C3)Cl)OCC4=NC=CC=C4)C#N)NC(/C=C/CN(C)C)=O)OCC,10,http://www.selleckchem.com/products/Neratinib(HKI-272).html,Protein Tyrosine Kinase,K04349b,D9,L1200-2,0187172792,9915743
135,S1207,Tivozanib (AV-951),Yes,,454.86,475108-18-0,free base,"VEGFR,PDGFR,c-Kit","Tivozanib (AV-951) is a potent and selective VEGFR inhibitor for VEGFR1/2/3 with IC50 of 30 nM/6.5 nM/15 nM, and also inhibits PDGFR and c-Kit, low activity observed against FGFR-1, Flt3, c-Met EGFR and IGF-1R. Phase 3.",C1(=CC=C(C(=C1)Cl)NC(=O)NC2C=C(ON=2)C)OC3=CC=NC4=C3C=C(C(=C4)OC)OC,43,http://www.selleckchem.com/products/AV-951.html,Protein Tyrosine Kinase,K04257c,E1,L1200-2,0187172783,9911830
136,S2194,R406,,,628.63,841290-81-1,besylate,"Syk,FLT3","R406 is a potent Syk inhibitor with IC50 of 41 nM, strongly inhibits Syk but not Lyn, 5-fold less potent to Flt3. Phase 2.",C1(=C(C=C(C=C1OC)NC2=NC(=C(C=N2)F)NC3=NC4=C(C=C3)OC(C(N4)=O)(C)C)OC)OC.C5=CC=CC(=C5)S(O)(=O)=O,200,http://www.selleckchem.com/products/R406.html,Angiogenesis,K04323c,E10,L1200-2,0187172774,11984591
137,S2218,PP242,,,308.34,1092351-67-1,free base,"mTOR,Autophagy","PP242 is a selective mTOR inhibitor with IC50 of 8 nM; targets both mTOR complexes with >10- and 100-fold selectivity for mTOR than PI3Kδ or PI3Kα/β/γ, respectively.",N1=CN=C2C(=C1N)C(=NN2C(C)C)C3NC4=C(C=3)C=C(C=C4)O,201,http://www.selleckchem.com/products/PP242.html,PI3K/Akt/mTOR,K04139b,E11,L1200-2,0187172773,135565635
138,S1266,WYE-354,,,495.53,1062169-56-5,free base,mTOR,"WYE-354 is a potent, specific and ATP-competitive inhibitor of mTOR with IC50 of 5 nM, blocks mTORC1/P-S6K(T389) and mTORC2/P-AKT(S473) not P-AKT(T308), selective for mTOR than PI3Kα (>100-fold) and PI3Kγ (>500-fold). ",C1=C(C=CC(=C1)C2=NC3=C(C(=N2)N4CCOCC4)C=NN3C5CCN(CC5)C(=O)OC)NC(OC)=O,199,http://www.selleckchem.com/products/WYE-354.html,PI3K/Akt/mTOR,K06359a,E2,L1200-2,0187172782,44219749
139,S1361,MGCD-265,Yes,,517.6,875337-44-3,free base,"Tie-2,VEGFR,c-Met","MGCD-265 is a potent, multi-target and ATP-competitive inhibitor of c-Met and VEGFR1/2/3 with IC50 of 1 nM, 3 nM/3 nM/4 nM, respectively; also inhibits Ron and Tie2. Phase 1/2.",C1(=CC=CC=C1)CC(NC(NC2=CC=C(C(=C2)F)OC3=C4C(=NC=C3)C=C(S4)C5N=CN(C=5)C)=S)=O,200,http://www.selleckchem.com/products/MGCD-265.html,Protein Tyrosine Kinase,K04275c,E3,L1200-2,0187172781,24901704
140,S1459,Thiazovivin,,,311.36,1226056-71-8,free base,ROCK,"Thiazovivin (Tzv) is a novel ROCK inhibitor with IC50 of 0.5 μM, promotes hESC survival after single-cell dissociation.",C1(SC=C(N=1)C(NCC2=CC=CC=C2)=O)NC3=CC=NC=N3,48,http://www.selleckchem.com/products/Thiazovivin.html,Cell Cycle,K06366a,E4,L1200-2,0187172780,46209426
141,S1487,PHA-793887,Yes,,361.48,718630-59-2,free base,CDK,"PHA-793887 is a novel and potent inhibitor of CDK2, CDK5 and CDK7 with IC50 of 8 nM, 5 nM and 10 nM. It is greater than 6-fold more selective for CDK2, 5, and 7 than CDK1, 4, and 9. Phase 1.",N1N=C(C2=C1C(N(C2)C(C3CCN(CC3)C)=O)(C)C)NC(CC(C)C)=O,199,http://www.selleckchem.com/products/PHA-793887.html,Cell Cycle,K04237c,E5,L1200-2,0187172779,46191454
142,S1529,Hesperadin,,,516.65,422513-13-1,free base,Aurora Kinase,"Hesperadin potently inhibits Aurora B with IC50 of 250 nM. It markedly reduces the activity of AMPK, Lck, MKK1, MAPKAP-K1, CHK1 and PHK while it does not inhibit MKK1 activity in vivo.",C1(=CC=C2C(=C1)/C(C(N2)=O)=C(\C3=CC=CC=C3)NC4=CC=C(C=C4)CN5CCCCC5)NS(CC)(=O)=O,199,http://www.selleckchem.com/products/Hesperadin.html,Cell Cycle,K04231b,E6,L1200-2,0187172778,135421442
143,S1557,KRN 633,,,416.86,286370-15-8,free base,"PDGFR,VEGFR","KRN 633 is an ATP-competitive inhibitor of VEGFR1/2/3 with IC50 of 170 nM/160 nM/125 nM, weakly inhibits PDGFR-α/β and c-Kit, does not block the phosphorylation of FGFR-1, EGFR or c-Met in cell.",C1(=C(C=C2C(=C1)C(=NC=N2)OC3=CC=C(C(=C3)Cl)NC(=O)NCCC)OC)OC,21,http://www.selleckchem.com/products/KRN-633.html,Protein Tyrosine Kinase,K00589d,E7,L1200-2,0187172777,9549295
144,S1577,Tie2 kinase inhibitor,,,439.53,948557-43-5,free base,Tie-2,"Tie2 kinase inhibitor is an optimized compound of SB-203580, selective to Tie2 with IC50 of 0.25 μM, 200-fold more potent than p38.",C12=C(C=CC(=C1)C3=C(N=C(N3)C4=CC=C(C=C4)S(C)=O)C5=CC=NC=C5)C=C(C=C2)OC,79,http://www.selleckchem.com/products/Tie2-kinase-inhibitor.html,Protein Tyrosine Kinase,K06379a,E8,L1200-2,0187172776,23625762
145,S2158,KW-2449,Yes,,332.4,1000669-72-6,free base,"Aurora Kinase,Bcr-Abl,FLT3","KW-2449 is a multiple-targeted inhibitor, mostly for Flt3 with IC50 of 6.6 nM, modestly potent to FGFR1, Bcr-Abl and Aurora A; little effect on PDGFRβ, IGF-1R, EGFR. Phase 1.",C1=CC=CC2=C1NN=C2/C=C/C3=CC=C(C=C3)C(=O)N4CCNCC4,201,http://www.selleckchem.com/products/KW-2449.html,Angiogenesis,K06017b,E9,L1200-2,0187172775,11427553
146,S1219,YM201636,,,467.48,371942-69-7,free base,PI3K,"YM201636 is a selective PIKfyve inhibitor with IC50 of 33 nM, less potent to p110α and insensitive to Fabl (yeast orthologue).",C1C(=CC=C(N=1)N)C(=O)NC2C=C(C=CC=2)C3N=C4C(=C(N=3)N5CCOCC5)OC6C(=CC=CN=6)4,74,http://www.selleckchem.com/products/ym201636.html,PI3K/Akt/mTOR,K02694b,F1,L1200-2,0187172760,9956222
147,S2198,SGI-1776 free base,Yes,,405.42,1025065-69-3,free base,Pim,"SGI-1776 is a novel ATP competitive inhibitor of Pim1 with IC50 of 7 nM, 50- and 10-fold selective versus Pim2 and Pim3, also potent to Flt3 and haspin. Phase 1.",C1C(=NN2C(C=1)=NC=C2C3=CC=CC(=C3)OC(F)(F)F)NCC4CCN(CC4)C,199,http://www.selleckchem.com/products/SGI-1776.html,JAK/STAT,K00997c,F10,L1200-2,0187172769,24795070
148,S2219,CYT387,Yes,,414.46,1056634-68-4,free base,JAK,"CYT387 is an ATP-competitive inhibitor of JAK1/JAK2 with IC50 of 11 nM/18 nM, ~10-fold selectivity versus JAK3. Phase 1/2.",C1=C(C=CC(=C1)NC2=NC=CC(=N2)C3=CC=C(C=C3)C(NCC#N)=O)N4CCOCC4,200,http://www.selleckchem.com/products/Cyt387.html,JAK/STAT,K04346c,F11,L1200-2,0187172770,25062766
149,S1267,"Vemurafenib (PLX4032, RG7204)",Yes,Yes,489.92,918504-65-1,free base,Raf,"Vemurafenib (PLX4032, RG7204) is a novel and potent inhibitor of B-RafV600E with IC50 of 31 nM.",C1(=CN=C2C(=C1)C(=CN2)C(=O)C3=C(C(=CC=C3F)NS(=O)(=O)CCC)F)C4=CC=C(C=C4)Cl,200,http://www.selleckchem.com/products/PLX-4032.html,MAPK,K04267c,F2,L1200-2,0187172761,42611257
150,S1362,Rigosertib (ON-01910),Yes,,473.47,1225497-78-8,sodium,PLK,Rigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM. It shows 30-fold greater selectivity against Plk2 and no activity to Plk3. Phase 3.,C1(=C(C=C(C=C1OC)OC)OC)/C=C/S(CC2=CC=C(C(=C2)NCC([O-])=O)OC)(=O)=O.[Na+],200,http://www.selleckchem.com/products/ON-01910.html,Cell Cycle,K06362a,F3,L1200-2,0187172762,23696523
151,S1460,SP600125,,,220.23,129-56-6,free base,JNK,"SP600125 is a broad-spectrum JNK inhibitor for JNK1, JNK2 and JNK3 with IC50 of 40 nM, 40 nM and 90 nM, respectively; 10-fold greater selectivity against MKK4, 25-fold greater selectivity against MKK3, MKK6, PKB, and PKCα, and 100-fold selectivity against ERK2, p38, Chk1, EGFR etc.",C1C=CC2=C(C=1)C(C3=C4C2=NNC4=CC=C3)=O,199,http://www.selleckchem.com/products/SP600125.html,MAPK,K00218h,F4,L1200-2,0187172763,8515
152,S1489,PIK-93,,,389.88,593960-11-3,free base,PI3K,"PIK-93 is the first potent, synthetic PI4K (PI4KIIIβ) inhibitor with IC50 of 19 nM; shown to inhibit PI3Kα with IC50 of 39 nM.",C1(=C(C=C(C=C1)C2SC(=NC=2C)NC(C)=O)S(=O)(=O)NCCO)Cl,200,http://www.selleckchem.com/products/PIK-93.html,PI3K/Akt/mTOR,K06369a,F5,L1200-2,0187172764,6852167
153,S1530,BIX 02188,,,412.48,1094614-84-2,free base,MEK,"BIX02188 is a selective inhibitor of MEK5 with IC50 of 4.3 nM, also inhibits ERK5 catalytic activity with IC50 of 810 nM, and does not inhibit closely related kinases MEK1, MEK2, ERK2, and JNK2.",C1=C(C=C2C(=C1)/C(C(N2)=O)=C(/NC3=CC(=CC=C3)CN(C)C)C4=CC=CC=C4)C(NC)=O,104,http://www.selleckchem.com/products/BIX-02188.html,MAPK,K06372a,F6,L1200-2,0187172765,135398492
154,S1558,AT7867,,,337.85,857531-00-1,free base,"S6 Kinase,Akt","AT7867 is a potent ATP-competitive inhibitor of Akt1/2/3 and p70S6K/PKA with IC50 of 32 nM/17 nM/47 nM and 85 nM/20 nM, respectively; little activity outside the AGC kinase family.",C1(=CC=C(C=C1)C2(C3=CC=C(C=C3)C4=CNN=C4)CCNCC2)Cl,201,http://www.selleckchem.com/products/AT7867.html,PI3K/Akt/mTOR,K06375a,F7,L1200-2,0187172766,11175137
155,S1582,H 89 2HCl,,,519.28,130964-39-5,2HCl,PKA,"H 89 2HCl is a potent PKA inhibitor with Ki of 48 nM, 10-fold selective for PKA than PKG, greater than 500-fold selectivity than PKC, MLCK, calmodulin kinase II and casein kinase I/II.",C1(=CC=C(C2=C1C=NC=C2)S(NCCNC/C=C/C3=CC=C(C=C3)Br)(=O)=O).Cl.Cl,200,http://www.selleckchem.com/products/H-89-dihydrochloride.html,PI3K/Akt/mTOR,K00084c,F8,L1200-2,0187172767,5702541
156,S2161,RAF265 (CHIR-265),Yes,,518.41,927880-90-8,free base,"VEGFR,Raf","RAF265 (CHIR-265) is a potent selective inhibitor of C-Raf/B-Raf/B-Raf V600E with IC50 of 3-60 nM, and exhibits potent inhibition on VEGFR2 phosphorylation with EC50 of 30 nM. Phase 2.",C12=C(C=CC(=C1)OC3=CC=NC(=C3)C4NC(=CN=4)C(F)(F)F)N(C(=N2)NC5=CC=C(C=C5)C(F)(F)F)C,192,http://www.selleckchem.com/products/RAF265(CHIR-265).html,MAPK,K04320c,F9,L1200-2,0187172768,11656518
157,S1220,OSI-930,Yes,,443.44,728033-96-3,free base,"c-Kit,CSF-1R,VEGFR","OSI-930 is a potent inhibitor of Kit, KDR and CSF-1R with IC50 of 80 nM, 9 nM and 15 nM, respectively; also potent to Flt-1, c-Raf and Lck and low activity against PDGFRα/β, Flt-3 and Abl. Phase 1.",C1=CC=C2C(=C1)C(=CC=N2)CNC3=C(SC=C3)C(NC4=CC=C(C=C4)OC(F)(F)F)=O,200,http://www.selleckchem.com/products/OSI-930.html,Protein Tyrosine Kinase,K06357a,G1,L1200-2,0187172759,9868037
158,S2201,BMS-794833,,,468.84,1174046-72-0,free base,"VEGFR,c-Met","BMS-794833 is a potent ATP competitive inhibitor of Met/VEGFR2 with IC50 of 1.7 nM/15 nM, also inhibits Ron, Axl and Flt3 with IC50 of <3 nM; a prodrug of BMS-817378. Phase 1.",N1=C(C(=C(C=C1)OC2=CC=C(C=C2F)NC(C3=CNC=C(C3=O)C4=CC=C(C=C4)F)=O)Cl)N,200,http://www.selleckchem.com/products/BMS-794833.html,Protein Tyrosine Kinase,K06383a,G10,L1200-2,0187172750,44155856
159,S2220,SB590885,,,453.54,405554-55-4,free base,Raf,"SB590885 is a potent B-Raf inhibitor with Ki of 0.16 nM, 11-fold greater selectivity for B-Raf over c-Raf, no inhibition to other human kinases.",N1C(=C(NC=1C2=CC=C(C=C2)OCCN(C)C)C3=CC=C4C(=C3)CCC/4=N/O)C5=CC=NC=C5,11,http://www.selleckchem.com/products/SB590885.html,MAPK,K06266b,G11,L1200-2,0187172749,135421339
160,S1274,BX-795,,,591.47,702675-74-9,free base,"IκB/IKK,PDK-1","BX795 is a potent and specific PDK1 inhibitor with IC50 of 6 nM, 140- and 1600-fold more selective for PDK1 than PKA and PKC, respectively. Meanwhile, in comparison to GSK3β more than 100-fold selectivity observed for PDK1.",N1(CCCC1)C(=O)NC2C=C(C=CC=2)NC3N=C(C(=CN=3)I)NCCCNC(C4=CC=CS4)=O,169,http://www.selleckchem.com/products/bx-795.html,PI3K/Akt/mTOR,K00984b,G2,L1200-2,0187172758,10077147
161,S1363,Ki8751,,,469.41,228559-41-9,free base,"PDGFR,c-Kit,VEGFR","Ki8751 is a potent and selective inhibitor of VEGFR2 with IC50 of 0.9 nM, >40-fold selective for VEGFR2 than c-Kit, PDGFRα and FGFR-2, little activity to EGFR, HGFR and InsR.",C1=CN=C2C(=C1OC3=CC=C(C(=C3)F)NC(NC4=CC=C(C=C4F)F)=O)C=C(C(=C2)OC)OC,100,http://www.selleckchem.com/products/Ki8751.html,Protein Tyrosine Kinase,K06363a,G3,L1200-2,0187172757,11317348
162,S1462,AZD6482,Yes,,408.45,1173900-33-8,free base,PI3K,"AZD6482 is a PI3Kβ inhibitor with IC50 of 10 nM, 8-, 87- and 109-fold more selective to PI3Kβ than PI3Kδ, PI3Kα and PI3Kγ. Phase 1.",C(C1C(=CC=CC=1)N[C@H](C)C2=CC(=CN3C(C=C(N=C32)N4CCOCC4)=O)C)(=O)O,200,http://www.selleckchem.com/products/azd6482.html,PI3K/Akt/mTOR,K06441a,G4,L1200-2,0187172756,44137675
163,S1490,Ponatinib (AP24534),Yes,Yes,532.56,943319-70-8,free base,"PDGFR,FGFR,VEGFR,Bcr-Abl","Ponatinib (AP24534) is a novel, potent multi-target inhibitor of Abl, PDGFRα, VEGFR2, FGFR1 and Src with IC50 of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM and 5.4 nM, respectively.",C1C=NN2C(C=1)=NC=C2C#CC3=C(C=CC(=C3)C(=O)NC4=CC(=C(C=C4)CN5CCN(CC5)C)C(F)(F)F)C,56,http://www.selleckchem.com/products/AP24534.html,Angiogenesis,K03704f,G5,L1200-2,0187172755,24826799
164,S1531,BIX 02189,,,440.54,1094614-85-3,free base,MEK,"BIX02189 is a selective inhibitor of MEK5 with IC50 of 1.5 nM, also inhibits ERK5 catalytic activity with IC50 of 810 nM, and does not inhibit closely related kinases MEK1, MEK2, ERK2, and JNK2.",C1=C(C=C2C(=C1)/C(C(N2)=O)=C(/NC3=CC(=CC=C3)CN(C)C)C4=CC=CC=C4)C(N(C)C)=O,199,http://www.selleckchem.com/products/BIX-02189.html,MAPK,K06373a,G6,L1200-2,0187172754,135659062
165,S1561,BMS-777607,Yes,,512.89,1025720-94-8,free base,"Axl,c-Met","BMS-777607 is a Met-related inhibitor for c-Met, Axl, Ron and Tyro3 with IC50 of 3.9 nM, 1.1 nM, 1.8 nM and 4.3 nM, 40-fold more selective for Met-related targets versus Lck, VEGFR-2, and TrkA/B, and more than 500-fold greater selectivity versus all other receptor and non receptor kinases. Phase 1/2.",C1(=C(N=CC=C1OC2=CC=C(C=C2F)NC(=O)C3C(N(C=CC=3OCC)C4=CC=C(C=C4)F)=O)N)Cl,91,http://www.selleckchem.com/products/BMS-777607.html,Protein Tyrosine Kinase,K06376a,G7,L1200-2,0187172753,24794418
166,S1590,TWS119,,,318.33,601514-19-6,free base,GSK-3,TWS119 is a GSK-3β inhibitor with IC50 of 30 nM; capable of inducing neuronal differentiation and may be useful to stem cell biology.,C1=CC=C(C=C1O)OC2=NC=NC3=C2C=C(N3)C4=CC=CC(=C4)N,201,http://www.selleckchem.com/products/TWS119.html,PI3K/Akt/mTOR,K00245c,G8,L1200-2,0187172752,9549289
167,S2163,PF-4708671,,,390.41,1255517-76-0,free base,S6 Kinase,"PF-4708671 is a cell-permeable inhibitor of p70 ribosomal S6 kinase (S6K1 isoform) with Ki/IC50 of 20 nM/160 nM, 400-fold greater selectivity for S6K1 than S6K2, and 4- and >20-fold selectivity for S6K1 than MSK1 and RSK1/2, respectively. First S6K1-specific inhibitor to be reported.",N1C(=NC2=C1C=CC(=C2)C(F)(F)F)CN3CCN(C4=NC=NC=C4CC)CC3,76,http://www.selleckchem.com/products/pf-4708671.html,PI3K/Akt/mTOR,K03184b,G9,L1200-2,0187172751,51371303
168,S1226,KU-0063794,,,465.54,938440-64-3,free base,mTOR,KU-0063794 is a potent and highly specific dual-mTOR inhibitor of mTORC1 and mTORC2 with IC50 of ~10 nM; no effect on PI3Ks.,N1=C(N=C2C(=C1N3CCOCC3)C=CC(=N2)C4=CC(=C(C=C4)OC)CO)N5C[C@H](O[C@H](C5)C)C,34,http://www.selleckchem.com/products/KU-0063794.html,PI3K/Akt/mTOR,K06358a,H1,L1200-2,0187170693,16736978
169,S2202,NVP-BHG712,,,503.48,940310-85-0,free base,"Raf,Src,Bcr-Abl,VEGFR,Ephrin receptor","NVP-BHG712 is a specific EphB4 inhibitor with ED50 of 25 nM that discriminates between VEGFR and EphB4 inhibition; also shows activity against c-Raf, c-Src and c-Abl with IC50 of 0.395 μM, 1.266 μM and 1.667 μM, respectively.",C12=C(N=C(N=C1NC3=CC(=CC=C3C)C(NC4=CC=CC(=C4)C(F)(F)F)=O)C5=CC=CN=C5)N(N=C2)C,200,http://www.selleckchem.com/products/NVP-BHG712.html,Protein Tyrosine Kinase,K06384a,H10,L1200-2,0187172745,16747388
170,S2221,Apatinib,Yes,Yes,493.58,811803-05-1,sulfate,VEGFR,"Apatinib is an orally bioavailable, selective VEGFR2 inhibitor with IC50 of 1 nM.",S(=O)(O)(C)=O.C1=CN=C(C(=C1)C(NC2=CC=C(C=C2)C3(CCCC3)C#N)=O)NCC4=CC=NC=C4,44,http://www.selleckchem.com/products/Apatinib-YN968D1.html,Protein Tyrosine Kinase,K06411a,H11,L1200-2,0187170717,11315474
171,S1275,BX-912,,,471.35,702674-56-4,free base,PDK-1,"BX912 is a potent and specific PDK1 inhibitor with IC50 of 12 nM, 9- and 105- fold greater selectivity for PDK1 than PKA and PKC, respectively. In comparison to GSK3β, selectivity for PDK1 is 600-fold.",N1(CCCC1)C(=O)NC2C=C(C=CC=2)NC3N=C(C(=CN=3)Br)NCCC4=CN=CN4,199,http://www.selleckchem.com/products/bx-912.html,PI3K/Akt/mTOR,K04353c,H2,L1200-2,0187170694,11754511
172,S1378,Ruxolitinib (INCB018424),Yes,Yes,306.37,941678-49-5,free base,JAK,"INCB018424 is the first potent, selective, JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM, >130-fold selectivity for JAK1/2 versus JAK3. Phase 3.",N1=CN=C2C(=C1C3=CN(N=C3)[C@@H](CC#N)C4CCCC4)C=CN2,199,http://www.selleckchem.com/products/INCB18424.html,JAK/STAT,K06412a,H3,L1200-2,0187170698,25126798
173,S1470,"TSU-68 (SU6668, Orantinib)",Yes,,310.35,252916-29-3,free base,"VEGFR,PDGFR,FGFR","SU6668 has greatest potency against PDGFR autophosphorylation with Ki of 8 nM, but also strongly inhibits Flk-1 and FGFR1 trans-phosphorylation, little activity against IGF-1R, Met, Src, Lck, Zap70, Abl and CDK2; does not inhibit EGFR. Phase 3.",C1=CC=C2C(=C1)/C(C(N2)=O)=C/C3NC(=C(C=3C)CCC(O)=O)C,199,http://www.selleckchem.com/products/TSU-68(SU6668).html,Protein Tyrosine Kinase,K04373c,H4,L1200-2,0187172739,5329099
174,S1494,LY2228820,Yes,,612.74,862507-23-1,mesylate,p38 MAPK,"LY2228820 is a novel and potent inhibitor of p38 MAPK with IC50 of 7 nM, does not alter p38 MAPK activation. Phase 1/2.",CC(C1=NC(=C(N1)C2=NC3=C(C=C2)N=C(N3CC(C)(C)C)N)C4=CC=C(C=C4)F)(C)C.CS(=O)(=O)O.CS(=O)(=O)O,57,http://www.selleckchem.com/products/LY2228820.html,MAPK,K04342b,H5,L1200-2,0187172740,11570805
175,S1532,AZD7762,Yes,,362.42,860352-01-8,free base,Chk,"AZD7762 is a potent and selective inhibitor of Chk1 with IC50 of 5 nM. It is equally potent against Chk2 and less potent against CAM, Yes, Fyn, Lyn, Hck and Lck. Phase 1.",C1(=CC=CC(=C1)C2SC(=C(C=2)NC(N)=O)C(N[C@@H]3CNCCC3)=O)F,137,http://www.selleckchem.com/products/AZD7762.html,Cell Cycle,K00983e,H6,L1200-2,0187172741,11152667
176,S1568,PD318088,,,561.09,391210-00-7,free base,MEK,"PD318088 is a non-ATP competitive allosteric MEK1/2 inhibitor, binds simultaneously with ATP in a region of the MEK1 active site that is adjacent to the ATP-binding site.",C1=C(C(=C(C(=C1C(NOCC(CO)O)=O)NC2=CC=C(C=C2F)I)F)F)Br,199,http://www.selleckchem.com/products/PD318088.html,MAPK,K06377a,H7,L1200-2,0187172742,10231331
177,S1802,Acadesine,Yes,Yes,258.23,2627-69-2,free base,AMPK,"Acadesine results in accumulation of ZMP, which mimics the stimulating effect of AMP on AMPK and AMPK kinase. Phase 3.",[C@@H]1([C@H]([C@@H](O[C@H]1CO)N2C=NC(=C2N)C(=O)N)O)O,10,http://www.selleckchem.com/products/Acadesine.html,PI3K/Akt/mTOR,K06450a,H8,L1200-2,0187172743,17513
178,S2179,LY2784544,Yes,,469.94,1229236-86-5,free base,JAK,"LY2784544 is a potent JAK2 inhibitor with IC50 of 3 nM, effective in JAK2V617F, 8- and 20-fold selective versus JAK1 and JAK3. Phase 2.",C1C(=NN2C(C=1CN3CCOCC3)=NC(=C2CC4=CC=C(C=C4F)Cl)C)NC5NN=C(C=5)C,200,http://www.selleckchem.com/products/LY2784544.html,JAK/STAT,K04290c,H9,L1200-2,0187172744,46213929
179,S2226,"CAL-101 (Idelalisib, GS-1101)",Yes,,415.42,870281-82-6,free base,PI3K,"CAL-101 (Idelalisib, GS-1101) is a selective p110δ inhibitor with IC50 of 2.5 nM; shown to have 40- to 300-fold greater selectivity for p110δ thanp110α/β/γ, and 400- to 4000-fold more selectivity to p110δ than C2β, hVPS34, DNA-PK and mTOR. Phase 3.",C1=CC=C2C(=C1F)C(N(C(=N2)[C@@H](NC3=C4C(=NC=N3)NC=N4)CC)C5=CC=CC=C5)=O,199,http://www.selleckchem.com/products/CAL-101.html,PI3K/Akt/mTOR,K04266b,A1,L1200-3,0187217567,11625818
180,S2769,Dovitinib (TKI-258) Dilactic Acid  ,Yes,,572.59,852433-84-2,dilactic Acid,"PDGFR,FGFR,c-Kit,FLT3,VEGFR","Dovitinib Dilactic acid (TKI258 Dilactic acid) is the Dilactic acid of Dovitinib, which is a multitargeted RTK inhibitor, mostly for class III (FLT3/c-Kit) with IC50 of 1 nM/2 nM, also potent to class IV (FGFR1/3) and class V (VEGFR1-4) RTKs with IC50 of 8-13 nM, less potent to InsR, EGFR, c-Met, EphA2, Tie2, IGFR1 and HER2. Phase 4.",N1(C(C(=C(C2C(=CC=CC1=2)F)N)C3=NC4C(N3)=CC(=CC=4)N5CCN(CC5)C)=O).CC(C(O)=O)O.CC(C(O)=O)O,157,http://www.selleckchem.com/products/dovitinib.html,Angiogenesis,K06429a,A10,L1200-3,0187217558,135985126
181,S2796,WP1066,Yes,,356.22,857064-38-1,free base,JAK,"WP1066 is a novel inhibitor of JAK2 and STAT3 with IC50 of 2.30 μM and 2.43 μM in HEL cells; shows activity to JAK2, STAT3, STAT5, and ERK1/2 not JAK1 and JAK3.",C(/C(=C/C1C=CC=C(N=1)Br)C#N)(=O)N[C@@H](C)C2C=CC=CC=2,202,http://www.selleckchem.com/products/wp1066.html,JAK/STAT,K06435a,A11,L1200-3,0187217557,11210478
182,S2310,Honokiol,,,266.334,35354-74-6,free base,"MEK,Akt",Honokiol is the active principle of magnolia extract that inhibits Akt-phosphorylation and promotes ERK1/2phosphorylation. Phase 3.,C1(=C(C=C(C=C1)C2=CC(=CC=C2O)CC=C)CC=C)O,198,http://www.selleckchem.com/products/Honokiol.html,PI3K/Akt/mTOR,K06390a,A2,L1200-3,0187217566,72303
183,S2622,PP121,,,319.36,1092788-83-4,free base,"DNA-PK,PDGFR,mTOR","PP-121 is a multi-targeted inhibitor of PDGFR, Hck, mTOR, VEGFR2, Src and Abl with IC50 of 2 nM, 8 nM, 10 nM, 12 nM, 14 nM and 18 nM, also inhibits DNA-PK with IC50 of 60 nM.",C1(=CN=C2C(=C1)C=CN2)C3=NN(C4=C3C(=NC=N4)N)C5CCCC5,200,http://www.selleckchem.com/products/PP121.html,Protein Tyrosine Kinase,K06398a,A3,L1200-3,0187217565,24905142
184,S2638,NU7441 (KU-57788),,,413.49,503468-95-9,free base,"DNA-PK,PI3K",NU7441 is a highly potent and selective DNA-PK inhibitor with IC50 of 14 nM and also inhibits PI3K with IC50 of 5 μM.,C1=C(OC2=C(C1=O)C=CC=C2C3=CC=CC4=C3SC5=C4C=CC=C5)N6CCOCC6,10,http://www.selleckchem.com/products/nu7441.html,DNA Damage,K06416a,A4,L1200-3,0187217564,11327430
185,S2680,Ibrutinib (PCI-32765),Yes,Yes,440.5,936563-96-1,free base,BTK,"Ibrutinib is a potent and highly selective Btk inhibitor with IC50 of 0.5 nM, modestly potent to Bmx, CSK, FGR, BRK, HCK, less potent to EGFR, Yes, ErbB2, JAK3, etc.",C1=NC(=C2C(=N1)N(N=C2C3=CC=C(C=C3)OC4=CC=CC=C4)[C@H]5CN(CCC5)C(C=C)=O)N,199,http://www.selleckchem.com/products/pci-32765.html,Angiogenesis,K04327c,A5,L1200-3,0187217563,24821094
186,S2696,GDC-0980 (RG7422),Yes,,498.6,1032754-93-0,free base,"mTOR,PI3K","GDC-0980 (RG7422) is a potent, class I PI3K inhibitor for PI3Kα/β/δ/γ with IC50 of 5 nM/27 nM/7 nM/14 nM, respectively. Also a mTOR inhibitor with Ki of 17 nM, and highly selective versus others PIKK family kinases. Phase 2.",C1(=CN=C(N=C1)N)C2=NC(=C3C(=N2)C(=C(S3)CN4CCN(CC4)C([C@@H](O)C)=O)C)N5CCOCC5,40,http://www.selleckchem.com/products/GDC-0980-RG7422.html,PI3K/Akt/mTOR,K04306b,A6,L1200-3,0187217562,25254071
187,S2726,PH-797804,Yes,,477.3,586379-66-0,free base,p38 MAPK,PH-797804 is a novel pyridinone inhibitor of p38α with IC50 of 26 nM; 4-fold more selective versus p38β and does not inhibit JNK2. Phase 2.,C1(=C(C=CC(=C1)C(=O)NC)C)N2C(=CC(=C(C2=O)Br)OCC3=CC=C(C=C3F)F)C,201,http://www.selleckchem.com/products/ph-797804.html,MAPK,K06244b,A7,L1200-3,0187217561,22049997
188,S2742,PHA-767491,,,213.24,845714-00-3,free base,CDK,"PHA-767491 is a potent ATP-competitive dual Cdc7/CDK9 inhibitor with IC50 of 10 nM and 34 nM, respectively.It displays ~20-fold selectivity against CDK1/2 and GSK3-β, 50-fold selectivity against MK2 and CDK5, 100-fold selectivity against PLK1 and CHK2.",C1=NC=CC(=C1)C2NC3=C(C=2)C(NCC3)=O,112,http://www.selleckchem.com/products/pha-767491.html,Cell Cycle,K00963b,A8,L1200-3,0187217560,11715767
189,S2752,HER2-Inhibitor-1,,,569.63,937265-83-3,free base,"HER2,EGFR","ARRY-380 is a potent and selective HER2 inhibitor with IC50 of 8 nM, equipotent against truncated p95-HER2, 500-fold more selective for HER2 versus EGFR. Phase 1.",N1C=NC(=C2C=C(C=CC=12)C3OC(=CC=3)CNCCS(=O)(=O)C)NC4C=C(C(=CC=4)OC5=CC6N(C=C5)N=CN=6)C,200,http://www.selleckchem.com/products/arry-380.html,Protein Tyrosine Kinase,K06422a,A9,L1200-3,0187217559,42598643
190,S2227,PIK-294,,,489.53,900185-02-6,free base,PI3K,"PIK-294 is a highly selective p110δ inhibitor with IC50 of 10 nM, 1000-, 49- and 16-fold less potent to PI3Kα/β/γ, respectively.",N1=CN=C2C(=C1N)C(=NN2CC3N(C(C4=C(N=3)C=CC=C4C)=O)C5=C(C=CC=C5)C)C6=CC(=CC=C6)O,200,http://www.selleckchem.com/products/PIK-294.html,PI3K/Akt/mTOR,K06394a,B1,L1200-3,0187217544,24905149
191,S2770,MK-5108 (VX-689),Yes,,461.94,1010085-13-8,free base,Aurora Kinase,"MK-5108 (VX-689) is a highly selective Aurora A inhibitor with IC50 of 0.064 nM and is 220- and 190-fold more selective for Aurora A than Aurora B/C, while it inhibits TrkA with less than 100-fold selectivity. Phase 1.",N1=C(C=CC=C1C[C@]2(CC[C@H](CC2)OC3=C(C(=CC=C3)Cl)F)C(=O)O)NC4SC=CN=4,199,http://www.selleckchem.com/products/mk-5108-vx-689.html,Cell Cycle,K04233b,B10,L1200-3,0187217553,24748204
192,S2801,AZD4547,Yes,,463.57,1035270-39-3,free base,FGFR,"AZD4547 is a novel selective FGFR inhibitor targeting FGFR1/2/3 with IC50 of 0.2 nM/2.5 nM/1.8 nM, weaker activity against FGFR4, VEGFR2(KDR), and little activity observed against IGFR, CDK2, and p38. Phase 1/2.",C1(=CC(=CC(=C1)CCC2=CC(=NN2)NC(=O)C3=CC=C(C=C3)N4C[C@@H](N[C@@H](C4)C)C)OC)OC,198,http://www.selleckchem.com/products/azd4547.html,Angiogenesis,K04310d,B11,L1200-3,0187217554,51039095
193,S2386,Indirubin,Yes,,262.26,479-41-4,free base,GSK-3,Indirubin is a potent cyclin-dependent kinases and GSK-3β inhibitor with IC50 of about 5 &mu;M and 0.6 &mu;M.,C1=CC=C2C(=C1)NC(C/2=C3\NC4=C(C3=O)C=CC=C4)=O,202,http://www.selleckchem.com/products/Indirubin.html,PI3K/Akt/mTOR,K06381a,B2,L1200-3,0187217545,10177
194,S2624,OSI-027,Yes,,406.44,936890-98-1,free base,mTOR,"OSI-027 is a selective and potent dual inhibitor of mTORC1 and mTORC2 with IC50 of 22 nM and 65 nM, and more than 100-fold selectivity observed for mTOR than PI3Kα, PI3Kβ, PI3Kγ or DNA-PK.",N1C=NN2C(C=1N)=C(N=C2[C@@H]3CC[C@H](CC3)C(=O)O)C4NC5=C(C=4)C=CC=C5OC,44,http://www.selleckchem.com/products/OSI027.html,PI3K/Akt/mTOR,K06397a,B3,L1200-3,0187217546,135398516
195,S2658,GSK2126458 (GSK458),Yes,,505.5,1086062-66-9,free base,"PI3K,mTOR","GSK2126458 is a highly selective and potent inhibitor of p110α/β/δ/γ, mTORC1/2 with Ki of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM, respectively. Phase 1.",C1(C(=CC(=CC=1)F)F)S(=O)(=O)NC2C(=NC=C(C=2)C3C=C4C(=CC=NC(=CC=3)4)C5C=NN=CC=5)OC,197,http://www.selleckchem.com/products/gsk2126458.html,PI3K/Akt/mTOR,K04326c,B4,L1200-3,0187217547,25167777
196,S2681,AS-604850,,,285.22,648449-76-7,free base,PI3K,"AS-604850 is a selective, ATP-competitive PI3Kγ inhibitor with IC50 of 250 nM, over 80-fold selectivity for PI3Kγ than PI3Kδ/β, and 18-fold more selective for PI3Kγ than PI3Kα.",C12=C(C=CC(=C1)/C=C3\SC(NC3=O)=O)OC(O2)(F)F,199,http://www.selleckchem.com/products/as-604850.html,PI3K/Akt/mTOR,K00828b,B5,L1200-3,0187217548,11492951
197,S2697,A-769662,,,360.39,844499-71-4,free base,AMPK,"A-769662 is a potent, reversible AMPK activator with EC50of 0.8 μM, little effect on GPPase/FBPase activity.",C1(=CC=C(C=C1)C2=CSC3=C2C(=C(C(N3)=O)C#N)O)C4=CC=CC=C4O,199,http://www.selleckchem.com/products/a-769662.html,PI3K/Akt/mTOR,K06414a,B6,L1200-3,0187217549,54708532
198,S2727,"Dacomitinib (PF299804, PF299)",Yes,,469.94,1110813-31-4,free base,EGFR,"PF-299804 is a potent, irreversible pan-ErbB inhibitor, mostly to EGFR with IC50 of 6 nM, effective against NSCLCs with EGFR or ERBB2 mutations (resistant to gefitinib) as well as those harboring the EGFR T790M mutation. Phase 2.",C(/C=C/C(NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC)=O)N4CCCCC4,40,http://www.selleckchem.com/products/pf299804.html,Protein Tyrosine Kinase,K06418a,B7,L1200-3,0187217550,11511120
199,S2743,PF-04691502,Yes,,425.48,1013101-36-4,free base,"Akt,mTOR,PI3K","PF-04691502 is an ATP-competitive PI3K(α/β/δ/γ)/mTOR dual inhibitor with Ki of 1.8 nM/2.1 nM/1.6 nM/1.9 nM and 16 nM, little activity against either Vps34, AKT, PDK1, p70S6K, MEK, ERK, p38, or JNK. Phase 2.",N1=C(N=C2C(=C1C)C=C(C(N2[C@H]3CC[C@@H](CC3)OCCO)=O)C4=CC=C(N=C4)OC)N,32,http://www.selleckchem.com/products/pf-04691502.html,PI3K/Akt/mTOR,K06420a,B8,L1200-3,0187217551,25033539
200,S2755,Varlitinib,,,466.94,845272-21-1,free base,EGFR,"ARRY334543 is a selective and potent ErbB1(EGFR) and ErbB2(HER2) inhibitor with IC50 of 7 nM and 2 nM, respectively. Phase 2.",C12=C(C(=NC=N1)NC3=CC(=C(C=C3)OCC4SC=CN=4)Cl)C=C(C=C2)NC5OC[C@H](N=5)C,12,http://www.selleckchem.com/products/arry334543.html,Protein Tyrosine Kinase,K06442a,B9,L1200-3,0187217552,42642648
201,S2231,Telatinib,Yes,,409.83,332012-40-5,free base,"VEGFR,PDGFR,c-Kit","Telatinib is a potent inhibitor of VEGFR2/3, c-Kit and PDGFRβ with IC50 of 6 nM/4 nM, 1 nM and 15 nM, respectively. Phase 2.",N1=C(C2=C(C(=N1)OCC3=CC(=NC=C3)C(=O)NC)OC=C2)NC4=CC=C(C=C4)Cl,200,http://www.selleckchem.com/products/Telatinib-BAY-57-9352.html,Protein Tyrosine Kinase,K06395a,C1,L1200-3,0187217543,9808844
202,S2774,MK-2461,Yes,,495.55,917879-39-1,free base,"c-Met,PDGFR,FGFR","MK-2461 is a potent, multi-targeted inhibitor for c-Met(WT/mutants) with IC50 of 0.4-2.5 nM, less potent to Ron, Flt1; 8- to 30-fold greater selectivity of c-Met targets versus FGFR1, FGFR2, FGFR3, PDGFRβ, KDR, Flt3, Flt4, TrkA, and TrkB. Phase 1/2.
.",C12=C(C(C3=C(C=C1)C=CC(=C3)NS(N(C[C@H]4OCCOC4)C)(=O)=O)=O)C=C(C=N2)C5=CN(N=C5)C,199,http://www.selleckchem.com/products/mk-2461.html,Protein Tyrosine Kinase,K06432a,C10,L1200-3,0187217534,44137946
203,S2806,CEP-33779,,,462.57,1257704-57-6,free base,JAK,"CEP33779 is a selective JAK2 inhibitor with IC50 of 1.8 nM, >40- and >800-fold versus JAK1 and TYK2.",C1(=CC=CC(=C1)NC2N=C3N(N=2)C=CC=C3C4=CC=C(C=C4)S(=O)(C)=O)N5CCN(CC5)C,201,http://www.selleckchem.com/products/cep33779.html,JAK/STAT,K06438a,C11,L1200-3,0187217533,57336812
204,S2391,Quercetin,,,302.24,117-39-5,free base,"PKC,Src,PI3K,Sirtuin","Quercetin is a natural flavonoid present in vegetables, fruit and wine and is a PI3K inhibitor with IC50 of 2.4 – 5.4 &mu;M.",C1(=CC(=C2C(=C1)OC(=C(C2=O)O)C3=CC=C(C(=C3)O)O)O)O,10,http://www.selleckchem.com/products/Quercetin(Sophoretin).html,Epigenetics,S00292f,C2,L1200-3,0187217542,5280343
205,S2625,Fostamatinib (R788),Yes,,580.46,901119-35-5,free base,Syk,"Fostamatinib (R788), a prodrug of the active metabolite R406, is a Syk inhibitor with IC50 of 41 nM, strongly inhibits Syk but not Lyn, 5-fold less potent to Flt3. Phase 2.",C1(=C(C(=CC(=C1)NC2=NC=C(C(=N2)NC3=CC=C4C(=N3)N(C(C(O4)(C)C)=O)COP(O)(O)=O)F)OC)OC)OC,199,http://www.selleckchem.com/products/R7935788-Fostamatinib.html,Angiogenesis,K06403a,C3,L1200-3,0187217541,11671467
206,S2661,WYE-125132 (WYE-132),,,519.6,1144068-46-1,free base,mTOR,"WYE-125132 is a highly potent, ATP-competitive mTOR inhibitor with IC50 of 0.19 nM; highly selective for mTOR versus PI3Ks or PI3K-related kinases hSMG1 and ATR.",C1(=NC(=NC2=C1C=NN2C3CCC4(CC3)OCCO4)C5=CC=C(C=C5)NC(=O)NC)N6CC7CCC(O7)C6,200,http://www.selleckchem.com/products/wye-125132.html,PI3K/Akt/mTOR,K06410a,C4,L1200-3,0187217540,25260757
207,S2682,CAY10505,,,289.28,1218777-13-9,free base,PI3K,"CAY10505 is dehydroxyl of AS-252424, which is a PI3Kγ inhibitor with IC50 of 33 nM.",C1(=CC=C(C=C1)C2OC(=CC=2)/C=C3\C(NC(S3)=O)=O)F,200,http://www.selleckchem.com/products/cay10505.html,PI3K/Akt/mTOR,K06406a,C5,L1200-3,0187217539,1204893
208,S2699,CH5132799,Yes,,377.42,1007207-67-1,free base,"mTOR,PI3K","CH5132799 inhibits class I PI3Ks, particularly PI3Kα with IC50 of 14 nM; less potent to PI3Kβδγ, while sensitive in PIK3CA mutations cell lines. Phase 1.",N1=C(N=CC(=C1)C2=C3C(=NC(=N2)N4CCOCC4)N(CC3)S(C)(=O)=O)N,31,http://www.selleckchem.com/products/ch5132799.html,PI3K/Akt/mTOR,K06415a,C6,L1200-3,0187217538,49784945
209,S2728,AG-1478 (Tyrphostin AG-1478),,,315.75,153436-53-4,free base,EGFR,"AG-1478 (Tyrphostin AG-1478) is a selective EGFR inhibitor with IC50 of 3 nM, almost no activity on HER2-Neu, PDGFR, Trk, Bcr-Abl and InsR.",C1=C2C(=CC(=C1OC)OC)C(=NC=N2)NC3=CC(=CC=C3)Cl,79,http://www.selleckchem.com/products/ag-1478-tyrphostin-ag-1478.html,Protein Tyrosine Kinase,K02637b,C7,L1200-3,0187217537,2051
210,S2744,CCT137690,,,551.48,1095382-05-0,free base,Aurora Kinase,"CCT137690 is a highly selective inhibitor of Aurora A, Aurora B and Aurora C with IC50 of 15 nM, 25 nM and 19 nM. It has little effect on hERG ion-channel.",C1(=CN=C2C(=C1N3CCN(CC3)CC4C=C(ON=4)C)N=C(N2)C5=CC=C(C=C5)N6CCN(CC6)C)Br,10,http://www.selleckchem.com/products/cct137690.html,Cell Cycle,K06423a,C8,L1200-3,0187217536,25154041
211,S2758,Wortmannin,,,428.43,19545-26-7,free base,"Autophagy,ATM/ATR,PI3K","Wortmannin is a PI3K with IC50 of 3 nM, first described PI3K inhibitors, but little selectivity within the PI3K family. Also blocks autophagosome formation and potently inhibits DNA-PK/ATM with IC50 of 16 nM and 150 nM. Phase 4.",C1(C2C3[C@]([C@H](O1)COC)(C4=C(C(C=3OC=2)=O)[C@@]5(CCC([C@@](C[C@@H]4OC(=O)C)5C)=O)[H])C)=O,200,http://www.selleckchem.com/products/wortmannin.html,PI3K/Akt/mTOR,X02387b,C9,L1200-3,0187217535,312145
212,S2235,Volasertib (BI 6727),Yes,,618.81,755038-65-4,free base,PLK,BI6727 (Volasertib) is a highly potent Plk1 inhibitor with IC50 of 0.87 nM. It shows 6- and 65-fold greater selectivity against Plk2 and Plk3. Phase 2.,[C@H]1(C(N(C2=C(N1C(C)C)N=C(N=C2)NC3=CC=C(C=C3OC)C(N[C@@H]4CC[C@H](CC4)N5CCN(CC5)CC6CC6)=O)C)=O)CC,80,http://www.selleckchem.com/products/BI6727-Volasertib.html,Cell Cycle,K04998b,D1,L1200-3,0187217520,10461508
213,S2783,AZD2014,Yes,,462.54,1009298-59-2,free base,mTOR,AZD2014 is a novel mTOR inhibitor with IC50 of 2.8 nM; highly selective against multiple PI3K isoforms (α/β/γ/δ). Phase 2.,C1=C(N=C2C(=C1)C(=NC(=N2)N3[C@H](COCC3)C)N4[C@H](COCC4)C)C5=CC(=CC=C5)C(NC)=O,82,http://www.selleckchem.com/products/azd2014.html,PI3K/Akt/mTOR,K04331b,D10,L1200-3,0187217529,25262792
214,S2807,Dabrafenib (GSK2118436),Yes,Yes,519.56,1195765-45-7,free base,Raf,"Dabrafenib (GSK2118436) is a mutant BRAFV600 specific inhibitor with IC50 of 0.8 nM, with 4- and 6-fold less potency against B-Raf(wt) and c-Raf, respectively. Phase 3.",C1(C(=CC=CC=1F)F)S(=O)(=O)NC2C(=C(C=CC=2)C3N=C(SC=3C4=NC(=NC=C4)N)C(C)(C)C)F,57,http://www.selleckchem.com/products/dabrafenib-gsk2118436a.html,MAPK,K04339d,D11,L1200-3,0187217530,44462760
215,S2406,Chrysophanic Acid,,,254.24,481-74-3,free base,"mTOR,EGFR","Chrysophanic acid (Chrysophanol), a natural anthraquinone isolated from Dianella longifolia, is a EGFR/mTOR pathway inhibitor.",C1=CC(=C2C(=C1)C(C3=C(C2=O)C(=CC(=C3)C)O)=O)O,10,http://www.selleckchem.com/products/Chrysophanic-acid-Chrysophanol.html,Protein Tyrosine Kinase,N13515b,D2,L1200-3,0187217521,10208
216,S2626,LY2603618,Yes,,436.3,911222-45-2,free base,Chk,LY2603618 is a selective Chk1 inhibitor with potential anti-tumor activity.,C1=C(C(=CC(=C1OC[C@@H]2CNCCO2)NC(NC3=CN=C(C=N3)C)=O)Br)C,29,http://www.selleckchem.com/products/LY2603618-IC-83.html,Cell Cycle,K04319d,D3,L1200-3,0187217522,11955855
217,S2670,A-674563,,,358.44,552325-73-2,free base,"PKA,CDK,Akt","A-674563 is an Akt1 inhibitor with Ki of 11 nM, modest potent to PKA and >30-fold selective for Akt1 over PKC.",C1=CC=CC(=C1)C[C@@H](COC2=CC(=CN=C2)C3=CC4=C(C=C3)NN=C4C)N,200,http://www.selleckchem.com/products/a-674563.html,PI3K/Akt/mTOR,K06405a,D4,L1200-3,0187217523,11314340
218,S2683,CHIR-124,,,419.91,405168-58-3,free base,Chk,"CHIR-124 is a novel and potent Chk1 inhibitor with IC50 of 0.3 nM. It shows 2,000-fold selectivity against Chk2, 500- to 5,000-fold less activity against CDK2/4 and Cdc2.",C1(C(=C(C2=C(N1)C=CC(=C2)Cl)N[C@H]3C4CCN(C3)CC4)C5=NC6=C(N5)C=CC=C6)=O,16,http://www.selleckchem.com/products/chir-124.html,Cell Cycle,K06248b,D5,L1200-3,0187217524,135399748
219,S2700,KX2-391,Yes,,431.53,897016-82-9,free base,Src,"KX2-391 (KX01), the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines. Phase 1/2.",C1=C(C=CC(=C1)C2=CC=C(N=C2)CC(NCC3=CC=CC=C3)=O)OCCN4CCOCC4,199,http://www.selleckchem.com/products/kx2-391.html,Angiogenesis,K04324c,D6,L1200-3,0187217525,23635314
220,S2729,SB415286,,,359.72,264218-23-7,free base,GSK-3,SB415286 is a potent GSK3α inhibitor with IC50/Ki of 78 nM/31 nM with equally effective inhibition of GSK-3β.,C1(C(=C(C(N1)=O)NC2=CC(=C(C=C2)O)Cl)C3=C(C=CC=C3)[N+](=O)[O-])=O,200,http://www.selleckchem.com/products/sb-415286.html,PI3K/Akt/mTOR,N13516b,D7,L1200-3,0187217526,4210951
221,S2745,CHIR-98014,,,486.31,252935-94-7,free base,GSK-3,"CHIR-98014 is a potent GSK-3α/β inhibitor with IC50 of 0.65 nM/0.58 nM, with the ability to distinguish GSK-3 from its closest homologs Cdc2 and ERK2.",C1=C(C=C(C(=C1)C2=NC(=NC=C2N3C=CN=C3)NCCNC4=CC=C(C(=N4)N)[N+](=O)[O-])Cl)Cl,10,http://www.selleckchem.com/products/chir-98014.html,PI3K/Akt/mTOR,K06424a,D8,L1200-3,0187217527,53396311
222,S2759,CUDC-907,Yes,,508.55,1339928-25-4,free base,"PI3K,HDAC","CUDC-907 is a dual PI3K and HDAC inhibitor for PI3Kα and HDAC1/2/3/10 with IC50 of 19 nM and 1.7 nM/5 nM/1.8 nM/2.8 nM, respectively. Phase 1.",C1=NC(=NC=C1C(NO)=O)N(C)CC2=CC3=C(S2)C(=NC(=N3)C4=CC=C(N=C4)OC)N5CCOCC5,200,http://www.selleckchem.com/products/cudc-907.html,Cytoskeletal Signaling,K06428a,D9,L1200-3,0187217528,54575456
223,S2238,Palomid 529 (P529),Yes,,406.43,914913-88-5,free base,mTOR,"Palomid 529 inhibits both the mTORC1 and mTORC2 complexes, reduces phosphorylation of pAktS473, pGSK3βS9, and pS6 but no effect observed on pMAPK or pAktT308. Phase 1.",C1=C(C=CC(=C1)COC2=C(C=C3C(=C2)OC(C4=C3C=CC(=C4)C(C)O)=O)OC)OC,199,http://www.selleckchem.com/products/Palomid-529-P529.html,PI3K/Akt/mTOR,K06371a,E1,L1200-3,0187217519,11998575
224,S2784,TAK-285,Yes,,547.96,871026-44-7,free base,"EGFR,HER2","TAK-285 is a novel dual HER2 and EGFR(HER1) inhibitor with IC50 of 17 nM and 23 nM, >10-fold selectivity for HER1/2 than HER4, less potent to MEK1/5, c-Met, Aurora B, Lck, CSK etc. Phase 1.",C12=C(C(=NC=N1)NC3=CC=C(C(=C3)Cl)OC4=CC=CC(=C4)C(F)(F)F)N(C=C2)CCNC(=O)CC(O)(C)C,200,http://www.selleckchem.com/products/tak-285.html,Protein Tyrosine Kinase,K06433a,E10,L1200-3,0187217510,11620908
225,S2808,GDC-0068,Yes,,458.0,1001264-89-6,free base,Akt,"GDC-0068 is a highly selective pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 5 nM/18 nM/8 nM, 620-fold selectivity over PKA. Phase 2.",C1CN(CCN1C([C@@H](C2=CC=C(C=C2)Cl)CNC(C)C)=O)C3=C4C(=NC=N3)[C@H](C[C@H]4C)O,200,http://www.selleckchem.com/products/gdc-0068.html,PI3K/Akt/mTOR,K04336c,E11,L1200-3,0187217509,24788740
226,S2475,Imatinib (STI571),Yes,Yes,493.6,152459-95-5,free base,PDGFR,"Imatinib is a multi-target inhibitor of v-Abl, c-Kit and PDGFR with IC50 of 0.6 μM, 0.1 μM and 0.1 μM, respectively.",N1=C(N=C(C=C1)C2=CC=CN=C2)NC3=CC(=CC=C3C)NC(=O)C4=CC=C(C=C4)CN5CCN(CC5)C,10,http://www.selleckchem.com/products/Imatinib(STI571).html,Protein Tyrosine Kinase,K00477c,E2,L1200-3,0187217518,5291
227,S2628,PF-05212384 (PKI-587),Yes,,615.73,1197160-78-3,free base,"mTOR,PI3K","PKI-587 is a highly potent dual inhibitor of PI3Kα, PI3Kγ and mTOR with IC50 of 0.4 nM, 5.4 nM and 1.6 nM, respectively. Phase 2.",N1=C(N=C(N=C1N2CCOCC2)C3=CC=C(C=C3)NC(NC4=CC=C(C=C4)C(N5CCC(CC5)N(C)C)=O)=O)N6CCOCC6,10,http://www.selleckchem.com/products/pki587.html,PI3K/Akt/mTOR,K06400a,E3,L1200-3,0187196042,44516953
228,S2671,AS-252424,,,305.28,900515-16-4,free base,PI3K,"AS-252424 is a novel, potent PI3Kγ inhibitor with IC50 of 30 nM with 30-fold selectivity for PI3Kγ than PI3Kα, and low inhibitory activity towards PI3Kδ/β.",C1(=CC(=C(C=C1)C2OC(=CC=2)/C=C3\SC(NC3=O)=O)O)F,199,http://www.selleckchem.com/products/as-252424.html,PI3K/Akt/mTOR,K00780c,E4,L1200-3,0187217516,11630874
229,S2686,NVP-BSK805 2HCl,,,563.47,1092499-93-8(freebase),hydrochloride,JAK,"NVP-BSK805 is a potent and selective ATP-competitive JAK2 inhibitor with IC50 of 0.5 nM,>20-fold selectivity towards JAK1, JAK3 and TYK2.",C1(=CC=C2C(=C1C3=CC(=C(C(=C3)F)CN4CCOCC4)F)N=C(C=N2)C5=CN(N=C5)C6CCNCC6).Cl.Cl,200,http://www.selleckchem.com/products/nvp-bsk805.html,JAK/STAT,K06380a,E5,L1200-3,0187217515,46398810
230,S2703,GSK1838705A,,,532.57,1116235-97-2,free base,"IGF-1R,ALK","GSK1838705A is a potent IGF-1R inhibitor with IC50 of 2.0 nM, modestly potent to IR and ALK with IC50 of 1.6 nM and 0.5 nM, respectively, and little activity to other protein kinases.",N1=C(N=C2C(=C1NC3=CC=CC(=C3C(=O)NC)F)C=CN2)NC4=C(C=C5C(=C4)N(CC5)C(=O)CN(C)C)OC,200,http://www.selleckchem.com/products/gsk1838705a.html,Protein Tyrosine Kinase,K04355c,E6,L1200-3,0187217514,25182616
231,S2730,Crenolanib (CP-868596),,,443.54,670220-88-9,free base,PDGFR,"Crenolanib (CP-868596) is a potent and selective inhibitor of PDGFRα/β with Kd of 2.1 nM/3.2 nM, also potently inhibits FLT3, sensitive to D842V mutation not V561D mutation, >100-fold more selective for PDGFR than c-Kit, VEGFR-2, TIE-2, FGFR-2, EGFR, erbB2, and Src.",C1=CC(=C2C(=C1)C=CC(=N2)N3C=NC4=C3C=CC(=C4)OCC5(COC5)C)N6CCC(CC6)N,200,http://www.selleckchem.com/products/crenolanib-cp-868596.html,Protein Tyrosine Kinase,K04343c,E7,L1200-3,0187217513,10366136
232,S2746,AZ 628,,,451.52,878739-06-1,free base,Raf,"AZ628 is a new pan-Raf inhibitor for BRAF, BRAFV600E, and c-Raf-1 with IC50 of 105 nM, 34 nM and 29 nM, also inhibits VEGFR2, DDR2, Lyn, Flt1, FMS, etc.",C1(=CC=CC(=C1)C(NC2=CC=C(C(=C2)NC3=CC4=C(C=C3)N=CN(C4=O)C)C)=O)C(C#N)(C)C,199,http://www.selleckchem.com/products/az628.html,MAPK,K05284b,E8,L1200-3,0187217512,11676786
233,S2761,NVP-BVU972,,,340.38,1185763-69-2,free base,c-Met,NVP-BVU972 is a selective and potent Met inhibitor with IC50 of 14 nM.,C1C(=NN2C(C=1)=NC=C2CC3=CC=C4C(=C3)C=CC=N4)C5C=NN(C=5)C,199,http://www.selleckchem.com/products/nvp-bvu972.html,Protein Tyrosine Kinase,K06427a,E9,L1200-3,0187217511,44206063
234,S2243,Degrasyn (WP1130),,,384.27,856243-80-6,free base,"DUB,Bcr-Abl","WP1130 (Degrasyn) is a selective deubiquitinase (DUB: USP5, UCH-L1, USP9x, USP14, and UCH37) inhibitor and also suppresses Bcr/Abl, also a JAK2 transducer (without affecting 20S proteasome) and activator of transcription (STAT).",C1(=CC=CC(=N1)/C=C(/C(N[C@H](C2=CC=CC=C2)CCC)=O)C#N)Br,200,http://www.selleckchem.com/products/WP1130.html,Angiogenesis,K06399a,F1,L1200-3,0187217496,11222830
235,S2788,INCB28060,,,412.42,1029712-80-8,free base,c-Met,"INCB28060 is a novel, ATP-competitive inhibitor of c-MET with IC50 of 0.13 nM, inactive against RONβ, as well as EGFR and HER-3. Phase 1.",C(C1C(=CC(=CC=1)C2C=NC3N(N=2)C(=CN=3)CC4C=C5C=CC=NC(=CC=4)5)F)(=O)NC,10,http://www.selleckchem.com/products/incb28060.html,Protein Tyrosine Kinase,K06434a,F10,L1200-3,0187217505,25145656
236,S2811,INK 128 (MLN0128),Yes,,309.33,1224844-38-5,free base,mTOR,"INK 128 is a potent and selective mTOR inhibitor with IC50 of 1 nM; >200-fold less potent to class I PI3K isoforms, superior in blocking mTORC1/2 and sensitive to pro-invasion genes (vs Rapamycin). Phase 1.",N1=CN=C2C(=C1N)C(=NN2C(C)C)C3=CC4=C(C=C3)OC(=N4)N,200,http://www.selleckchem.com/products/ink128.html,PI3K/Akt/mTOR,K06419a,F11,L1200-3,0187217506,45375953
237,S2542,Phenformin HCl,,Yes,241.72,834-28-6,hydrochloride,AMPK,Phenformin hydrochloride is a hydrochloride salt of phenformin that is an anti-diabetic drug from the biguanide class.,C1(=CC=C(C=C1)CCNC(NC(=N)N)=N).Cl,198,http://www.selleckchem.com/products/Phenformin-hydrochloride.html,PI3K/Akt/mTOR,K06396a,F2,L1200-3,0187217497,13266
238,S2634,DCC-2036 (Rebastinib),Yes,,553.59,1020172-07-9,free base,Bcr-Abl,"DCC-2036 is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1/2.",C1(=C(C=C(C=C1)OC2=CC(=NC=C2)C(NC)=O)F)NC(NC3N(N=C(C=3)C(C)(C)C)C4=CC5=C(C=C4)N=CC=C5)=O,200,http://www.selleckchem.com/products/dcc-2036.html,Angiogenesis,K04332c,F3,L1200-3,0187217498,25066467
239,S2672,PF-00562271,Yes,,665.66,939791-38-5,benzenesulfonic,FAK,"PF-00562271 is the benzenesulfonate salt of PF-562271, which is a potent, ATP-competitive, reversible inhibitor of FAK with IC50 of 1.5 nM, ~10-fold less potent for Pyk2 than FAK and >100-fold selectivity against other protein kinases, except for some CDKs. Phase 1.",C1(=NC(=C(C=C1)CNC2=C(C=NC(=N2)NC3=CC=C4C(=C3)CC(N4)=O)C(F)(F)F)N(C)S(=O)(C)=O).C5=CC=CC(=C5)S(O)(=O)=O,21,http://www.selleckchem.com/products/pf-00562271.html,Angiogenesis,K06407a,F4,L1200-3,0187217499,16118986
240,S2688,R547,,,441.45,741713-40-6,free base,CDK,"R547 is a potent ATP-competitive inhibitor of CDK1/2/4 with Ki of 2 nM/3 nM/1 nM. It is less potent to CDK7 and GSK3α/β, while inactive to other kinases.",N1=C(N=CC(=C1N)C(C2=C(C(=CC=C2OC)F)F)=O)NC3CCN(CC3)S(=O)(C)=O,135,http://www.selleckchem.com/products/r547.html,Cell Cycle,K06408a,F5,L1200-3,0187217500,6918852
241,S2718,TAK-901,Yes,,504.64,934541-31-8,free base,Aurora Kinase,"TAK-901 is a novel inhibitor of Aurora A/B with IC50 of 21 nM/15 nM. It is not a potent inhibitor of cellular JAK2, c-Src or Abl. Phase 1.",C1N(CCC(C1)NC(C2=C(C3=C(C(=C2)C4=CC(=CC=C4)S(CC)(=O)=O)C5=C(N3)N=CC(=C5)C)C)=O)C,200,http://www.selleckchem.com/products/tak-901.html,Cell Cycle,K04240c,F6,L1200-3,0187217501,16124208
242,S2735,MK-8776 (SCH 900776),Yes,,376.25,891494-63-6,free base,"CDK,Chk",SCH 900776 is a selective Chk1 inhibitor with IC50 of 3 nM. It shows 500-fold selectivity against Chk2. Phase 2.,C12N=C(C(=C(N1N=CC=2C3=CN(N=C3)C)N)Br)[C@H]4CNCCC4,10,http://www.selleckchem.com/products/sch-900776.html,Cell Cycle,K06243b,F7,L1200-3,0187217502,46239015
243,S2747,AMG-458,,,539.58,913376-83-7,free base,c-Met,"AMG 458 is a potent c-Met inhibitor with Ki of 1.2 nM, ~350-fold selectivity for c-Met than VEGFR2 in cells.",N1(N(C(C(=C1C)C(=O)NC2C=CC(=CN=2)OC3C=CN=C4C=C(C=CC=34)OC)=O)C5C=CC=CC=5)CC(C)(C)O,38,http://www.selleckchem.com/products/amg458.html,Protein Tyrosine Kinase,K06421a,F8,L1200-3,0187217503,24764449
244,S2762,Alectinib (CH5424802),Yes,,482.62,1256580-46-7,free base,ALK,"CH5424802 is a potent ALK inhibitor with IC50 of 1.9 nM, sensitive to L1196M mutation and higher selectivity for ALK than PF-02341066, NVP-TAE684 and PHA-E429. Phase 1/2.",C1(=CC=C2C(=C1)NC3=C2C(C4=C(C3(C)C)C=C(C(=C4)CC)N5CCC(CC5)N6CCOCC6)=O)C#N,10,http://www.selleckchem.com/products/ch5424802.html,Protein Tyrosine Kinase,K06426a,F9,L1200-3,0187217504,49806720
245,S2247,"BKM120 (NVP-BKM120, Buparlisib)",Yes,,410.39,944396-07-0,free base,PI3K,"BKM120 is a selective PI3K inhibitor of p110α/β/δ/γ with IC50 of 52 nM/166 nM/116 nM/262 nM, respectively. Reduced potency against VPS34, mTOR, DNAPK, with little activity to PI4Kβ. Phase 1/2.",C1=C(N=CC(=C1C(F)(F)F)C2=NC(=NC(=C2)N3CCOCC3)N4CCOCC4)N,199,http://www.selleckchem.com/products/BKM-120.html,PI3K/Akt/mTOR,K04316b,G1,L1200-3,0187217495,16654980
246,S2789,"Tofacitinib (CP-690550,Tasocitinib)",Yes,,312.37,477600-75-2,free base,JAK,"Tofacitinib is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1.",N1=CN=C2C(=C1N(C)[C@H]3CN(CC[C@@H]3C)C(=O)CC#N)C=CN2,198,http://www.selleckchem.com/products/tofacitinib-cp-690550.html,JAK/STAT,K04288b,G10,L1200-3,0187217486,9926791
247,S2814,BYL719,Yes,,441.47,1217486-61-7,free base,PI3K,"BYL719 is a potent and selective PI3Kα inhibitor with IC50 of 5 nM, and minimal effect on PI3Kβ/γ/δ. Phase 1/2.",N1([C@@H](CCC1)C(=O)N)C(=O)NC2SC(=C(N=2)C)C3=CC(=NC=C3)C(C(F)(F)F)(C)C,199,http://www.selleckchem.com/products/byl719.html,PI3K/Akt/mTOR,K04351b,G11,L1200-3,0187217485,56649450
248,S2617,TAK-733,Yes,,504.23,1035555-63-5,free base,MEK,"TAK-733 is a potent and selective MEK allosteric site inhibitor for MEK1 with IC50 of 3.2 nM, inactive to Abl1, AKT3, c-RAF, CamK1, CDK2, c-Met, etc. Phase 1.",N1(C=NC2=C(C1=O)C(=C(C(N2C)=O)F)NC3=CC=C(C=C3F)I)C[C@@H](O)CO,200,http://www.selleckchem.com/products/tak-733.html,MAPK,K06401a,G2,L1200-3,0187217494,24963252
249,S2635,CCT128930,,,341.84,885499-61-6,free base,Akt,"CCT128930 is a potent, ATP-competitive and selective inhibitor of Akt2 with IC50 of 6 nM, 28-fold greater selectivity for Akt2 than the closely related PKA kinase.",N1=CN=C2C(=C1N3CCC(CC3)(N)CC4=CC=C(C=C4)Cl)C=CN2,198,http://www.selleckchem.com/products/cct128930.html,PI3K/Akt/mTOR,K06402a,G3,L1200-3,0187217493,17751819
250,S2673,Trametinib (GSK1120212),Yes,,615.39,871700-17-3,free base,MEK,"Trametinib (GSK1120212) is a highly specific and potent MEK1/2 inhibitor with IC50 of 0.92 nM/1.8 nM, no inhibition of the kinase activities of c-Raf, B-Raf, ERK1/2. Phase 3.",C1(N(C(=C2C(=C1C)N(C(N(C2=O)C3CC3)=O)C4=CC(=CC=C4)NC(C)=O)NC5=CC=C(C=C5F)I)C)=O,162,http://www.selleckchem.com/products/gsk1120212-(jtp-74057).html,MAPK,K04299c,G4,L1200-3,0187217492,11707110
251,S2689,WAY-600,,,494.59,1062159-35-6,free base,mTOR,"WAY-600 is a potent, ATP-competitive and selective inhibitor of mTOR with IC50 of 9 nM; blocks mTORC1/P-S6K(T389) and mTORC2/P-AKT(S473) but not P-AKT(T308); selective for mTOR than PI3Kα (>100-fold) and PI3Kγ (>500-fold). ",C12=C(C=CC(=C1)C3=NC4=C(C(=N3)N5CCOCC5)C=NN4C6CCN(CC6)CC7=CC=CN=C7)NC=C2,44,http://www.selleckchem.com/products/way-600.html,PI3K/Akt/mTOR,K06409a,G5,L1200-3,0187217491,25229526
252,S2719,AMG-900,,,503.58,945595-80-2,free base,Aurora Kinase,"AMG 900 is a potent and highly selective pan-Aurora kinases inhibitor for Aurora A/B/C with IC50 of 5 nM/4 nM /1 nM. It is >10-fold selective for Aurora kinases than p38α, Tyk2, JNK2, Met and Tie2. Phase 1.",C1=CC(=C(N=C1)OC2=CC=C(C=C2)NC3C4=C(C(=NN=3)C5SC=C(C=5)C)C=CC=C4)C6=NC(=NC=C6)N,198,http://www.selleckchem.com/products/amg-900.html,Cell Cycle,K04225b,G6,L1200-3,0187217490,24856041
253,S2736,TG101348 (SAR302503),Yes,,524.68,936091-26-8,free base,JAK,"TG-101348 (SAR302503) is a selective inhibitor of JAK2 with IC50 of 3 nM, 35- and 334-fold more selective for JAK2 versus JAK1 and JAK3. Phase 1/2.",C1(=CC=C(C=C1)NC2=NC(=C(C=N2)C)NC3=CC=CC(=C3)S(NC(C)(C)C)(=O)=O)OCCN4CCCC4,190,http://www.selleckchem.com/products/tg-101348.html,JAK/STAT,K03971d,G7,L1200-3,0187217489,16722836
254,S2749,BGT226 (NVP-BGT226),Yes,,650.6,1245537-68-1,free base,"PI3K,mTOR",NVP-BGT226 is a novel class I PI3K/mTOR inhibitor for PI3Kα/β/γ with IC50 of 4 nM/63 nM/38 nM. Phase 1/2.,C(/C=C\C(=O)O)(=O)O.N1=CC2=C(C3=CC(=CC=C13)C4C=NC(=CC=4)OC)N(C(N2C)=O)C5C=C(C(=CC=5)N6CCNCC6)C(F)(F)F,46,http://www.selleckchem.com/products/nvp-bgt226.html,PI3K/Akt/mTOR,K06425a,G8,L1200-3,0187217488,57336745
255,S2767,3-Methyladenine,,,149.15,5142-23-4,free base,"Autophagy,PI3K","3-Methyladenine is a selective PI3K inhibitor for Vps34 and PI3Kγ with IC50 of 25 μM and 60 μM;  blocks class I PI3K consistently, whereas suppression of class III PI3K is transient, and also blocks autophagosome formation.",N1=CN=C2N(C=NC(=C12)N)C,26,http://www.selleckchem.com/products/3-methyladenine.html,PI3K/Akt/mTOR,Z01018b,G9,L1200-3,0187217487,135398661
256,S2266,Asiatic Acid,,,488.7,464-92-6,free base,p38 MAPK,"Asiatic acid is the aglycone of asiaticoside isolated from the plant Centella asiatica, commonly used in wound healing. ",[C@@H]1([C@@H]([C@]([C@]2([C@](C1)([C@]3([C@@](CC2)([C@]4(C(=CC3)[C@@]5([C@@](CC4)(CC[C@H]([C@H]5C)C)C(O)=O)[H])C)C)[H])C)[H])(CO)C)O)O,200,http://www.selleckchem.com/products/Asiatic-acid.html,MAPK,K06389a,H1,L1200-3,0187196041,119034
257,S2791,Sotrastaurin,Yes,,438.48,425637-18-9,free base,PKC,"Sotrastaurin is a potent and selective pan-PKC inhibitor, mostly for PKCθ with Ki of 0.22 nM; inactive to PKCζ. Phase 1/2.",N1C(C(=C(C1=O)C2N=C(N=C3C=CC=CC=23)N4CCN(CC4)C)C5=CNC6C=CC=CC5=6)=O,198,http://www.selleckchem.com/products/sotrastaurin-aeb071.html,TGF-beta/Smad,K04293c,H10,L1200-3,0187196043,10296883
258,S2816,Tyrphostin AG 879,,,316.46,148741-30-4,free base,HER2,"Tyrphostin AG 879 potently inhibits HER2/ErbB2 with IC50 of 1 μM, 100- and 500-fold higher selective to ErbB2 than PDGFR and EGFR.",C(/C(=C/C1C=C(C(=C(C=1)C(C)(C)C)O)C(C)(C)C)C#N)(N)=S,113,http://www.selleckchem.com/products/tyrphostin-ag-879-ag-879.html,Protein Tyrosine Kinase,K06436a,H11,L1200-3,0187217482,135419190
259,S2621,AZD5438,Yes,,371.46,602306-29-6,free base,CDK,AZD5438 is a potent inhibitor of CDK1/2/9 with IC50 of 16 nM/6 nM/20 nM. It is less potent to CDK5/6 and also inhibits GSK3β. Phase 1.,C1=C(C=CC(=C1)NC2=NC=CC(=N2)C3=CN=C(N3C(C)C)C)S(=O)(C)=O,199,http://www.selleckchem.com/products/AZD5438.html,Cell Cycle,K04226b,H2,L1200-3,0187217473,16747683
260,S2636,A66,,,393.53,1166227-08-2,free base,PI3K,"A66 is a potent and specific p110α inhibitor with IC50 of 32 nM, >100 fold selectivity for p110α over other class-I PI3K isoforms.",C1SC(=NC=1C2SC(=NC=2C)NC(N3[C@@H](CCC3)C(=O)N)=O)C(C)(C)C,200,http://www.selleckchem.com/products/a66.html,PI3K/Akt/mTOR,K06404a,H3,L1200-3,0187217474,42636535
261,S2679,Flavopiridol HCl,Yes,,438.3,131740-09-5,hydrochloride,CDK,"Flavopiridol competes with ATP to inhibit CDKs including CDK1, CDK2, CDK4 and CDK6 with IC50 of ~ 40 nM. It is 7.5-fold more selective for CDK1/2/4/6 than CDK7. Flavopiridol is initially found to inhibit EGFR and PKA. Phase 1/2.",C1(=C(C(=C2C(=C1O)C(C=C(O2)C3=C(C=CC=C3)Cl)=O)[C@@]4([C@@H](CN(CC4)C)O)[H])O).Cl,200,http://www.selleckchem.com/products/flavopiridol-hydrochloride.html,Cell Cycle,K06417a,H4,L1200-3,0187217475,9910986
262,S2692,TG101209,,,509.67,936091-14-4,free base,"JAK,FLT3,c-RET","TG101209 is a selective JAK2 inhibitor with IC50 of 6 nM, less potent to Flt3 and RET with IC50 of 25 nM and 17 nM, ~30-fold selective for JAK2 than JAK3, sensitive to JAK2V617F and MPLW515L/K mutations.",C1=C(C=C(C=C1)NC2=NC(=NC=C2C)NC3=CC=C(C=C3)N4CCN(CC4)C)S(NC(C)(C)C)(=O)=O,200,http://www.selleckchem.com/products/tg101209.html,JAK/STAT,K04138b,H5,L1200-3,0187217476,16722832
263,S2720,ZM 336372,,,389.45,208260-29-1,free base,Raf,"ZM 336372 is a potent and selective c-Raf inhibitor with IC50 of 70 nM, 10-fold selectivity over B-RAF, no inhibition to PKA/B/C, AMPK, p70S6, etc.",C1(=CC=CC(=C1)C(NC2=CC(=C(C=C2)C)NC(C3=CC=C(C=C3)O)=O)=O)N(C)C,200,http://www.selleckchem.com/products/zm-336372.html,MAPK,K00085d,H6,L1200-3,0187217477,5730
264,S2740,GSK1070916,Yes,,507.63,942918-07-2,free base,Aurora Kinase,GSK1070916 is a reversible and ATP-competitive inhibitor of Aurora B/C with IC50 of 3.5 nM/6.5 nM. It displays >100-fold selectivity against the closely related Aurora A-TPX2 complex. Phase 1.,C1=CN=C2C(=C1C3=CN(N=C3C4=CC=C(C=C4)NC(N(C)C)=O)CC)C=C(N2)C5=CC=CC(=C5)CN(C)C,200,http://www.selleckchem.com/products/gsk1070916.html,Cell Cycle,K04230b,H7,L1200-3,0187217478,46885626
265,S2751,Milciclib (PHA-848125),Yes,,460.57,802539-81-7,free base,CDK,"PHA-848125 is a potent, ATP-competitive CDK inhibitor for CDK2 with IC50 of 45 nM. It is >3-fold more selective for CDK2 than CDK1, 2, 4, 5, and 7. Phase 2.",C12CC(C3=C(C(=NC(=NC=1)NC4=CC=C(C=C4)N5CCN(CC5)C)2)N(N=C3C(NC)=O)C)(C)C,199,http://www.selleckchem.com/products/pha-848125.html,Cell Cycle,K04372d,H8,L1200-3,0187217479,16718576
266,S2768,Dinaciclib (SCH727965),Yes,,396.49,779353-01-4,free base,CDK,"Dinaciclib (SCH727965) is a novel and potent CDK inhibitor for CDK2, CDK5, CDK1 and CDK9 with IC50 of 1 nM, 1 nM, 3 nM and 4 nM, respectively. It also blocks thymidine (dThd) DNA incorporation. Phase 3.",C1C[C@H](N(CC1)C2C=C(N3C(N=2)=C(C=N3)CC)NCC4=CC=C[N+](=C4)[O-])CCO,199,http://www.selleckchem.com/products/dinaciclib-sch727965.html,Cell Cycle,K04338c,H9,L1200-3,0187217480,46926350
267,S2817,Torin 2,,,432.4,1223001-51-1,free base,"ATM/ATR,mTOR","Torin 2 is a potent and selective mTOR inhibitor with IC50 of 0.25 nM; 800-fold greater selectivity for mTOR than PI3K and improved pharmacokinetic properties. Inhibition of ATM/ATR/DNA-PK with EC50 of 28 nM/35 nM/118 nM, respectively.",N1(C(C=CC2C=NC3C(C1=2)=CC(=CC=3)C4C=NC(=CC=4)N)=O)C5C=C(C=CC=5)C(F)(F)F,46,http://www.selleckchem.com/products/torin-2.html,PI3K/Akt/mTOR,K06437a,A1,L1200-4,0187169943,51358113
268,S7435,AR-A014418,,,308.31,487021-52-3,free base,GSK-3,"AR-A014418 is an ATP-competitive, and selective GSK3β inhibitor with IC50 and Ki of 104 nM and 38 nM, without significant inhibition on 26 other kinases tested.",C1=C(SC(=N1)NC(NCC2=CC=C(C=C2)OC)=O)[N+](=O)[O-],201,http://www.selleckchem.com/products/ar-a014418.html,PI3K/Akt/mTOR,K00082c,A10,L1200-4,0187172150,448014
269,S8019,AZD5363,Yes,,428.92,1143532-39-1,free base,Akt,"AZD5363 potently inhibits all isoforms of Akt(Akt1/Akt2/Akt3) with IC50 of 3 nM/8 nM/8 nM, similar to P70S6K/PKA and lower activity towards ROCK1/2. Phase 1/2.",N1(CCC(CC1)(C(=O)N[C@@H](CCO)C2C=CC(=CC=2)Cl)N)C3C4=C(N=CN=3)NC=C4,200,http://www.selleckchem.com/products/azd5363.html,PI3K/Akt/mTOR,K04359c,A11,L1200-4,0187169936,25227436
270,S2859,Golvatinib (E7050),Yes,,633.69,928037-13-2,free base,"VEGFR,c-Met","Golvatinib (E7050) is a dual c-Met and VEGFR-2 inhibitor with IC50 of 14 nM and 16 nM, does not inhibit bFGF-stimulated HUVEC growth (up to 1000 nM). Phase 1/2. ",C1=C(C=CC(=C1F)NC(C2(C(NC3=CC=C(C=C3)F)=O)CC2)=O)OC4=CC(=NC=C4)NC(N5CCC(CC5)N6CCN(CC6)C)=O,31,http://www.selleckchem.com/products/golvatinib-e7050.html,Protein Tyrosine Kinase,K06446a,A2,L1200-4,0187172158,16118392
271,S2895,Tyrphostin 9 ,,,282.38,10537-47-0,free base,EGFR,"Tyrphostin 9 is firstly designed as an EGFR inhibitor with IC50 of 460 μM, but is also found to be more potent to PDGFR with IC50 of 0.5 μM.",C1(C(=C(C=C(C=1)C=C(C#N)C#N)C(C)(C)C)O)C(C)(C)C,198,http://www.selleckchem.com/products/tyrphostin-9-sf-6847.html,Protein Tyrosine Kinase,N11499b,A3,L1200-4,0187172157,5614
272,S2922,Icotinib,Yes,,391.42,610798-31-7,free base,EGFR,"Icotinib is a potent and specific EGFR inhibitor with IC50 of 5 nM, including the EGFR, EGFR(L858R), EGFR(L861Q), EGFR(T790M) and EGFR(T790M, L858R). Phase 4.",C1=C(C=CC=C1NC2=NC=NC3=C2C=C4C(=C3)OCCOCCOCCO4)C#C,199,http://www.selleckchem.com/products/icotinib.html,Protein Tyrosine Kinase,K04369d,A4,L1200-4,0187172156,22024915
273,S6005,VX-702,Yes,,404.3,745833-23-2,free base,p38 MAPK,"VX-702 is a highly selective inhibitor of p38α MAPK, 14-fold higher potency against the p38α versus p38β. Phase 2.",C1=CC(=C(C(=C1)F)N(C2=NC(=C(C=C2)C(N)=O)C3=C(C=C(C=C3)F)F)C(=O)N)F,200,http://www.selleckchem.com/products/VX-702.html,MAPK,K06392a,A5,L1200-4,0187172155,10341154
274,S7036,XL019,Yes,,444.53,945755-56-6,free base,JAK,"XL019 is a potent and selective JAK2 inhibitor with IC50 of 2.2 nM, exhibiting >50-fold selectivity over JAK1, JAK3 and TYK2. Phase 1.",C1=CC(=CC=C1NC([C@@H]2CCCN2)=O)C3=CC=NC(=N3)NC4=CC=C(C=C4)N5CCOCC5,35,http://www.selleckchem.com/products/xl019.html,JAK/STAT,K06480a,A6,L1200-4,0187172154,57990869
275,S7106,AZD3463,,,448.95,1356962-20-3,free base,ALK,"AZD3463 is a novel orally bioavailable ALK inhibitor with Ki of 0.75 nM, which also inhibits IGF1R with equivalent potency. ",C12=C(C=CC=C1)C(=CN2)C3=C(C=NC(=N3)NC4=C(C=C(C=C4)N5CCC(CC5)N)OC)Cl,53,http://www.selleckchem.com/products/azd3463.html,Protein Tyrosine Kinase,K06466a,A7,L1200-4,0187172153,56599293
276,S7173,AVL-292,Yes,,423.44,1202757-89-8,free base,BTK,"AVL-292 is a covalent, orally active, and highly selective BTK inhibitor with IC50 of <0.5 nM, displaying at least 1400-fold selectivity over the other kinases assayed. Phase 1.",C1(=CN=C(N=C1NC2=CC(=CC=C2)NC(C=C)=O)NC3=CC=C(C=C3)OCCOC)F,200,http://www.selleckchem.com/products/avl-292.html,Angiogenesis,K06483a,A8,L1200-4,0187172152,59174488
277,S7257,CNX-774,,,499.5,1202759-32-7,free base,BTK,"CNX-774 is an irreversible, orally active, and highly selective BTK inhibitor with IC50 of <1 nM.",C1=C(C=C(C=C1)NC(C=C)=O)NC2=C(C=NC(=N2)NC3=CC=C(C=C3)OC4=CC=NC(=C4)C(NC)=O)F,200,http://www.selleckchem.com/products/cnx-774.html,Angiogenesis,K06486a,A9,L1200-4,0187172151,59174579
278,S2820,TAE226 (NVP-TAE226),,,468.94,761437-28-9,free base,FAK,"NVP-TAE226 is a potent FAK inhibitor with IC50 of 5.5 nM and modestly potent to Pyk2, ~10- to 100-fold less potent against InsR, IGF-1R, ALK, and c-Met.",C1(=CC(=C(C=C1)NC2=NC(=C(C=N2)Cl)NC3=C(C=CC=C3)C(NC)=O)OC)N4CCOCC4,200,http://www.selleckchem.com/products/nvp-tae226.html,Angiogenesis,K05000b,B1,L1200-4,0187172136,9934347
279,S8002,GSK2636771,Yes,,433.42,1372540-25-4,free base,PI3K,"GSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, sensitive to PTEN null cell lines. Phase 1/2a.",C1=C(C=C2C(=C1C(=O)O)N=C(N2CC3=CC=CC(=C3C)C(F)(F)F)C)N4CCOCC4,64,http://www.selleckchem.com/products/gsk2636771.html,PI3K/Akt/mTOR,K04329b,B10,L1200-4,0187172145,56949517
280,S8023,TCS 359,,,360.43,301305-73-7,free base,FLT3,TCS 359 is a potent FLT3 inhibitor with IC50 of 42 nM.,C12=C(C(=C(S1)NC(C3C=C(C(=CC=3)OC)OC)=O)C(=O)N)CCCC2,41,http://www.selleckchem.com/products/tcs-359.html,Angiogenesis,K00612b,B11,L1200-4,0187172146,1048845
281,S2864,IMD 0354,,,383.67,978-62-1,free base,IκB/IKK,IMD-0354 is an IKKβ inhibitor and blocks IκBα phosphorylation in NF-κB pathway.,C1=CC(=CC(=C1O)C(NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)=O)Cl,26,http://www.selleckchem.com/products/imd-0354.html,NF-κB,K02680b,B2,L1200-4,0187172137,5081913
282,S2896,ZM 323881 HCl,,,411.86,193000-39-4,hydrochloride,VEGFR,"ZM 323881 is a potent and selective VEGFR2 inhibitor with IC50 of <2 nM, almost no activity on VEGFR1, PDGFRβ, FGFR1, EGFR and ErbB2.",C1(C(=CC(=C(C=1)NC2N=CN=C3C=C(C=CC=23)OCC4C=CC=CC=4)F)C)O.Cl,24,http://www.selleckchem.com/products/zm-323881-hcl.html,Protein Tyrosine Kinase,K06447a,B3,L1200-4,0187172138,22624897
283,S2924,CHIR-99021 (CT99021) HCl,,,501.8,252917-06-9(freebase),hydrochloride,GSK-3,"CHIR-99021 HCl (CT99021) is hydrochloride of CHIR-99021, which is a GSK-3α/β inhibitor with IC50 of 10 nM/6.7 nM; ability to distinguish between GSK-3 and its closest homologs Cdc2 and ERK2.",C1(=NC=C(C(=N1)C2=CC=C(C=C2Cl)Cl)C3NC=C(N=3)C)NCCNC4(=NC=C(C=C4)C#N).Cl,185,http://www.selleckchem.com/products/chir-99021-ct99021-hcl.html,PI3K/Akt/mTOR,K05652c,B4,L1200-4,0187172139,9956119
284,S7000,AP26113,Yes,,529.01,1197958-12-5,free base,ALK,"AP26113 is a potent ALK inhibitor with IC50 of 0.62 nM, demonstrated ability overcome Crizotinib resistance mediated by a L1196M mutation. Phase 1/2.",C1(N=C(C(=CN=1)Cl)NC2C(=CC=CC=2)P(=O)(C)C)NC3C(=CC(=CC=3)N4CCC(CC4)N(C)C)OC,85,http://www.selleckchem.com/products/ap26113.html,Protein Tyrosine Kinase,K04367d,B5,L1200-4,0187172140,57390074
285,S7039,PD168393,,,369.22,194423-15-9,free base,EGFR,"PD168393 is an irreversible EGFR inhibitor with IC50 of 0.70 nM, irreversibly alkylate Cys-773; inactive against insulin, PDGFR, FGFR and PKC.",C1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)Br)NC(C=C)=O,200,https://www.selleckchem.com/products/pd168393.html,Protein Tyrosine Kinase,K06458a,B6,L1200-4,0187172141,4708
286,S7114,NU6027,,,251.28,220036-08-8,free base,CDK,"NU6027 is a potent ATR/CDK inhibitor, inhibits CDK1/2, ATR and DNA-PK with Ki of 2.5 μM/1.3 μM, 0.4 μM and 2.2 μM, enter cells more readily than the 6-aminopurine-based inhibitors.",C1CCCC(C1)COC2=NC(=NC(=C2N=O)N)N,198,http://www.selleckchem.com/products/nu6027.html,Cell Cycle,K06463a,B7,L1200-4,0187172142,398148
287,S7176,SKI II,,,302.78,312636-16-1,free base,S1P Receptor,"SKI II is a highly selective and non ATP-competitive S1P receptor inhibitor with IC50 of 0.5 μM, while exhibits no inhibitory on other kinases including PI3K, PKCα and ERK2.",C1(C2=CC=C(C=C2)Cl)N=C(NC3=CC=C(C=C3)O)SC=1,201,http://www.selleckchem.com/products/ski-ii.html,GPCR & G Protein,K06467a,B8,L1200-4,0187172143,753704
288,S7284,CO-1686 (AVL-301),Yes,,555.55,1374640-70-6,free base,EGFR,"CO-1686 is an irreversible, mutant-selective EGFR inhibitor with Ki of 21.5 nM and 303.3 nM for EGFRL858R/T790M and EGFRWT, respectively. Phase 1/2.",C1(=CN=C(N=C1NC2=CC=CC(=C2)NC(=O)C=C)NC3=C(C=C(C=C3)N4CCN(CC4)C(C)=O)OC)C(F)(F)F,180,http://www.selleckchem.com/products/co-1686.html,Protein Tyrosine Kinase,K06476a,B9,L1200-4,0187172144,57335384
289,S2823,Tideglusib,Yes,,334.39,865854-05-3,free base,GSK-3,"Tideglusib is an irreversible, non ATP-competitive GSK-3β inhibitor with IC50 of 60 nM; fails to inhibit kinases with a Cys homologous to Cys-199 located in the active site. Phase 1/2.",S1N(C(N(C1=O)CC2C=CC=CC=2)=O)C3C=CC=C4C=CC=CC=34,10,http://www.selleckchem.com/products/tideglusib.html,PI3K/Akt/mTOR,K04375b,C1,L1200-4,0187172135,11313622
290,S8003,PQ 401,,,341.79,196868-63-0,free base,IGF-1R,PQ401 inhibits autophosphorylation of IGF-1R domain with IC50 of <1 μM.,N(C(=O)NC1C=C(N=C2C=CC=CC=12)C)C3=C(C=CC(=C3)Cl)OC,93,http://www.selleckchem.com/products/pq-401.html,Protein Tyrosine Kinase,K00614b,C10,L1200-4,0187172126,9549305
291,S8024,Tyrphostin AG 1296,,,266.29,146535-11-7,free base,"FGFR,c-Kit,PDGFR","Tyrphostin AG 1296 is an inhibitor of PDGFR with IC50 of 0.3-0.5 μM, no activity to EGFR.",N1C(=CN=C2C=C(C(=CC=12)OC)OC)C3C=CC=CC=3,22,http://www.selleckchem.com/products/tyrphostin-ag-1296-ag-1296.html,Protein Tyrosine Kinase,K02636b,C11,L1200-4,0187172125,2049
292,S2867,WHI-P154,,,376.2,211555-04-3,free base,"JAK,EGFR","WHI-P154 is a potent JAK3 inhibitor with IC50 of 1.8 μM, no activity against JAK1 or JAK2, also inhibits EGFR, Src, Abl, VEGFR and MAPK, prevents Stat3, but not Stat5 phosphorylation.",N1C=NC(=C2C=C(C(=CC=12)OC)OC)NC3C=C(C(=CC=3)O)Br,199,http://www.selleckchem.com/products/whi-p154.html,JAK/STAT,K02614b,C2,L1200-4,0187172134,3795
293,S2897,ZM 306416,,,333.74,690206-97-4,free base,VEGFR,"ZM 306416 is a VEGFR (Flt and KDR) inhibitor for VEGFR1 with IC50 of 0.33 μM, but also found to inhibit EGFR with IC50 of <10 nM.",C12C(C=C(C(=C1)OC)OC)=NC=NC=2NC3=C(C=C(C=C3)Cl)F,200,http://www.selleckchem.com/products/zm-306416.html,Protein Tyrosine Kinase,K06448a,C3,L1200-4,0187172133,5329006
294,S2928,TAK-715,Yes,,399.51,303162-79-0,free base,p38 MAPK,"TAK-715 is a p38 MAPK inhibitor for p38α with IC50 of 7.1 nM, 28-fold more selective for p38α over p38β, no inhibition to p38γ/δ, JNK1, ERK1, IKKβ, MEKK1 or TAK1. Phase 2.",C(C1C=CC=CC=1)(=O)NC2C=C(C=CN=2)C3=C(N=C(S3)CC)C4C=C(C=CC=4)C,200,http://www.selleckchem.com/products/tak-715.html,MAPK,K06251b,C4,L1200-4,0187172132,9952773
295,S8078,Bardoxolone Methyl,Yes,,505.69,218600-53-4,free base,IκB/IKK,"Bardoxolone Methyl is an IKK inhibitor, showing potent proapoptotic and anti-inflammatory activities. Phase 3.",C1C(CC[C@@]2(CC[C@]3([C@@]4(CC[C@]5(C(C(C(=C[C@]5(C4=CC([C@]3([C@]2(1)[H])[H])=O)C)C#N)=O)(C)C)[H])C)C)C(=O)OC)(C)C,41,http://www.selleckchem.com/products/bardoxolone-methyl.html,NF-κB,K06472a,C5,L1200-4,0187172131,400769
296,S7050,AZ20,,,412.51,1233339-22-4,free base,ATM/ATR,"AZ20 is a novel potent and selective inhibitor of ATR kinase with IC50 of 5 nM, 8-fold selectivity over mTOR.",C1=C(N=C(N=C1N2[C@@H](COCC2)C)C3=CC=CC4=C3C=CN4)C5(S(C)(=O)=O)CC5,201,http://www.selleckchem.com/products/az20.html,PI3K/Akt/mTOR,K06485a,C6,L1200-4,0187172130,46244454
297,S7127,TIC10,,,386.49,41276-02-2,free base,Akt,"TIC10 inactivates Akt and ERK to induce TRAIL through Foxo3a, possesses superior drug properties: delivery across the blood-brain barrier, superior stability and improved pharmacokinetics.",C1=CC=CC(=C1)CN2CCC3=C(C2)C(N4C(N3CC5=C(C=CC=C5)C)=NCC4)=O,28,http://www.selleckchem.com/products/tic10.html,PI3K/Akt/mTOR,K06469a,C7,L1200-4,0187172129,336423
298,S7194,GZD824,,,724.77,1421783-64-3,mesylate,Bcr-Abl,"GZD824 is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I) with IC50 of 0.34 nM and 0.68 nM, respectively. ",C1(=CC(=CC(=C1C)C#CC2=CC3=C(N=C2)NN=C3)C(NC4=CC(=C(C=C4)CN5CCN(CC5)C)C(F)(F)F)=O).CS(=O)(=O)O.CS(=O)(=O)O,137,http://www.selleckchem.com/products/gzd824.html,Angiogenesis,K06464a,C8,L1200-4,0187172128,71519689
299,S7291,TAK-632,,,554.52,1228591-30-7,free base,Raf,"TAK-632 is a potent pan-Raf inhibitor with IC50 of 8.3 nM and 1.4 nM for B-Raf(wt) and C-Raf, respectively, showing less or no inhibition against other tested kinases.",C12=C(C(=C(C=C1)OC3=CC(=C(C=C3)F)NC(CC4=CC=CC(=C4)C(F)(F)F)=O)C#N)SC(=N2)NC(C5CC5)=O,180,http://www.selleckchem.com/products/tak-632.html,MAPK,K06240b,C9,L1200-4,0187172127,46209401
300,S2824,TPCA-1,,,279.29,507475-17-4,free base,IκB/IKK,"TPCA-1 is an inhibitor of IKK-2 with IC50 of 17.9 nM, inhibits NF-κB pathway, exhibits 22-fold selectivity over IKK-1.",C1(=C(C=C(S1)C2C=CC(=CC=2)F)C(=O)N)NC(=O)N,200,http://www.selleckchem.com/products/tpca-1.html,NF-κB,K02029b,D1,L1200-4,0187172112,9903786
301,S8004,ZM 39923 HCl,,,367.91,1021868-92-7,hydrochloride,JAK,"ZM 39923 is an JAK1/3 inhibitor with pIC50 of 4.4/7.1, almost no activity to JAK2 and modestly potent to EGFR; also found to be sensitive to transglutaminase.",C(CCN(C(C)C)CC1C=CC=CC=1)(=O)C2(C=C3C=CC=CC(=CC=2)3).Cl,81,http://www.selleckchem.com/products/zm-39923-hcl.html,JAK/STAT,K02615c,D10,L1200-4,0187172121,176406
302,S8031,NSC 23766,,,530.96,1177865-17-6,hydrochloride,Rac,"NSC 23766 is an inhibitor of Rac GTPase targeting Rac activation by guanine nucleotide exchange factors (GEFs) with IC50 of ~50 μM; does not inhibit the closely related  targets, Cdc42 or RhoA.",N1(C(=CC(=C2C=C(C=CC=12)NC3=NC(=NC(=C3)C)NC(CCCN(CC)CC)C)N)C).Cl.Cl.Cl,199,http://www.selleckchem.com/products/nsc-23766.html,Cell Cycle,K06454a,D11,L1200-4,0187172122,16759159
303,S2870,TG100713,,,254.25,925705-73-3,free base,PI3K,"TG100713 is a pan-PI3K inhibitor against PI3Kγ, PI3Kδ, PI3Kα and PI3Kβ with IC50 of 50 nM, 24 nM, 165 nM and 215 nM, respectively.",C1(C=C(C=CC=1)C2=NC3=C(N=C(N=C(N=C2)3)N)N)O,10,http://www.selleckchem.com/products/tg-100713.html,PI3K/Akt/mTOR,K06445a,D2,L1200-4,0187172113,17751063
304,S2899,GNF-2,,,374.32,778270-11-4,free base,Bcr-Abl,"GNF-2 is a highly selective non-ATP competitive inhibitor of Bcr-Abl, shows no activity to Flt3-ITD, Tel-PDGFR, TPR-MET and Tel-JAK1 transformed tumor cells.",C1=CC(=CC(=C1)C(=O)N)C2=NC=NC(=C2)NC3=CC=C(C=C3)OC(F)(F)F,200,http://www.selleckchem.com/products/gnf-2.html,Angiogenesis,K02605b,D3,L1200-4,0187172114,5311510
305,S3012,Pazopanib,Yes,Yes,437.52,444731-52-6,free base,"PDGFR,c-Kit,VEGFR","Pazopanib is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEGFR3, PDGFR, FGFR, c-Kit and c-Fms with IC50 of 10 nM, 30 nM, 47 nM, 84 nM, 74 nM, 140 nM and 146 nM, respectively.",C1(C(=CC=C(C=1)NC2N=C(C=CN=2)N(C)C3C=CC4=C(N(N=C(C=3)4)C)C)C)S(=O)(=O)N,201,http://www.selleckchem.com/products/pazopanib.html,Protein Tyrosine Kinase,K00959d,D4,L1200-4,0187172115,10113978
306,S7007,"MEK162 (ARRY-162, ARRY-438162)",,,441.23,606143-89-9,free base,MEK,ARRY-438162 is a potent inhibitor of MEK1/2 with IC50 of 12 nM.,C12=C(C=C(C(=C1F)NC3=C(C=C(C=C3)Br)F)C(NOCCO)=O)N(C=N2)C,199,http://www.selleckchem.com/products/mek162.html,MAPK,K04308b,D5,L1200-4,0187172116,10288191
307,S7060,PP1,Yes,,281.36,172889-26-8,free base,Src,PP1 is a potent and selective Src inhibitor for Lck/Fyn with IC50 of 5 nM/ 6 nM.,N1=CN=C2C(=C1N)C(=NN2C(C)(C)C)C3=CC=C(C=C3)C,14,http://www.selleckchem.com/products/pp1.html,Angiogenesis,K06489b,D6,L1200-4,0187172117,1400
308,S7136,CGK 733,,,555.84,905973-89-9,free base,ATM/ATR,CGK 733 is a potent and selective inhibitor of ATM/ATR with IC50 of ~200 nM.,C1=C(C(=CC(=C1)NC(NC(C(Cl)(Cl)Cl)NC(C(C2=CC=CC=C2)C3=CC=CC=C3)=O)=S)[N+](=O)[O-])F,179,http://www.selleckchem.com/products/cgk-733.html,DNA Damage,K00621b,D7,L1200-4,0187172118,6605258
309,S7195,RKI-1447,,,326.37,1342278-01-6,free base,ROCK,"RKI-1447 is a potent inhibitor of ROCK1 and ROCK2, with IC50 of 14.5 nM and 6.2 nM, respectively, has anti-invasive and antitumor activities.",C1=NC=CC(=C1)C2N=C(SC=2)NC(NCC3=CC=CC(=C3)O)=O,199,http://www.selleckchem.com/products/rki-1447.html,Cell Cycle,K06465a,D8,L1200-4,0187172119,60138149
310,S7293,ZCL278,,,584.89,587841-73-4,free base,Rac,ZCL278 is a selective Cdc42 GTPase inhibitor with Kd of 11.4 μM.,C1=C(N=C(N=C1C)NS(C2=CC=C(C=C2)NC(NC(COC3=C(C=C(C=C3)Br)Cl)=O)=S)(=O)=O)C,170,http://www.selleckchem.com/products/zcl278.html,Cell Cycle,K06482a,D9,L1200-4,0187172120,1791111
311,S2827,Torin 1,,,607.62,1222998-36-8,free base,"Autophagy,mTOR",Torin 1 is a potent inhibitor of mTORC1/2 with IC50 of 2 nM/10 nM; exhibits 1000-fold selectivity for mTOR than PI3K. ,N1(C(C=CC2C=NC3C(C1=2)=CC(=CC=3)C4C=NC5=CC=CC=C(C=4)5)=O)C6C=C(C(=CC=6)N7CCN(CC7)C(CC)=O)C(F)(F)F,10,http://www.selleckchem.com/products/torin-1.html,PI3K/Akt/mTOR,K06440a,E1,L1200-4,0187172111,49836027
312,S8005,SMI-4a,,,273.23,438190-29-5,free base,Pim,"SMI-4a is a potent inhibitor of Pim1 with IC50 of 17 nM, modest potent to Pim-2, does not significantly inhibit other serine/threonine- or tyrosine-kinases.",S1C(NC(C/1=C\C2C=C(C=CC=2)C(F)(F)F)=O)=O,201,http://www.selleckchem.com/products/smi-4a.html,JAK/STAT,K02695c,E10,L1200-4,0187172102,1361334
313,S8032,"PRT062607 (P505-15, BIIB057) HCl",Yes,,429.91,1370261-97-4,hydrochloride,Syk,"PRT062607 (P505-15) HCl is a novel, highly selective Syk inhibitor with IC50 of 1 nM, >80-fold selective for Syk than Fgr, Lyn, FAK, Pyk2 and Zap70.",N1(=C(N=C(C(=C1)C(N)=O)NC2=CC(=CC=C2)N3N=CC=N3)N[C@@H]4CCCC[C@H]4N).Cl,200,https://www.selleckchem.com/products/prt062607-p505-15-hcl.html,Angiogenesis,K06459a,E11,L1200-4,0187172101,56948527
314,S2872,GW5074,,,520.94,220904-83-6,free base,Raf,"GW5074 is a potent and selective c-Raf inhibitor with IC50 of 9 nM, no effect on the activities of JNK1/2/3, MEK1, MKK6/7, CDK1/2, c-Src, p38 MAP, VEGFR2 or c-Fms is noted.",C1=C2C(=CC=C1I)NC(C/2=C/C3=CC(=C(C(=C3)Br)O)Br)=O,199,http://www.selleckchem.com/products/gw5074.html,MAPK,K06452a,E2,L1200-4,0187172110,5924208
315,S2902,S-Ruxolitinib (INCB018424),Yes,,306.37,941685-37-6,free base,JAK,"S-Ruxolitinib is the chirality of INCB018424, which is the first potent, selective, JAK1/2 inhibitor to enter the clinic with IC50 of 3.3 nM/2.8 nM, >130-fold selectivity for JAK1/2 versus JAK3. Phase 3.",N1C2=C(C(=NC=1)C3=CN(N=C3)[C@H](C4CCCC4)CC#N)C=CN2,199,http://www.selleckchem.com/products/s-ruxolitinib.html,JAK/STAT,K04258c,E3,L1200-4,0187172109,50878566
316,S3026,Piceatannol,,,244.24,10083-24-6,free base,Syk,"Piceatannol, a natural stilbene, is a selective Syk inhibitor and ~10-fold selectivity versus Lyn.",C1(C(=CC(=CC=1)/C=C/C2C=C(C=C(C=2)O)O)O)O,196,http://www.selleckchem.com/products/piceatannol.html,Angiogenesis,K00089c,E4,L1200-4,0187172108,667639
317,S7008,PP2,,,301.77,172889-27-9,free base,Src,"PP2 is Src family kinase inhibitor, potently inhibits Lck/Fyn with IC50 of 4 nM/5 nM, ~100-fold less potent to EGFR, inactive for ZAP-70, JAK2 and PKA.",N1=CN=C2C(=C1N)C(=NN2C(C)(C)C)C3=CC=C(C=C3)Cl,198,https://www.selleckchem.com/products/pp2.html,Angiogenesis,K00048f,E5,L1200-4,0187172107,4878
318,S7065,MK-8745,,,431.91,885325-71-3,free base,Aurora Kinase,"MK-8745 is a potent and selective Aurora A inhibitor with IC50 of 0.6 nM, more than 450-fold selectivity for Aurora A over Aurora B.",C1(=CC=CC(=C1F)C(N2CCN(CC2)CC3=CC=CC(=N3)NC4=NC=CS4)=O)Cl,199,http://www.selleckchem.com/products/mk-8745.html,Cell Cycle,K06488a,E6,L1200-4,0187172106,11676373
319,S7145,AZD1080,,,334.37,612487-72-6,free base,GSK-3,"AZD1080 is a selective, orally active, brain permeable GSK3 inhibitor, inhibits human GSK3α and GSK3β with Ki of 6.9 nM and 31 nM, respectively, shows >14-fold selectivity against CDK2, CDK5, CDK1 and Erk2.",C1=C(C=C2C(=C1)NC(=C2C3=CC=C(C=N3)CN4CCOCC4)O)C#N,155,http://www.selleckchem.com/products/azd1080.html,PI3K/Akt/mTOR,K05738b,E7,L1200-4,0187172105,135564570
320,S7198,BIO,Yes,,356.17,667463-62-9,free base,GSK-3,"BIO (6-bromoindirubin-3'-oxime) is a specific inhibitor of GSK-3 with IC50 of 5 nM for GSK-3α/β, shows >16-fold selectivity over CDK5, also a pan-JAK inhibitor.",C1=CC=C2C(=C1)C(\C(N2)=C3\C(NC4=C3C=CC(=C4)Br)=O)=N\O,199,http://www.selleckchem.com/products/bio.html,PI3K/Akt/mTOR,K06470a,E8,L1200-4,0187172104,448949
321,S7317,WZ4003,,,496.99,1214265-58-3,free base,AMPK,"WZ4003 is a highly specific NUAK kinase inhibitor with IC50 of 20 nM and 100 nM for NUAK1 and NUAK2, respectively, without significant inhibition on 139 other kinases.",N1=C(N=C(C(=C1)Cl)OC2=CC(=CC=C2)NC(CC)=O)NC3=C(C=C(C=C3)N4CCN(CC4)C)OC,14,http://www.selleckchem.com/products/wz4003.html,PI3K/Akt/mTOR,K05788b,E9,L1200-4,0187172103,72200024
322,S2842,SAR131675,,,358.39,1433953-83-3,free base,VEGFR,"SAR131675 is a VEGFR3 inhibitor with IC50/Ki of 23 nM/12 nM, about 50- and 10-fold more selective for VEGFR3 than VEGFR1/2, little activity against Akt1, CDKs, PLK1, EGFR, IGF-1R, c-Met, Flt2 etc.",C12C(N(C(=C(C1=O)C(NC)=O)N)CC)=NC(=CC=2)C#C[C@](O)(C)COC,83,http://www.selleckchem.com/products/sar131675.html,Protein Tyrosine Kinase,K06444a,F1,L1200-4,0187172088,71295845
323,S8007,VE-821,,,368.41,1232410-49-9,free base,ATM/ATR,"VE-821 is a potent and selective ATP competitive inhibitor of ATR with Ki/IC50 of 13 nM/26 nM, shows inhibition of H2AX phosphorylation, minimal activity against PIKKs ATM, DNA-PK, mTOR and PI3Kγ.",C1(C(=NC=C(N=1)C2C=CC(=CC=2)S(=O)(=O)C)N)C(=O)NC3C=CC=CC=3,200,http://www.selleckchem.com/products/ve-821.html,DNA Damage,K06449a,F10,L1200-4,0187172097,51000408
324,S8036,Butein,,,272.25,487-52-5,free base,EGFR,"Butein, a plant polyphenol isolated from <i>Rhus verniciflua</i>, is able to inhibit the activation of protein tyrosine kinase, NF-κB and STAT3, also inhibits EGFR",C1(=C(C=C(C=C1)O)O)C(/C=C/C2=CC(=C(C=C2)O)O)=O,10,https://www.selleckchem.com/products/butein.html,Protein Tyrosine Kinase,K06456a,F11,L1200-4,0187172098,5281222
325,S2882,IKK-16 (IKK Inhibitor VII),,,483.63,873225-46-8,free base,IκB/IKK,"IKK 16 is a selective IκB kinase (IKK) inhibitor for IKK-2, IKK complex and IKK-1 with IC50 of 40 nM, 70 nM and 200 nM, respectively.",C1(C=CC(=CC=1)NC2N=C(C=CN=2)C3=CC4C(S3)=CC=CC=4)C(=O)N5CCC(CC5)N6CCCC6,200,http://www.selleckchem.com/products/ikk-16.html,NF-κB,K00596c,F2,L1200-4,0187172089,9549298
326,S2904,PF-477736,Yes,,419.48,952021-60-2,free base,Chk,"PF-477736 is a selective, potent and ATP-competitive Chk1 inhibitor with Ki of 0.49 nM and also inhibits VEGFR2, Aurora-A, FGFR3, Flt3, Fms (CSF1R), Ret and Yes. It shows ~100-fold selectivity for Chk1 than Chk2. Phase 1. ",C1=C(C=C2C3=C1C(NN=CC(=C(N2)C4C=NN(C=4)C)3)=O)NC([C@@H](C5CCCCC5)N)=O,14,http://www.selleckchem.com/products/pf-477736.html,Cell Cycle,K06246b,F3,L1200-4,0187172090,135565545
327,S4907,SC-514,,,224.3,354812-17-2,free base,IκB/IKK,"SC-514 is an orally active, ATP-competitive IKK-2 inhibitor with IC50 of 3-12 μM, blocks NF-κB-dependent gene expression, does not inhibit other IKK isoforms or other serine-threonine and tyrosine kinases.",C1(=CC(=C(S1)C(=O)N)N)C2=CSC=C2,200,http://www.selleckchem.com/products/sc-514.html,NF-κB,K06455a,F4,L1200-4,0187172091,2807869
328,S7018,CZC24832,,,364.4,1159824-67-5,free base,PI3K,"CZC24832 is the first selective PI3Kγ inhibitor with IC50 of 27 nM, with 10-fold selectivity over PI3Kβ and >100-fold selectivity over PI3Kα and PI3Kδ.",C1(=CN=CC(=C1)C2C=C(C3=NC(=NN(C=2)3)N)F)S(=O)(=O)NC(C)(C)C,13,http://www.selleckchem.com/products/czc24832.html,PI3K/Akt/mTOR,K06473a,F5,L1200-4,0187172092,42623951
329,S7083,LDK378,Yes,,558.14,1032900-25-6,free base,ALK,"LDK378 is potent inhibitor against ALK with IC50 of 0.2 nM, shows 40- and 35-fold selectivity against IGF-1R and InsR, respectively. Phase 2.",C1=CC(=C(C=C1)NC2=C(Cl)C=NC(=N2)NC3=C(C=C(C(=C3)C)C4CCNCC4)OC(C)C)S(C(C)C)(=O)=O,35,http://www.selleckchem.com/products/ldk378.html,Protein Tyrosine Kinase,K05302b,F6,L1200-4,0187172093,57379345
330,S7153,10058-F4,,,249.35,403811-55-2,free base,c-Myc,10058-F4 is a c-Myc inhibitor that specificallly inhibits the c-Myc-Max interaction and prevents transactivation of c-Myc target gene expression.,C1=C(C=CC(=C1)/C=C2\C(NC(S2)=S)=O)CC,200,https://www.selleckchem.com/products/10058-f4.html,Cell Cycle,K06460a,F7,L1200-4,0187172094,1271002
331,S7207,Ro 31-8220 Mesylate,,,553.65,138489-18-6,mesylate,PKC,"Ro 31-8220 is a pan-PKC inhibitor with IC50 of 5 nM, 24 nM, 14 nM, 27 nM, and 24 nM for PKC-α, PKC-βI, PKC-βII, PKC-γ, and PKC-ε, respectively, and also shows potent inhibition against MAPKAP-K1b, MSK1, GSK3β and S6K1.",C1(=C2C(=CC=C1)C(=CN2CCCSC(=N)N)C3C(=O)NC(C(C4=CN(C5=CC=CC=C54)C)=3)=O).CS(=O)(=O)O,180,http://www.selleckchem.com/products/ro-31-8220-mesylate.html,TGF-beta/Smad,K02706b,F8,L1200-4,0187172095,11628205
332,S7319,EHop-016 ,,,430.55,1380432-32-5,free base,Rac,"EHop-016 is a specific Rac GTPase inhibitor with IC50 of 1.1 μM for Rac1, equally potent inhibition for Rac3.",C1(N=C(C=CN=1)NC2C=CC3N(C4C=CC=CC(C(C=2)=3)=4)CC)NCCCN5CCOCC5,199,http://www.selleckchem.com/products/ehop-016.html,Cell Cycle,K06477a,F9,L1200-4,0187172096,51031035
333,S2843,BI-D1870,,,391.42,501437-28-1,free base,S6 Kinase,"BI-D1870 is an ATP-competitive inhibitor of S6 ribosome for RSK1/2/3/4 with IC50 of 31 nM/24 nM/18 nM/15 nM, respectively; 10- to 100-fold selectivity for RSK than MST2, GSK-3β, MARK3, CK1 and Aurora B.",C1(=C(C=C(C=C1F)NC2=NC3=C(C=N2)N(C(C(N3CCC(C)C)C)=O)C)F)O,199,http://www.selleckchem.com/products/bi-d1870.html,PI3K/Akt/mTOR,K04201b,G1,L1200-4,0187172087,25023738
334,S8009,AG-18,,,186.17,118409-57-7,free base,EGFR,AG-18 inhibits EGFR with IC50 of 35 μM.,C1(C=C(C#N)C#N)=CC(=C(C=C1)O)O,198,http://www.selleckchem.com/products/ag-18-tyrphostin-23.html,Protein Tyrosine Kinase,K00063c,G10,L1200-4,0187172078,2052
335,S8040,GDC-0349,Yes,,452.55,1207360-89-1,free base,mTOR,"GDC-0349 is a potent and selective ATP-competitive inhibitor of mTOR with Ki of 3.8 nM, 790-fold inhibitory effect against PI3Kα and other 266 kinases. Phase 1.",N(C(=O)NC1C=CC(=CC=1)C2N=C3C(=C(N=2)N4[C@H](COCC4)C)CCN(C3)C5COC5)CC,201,https://www.selleckchem.com/products/gdc-0349.html,PI3K/Akt/mTOR,K06457a,G11,L1200-4,0187169944,59239165
336,S2890,PF-562271,,,507.49,717907-75-0,free base,FAK,"PF-562271 is a potent, ATP-competitive, reversible inhibitor of FAK with IC50 of 1.5 nM, ~10-fold less potent for Pyk2 than FAK and >100-fold selectivity against other protein kinases, except for some CDKs.",C1=NC(=C(C=C1)CNC2=C(C=NC(=N2)NC3=CC=C4C(=C3)CC(N4)=O)C(F)(F)F)N(C)S(=O)(=O)C,199,http://www.selleckchem.com/products/pf-562271.html,Angiogenesis,K05001b,G2,L1200-4,0187172086,11713159
337,S2911,Go 6983,,,442.51,133053-19-7,free base,PKC,"Go 6983 is a pan-PKC inhibitor against for PKCα, PKCβ, PKCγ and PKCδ with IC50 of 7 nM, 7 nM, 6 nM and 10 nM, respectively; less potent to PKCζ and inactive to PKCμ.",C1(=CC=C2C(=C1)C(=CN2CCCN(C)C)C3C(NC(C=3C4C5=C(C=CC=C5)NC=4)=O)=O)OC,133,http://www.selleckchem.com/products/go-6983.html,TGF-beta/Smad,K02611b,G3,L1200-4,0187172085,3499
338,S5001,Tofacitinib (CP-690550) Citrate,Yes,Yes,504.49,540737-29-9,citrate,JAK,"Tofacitinib citrate (CP-690550 citrate) is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1.",N1(=CN=C2C(=C1N(C)[C@H]3CN(CC[C@@H]3C)C(=O)CC#N)C=CN2).C(C(C(O)=O)(CC(=O)O)O)C(O)=O,198,http://www.selleckchem.com/products/CP-690550.html,JAK/STAT,K06393a,G4,L1200-4,0187172084,10174505
339,S7028,IPI-145 (INK1197),Yes,,416.86,1201438-56-3,free base,PI3K,"IPI-145 (INK1197) is a novel and selective PI3K δ/γ inhibitor with Ki and IC50 of 23 pM/243 pM and 1 nM/50 nM, highly selective for PI3K δ/γ than other protein kinases. Phase 2.",C1=CC=C2C(=C1Cl)C(N(C(=C2)[C@H](C)NC3=NC=NC4=C3N=CN4)C5=CC=CC=C5)=O,201,http://www.selleckchem.com/products/ipi-145-ink1197.html,Angiogenesis,K04370b,G5,L1200-4,0187172083,50905713
340,S7093,IPA-3,,,350.45,42521-82-4,free base,PAK,"IPA-3 is a selective non-ATP competitive Pak1 inhibitor with IC50 of 2.5 μM, no inhibition to group II PAKs (PAKs 4-6).",S(SC1C(=CC=C2C=CC=CC=12)O)C3C(=CC=C4C=CC=CC=34)O,199,https://www.selleckchem.com/products/ipa-3.html,Cytoskeletal Signaling,K02689b,G6,L1200-4,0187172082,521106
341,S7158,LY2835219,Yes,,602.7,1231930-82-7,mesylate,CDK,"LY2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC50 of 2 nM and 10 nM, respectively.",C1(=CC=C(N=C1)NC2=NC(=C(C=N2)F)C3=CC(=C4C(=C3)N(C(=N4)C)C(C)C)F)CN5(CCN(CC5)CC).CS(=O)(=O)O,137,http://www.selleckchem.com/products/ly2835219.html,Cell Cycle,K06462a,G7,L1200-4,0187172081,71576678
342,S7214,Skepinone-L,,,425.42,1221485-83-1,free base,p38 MAPK,Skepinone-L is a selective p38α-MAPK inhibitor with IC50 of 5 nM.,C12C(C(C3C(CC1)=CC=C(C=3)OC[C@@H](CO)O)=O)=CC=C(C=2)NC4C(=CC(=CC=4)F)F,199,http://www.selleckchem.com/products/skepinone-l.html,MAPK,K06478a,G8,L1200-4,0187172080,45279963
343,S7320,TG003,,,249.33,300801-52-9,free base,CDK,"TG003 is a potent and ATP-competitive Cdc2-like kinase (Clk) inhibitor with IC50 of 20 nM, 200 nM, and 15 nM for Clk1, Clk2, and Clk4, respectively. No inhibitory effect on Clk3, SRPK1, SRPK2, or PKC.",C12N(/C(=C/C(C)=O)SC=1C=CC(=C2)OC)CC,24,http://www.selleckchem.com/products/tg003.html,Cell Cycle,K00243d,G9,L1200-4,0187172079,1893668
344,S2845,Semaxanib (SU5416),Yes,,238.28,194413-58-6,free base,VEGFR,"Semaxanib (SU5416) is a potent and selective VEGFR(Flk-1/KDR) inhibitor with IC50 of 1.23 μM, 20-fold more selective for VEGFR than PDGFRβ, lack of activity against EGFR, InsR and FGFR. Phase 3.",C1=CC=C2C(=C1)/C(C(N2)=O)=C/C3NC(=CC=3C)C,92,http://www.selleckchem.com/products/semaxanib-su5416.html,Protein Tyrosine Kinase,K06443a,H1,L1200-4,0187172064,5329098
345,S8015,CEP-32496,Yes,,517.46,1188910-76-0,free base,"CSF-1R,Raf","CEP-32496 is a highly potent inhibitor of BRAF(V600E/WT) and c-Raf with Kd of 14 nM/36 nM and 39 nM, also potent to Abl-1, c-Kit, Ret, PDGFRβ and VEGFR2, respectively; insignificant affinity for MEK-1, MEK-2, ERK-1 and ERK-2. Phase 1/2.",N(C(=O)NC1=NOC(=C1)C(C(F)(F)F)(C)C)C2C=C(C=CC=2)OC3N=CN=C4C=C(C(=CC=34)OC)OC,17,http://www.selleckchem.com/products/cep-32496.html,MAPK,K06451a,H10,L1200-4,0187172073,56846693
346,S8044,BMS-345541,,,255.32,445430-58-0,free base,IκB/IKK,"BMS-345541 is a highly selective inhibitor of the catalytic subunits of IKK-2 and IKK-1 with IC50 of 0.3 μM and 4 μM, respectively.",C1(=CC=C2C(=C1)N3C(C(=N2)NCCN)=NC=C3C)C,35,http://www.selleckchem.com/products/bms-345541.html,NF-κB,K06479a,H11,L1200-4,0187172074,9813758
347,S2893,NU7026,,,281.31,154447-35-5,free base,DNA-PK,"NU7026 is a potent DNA-PK inhibitor with IC50 of 0.23 μM, 60-fold selective for DNA-PK than PI3K and inactive against both ATM and ATR.",C1(OC2=C(C=CC3=C2C=CC=C3)C(C=1)=O)N4CCOCC4,10,http://www.selleckchem.com/products/nu7026.html,DNA Damage,K00019c,H2,L1200-4,0187169942,9860529
348,S2913,BAY 11-7082,,,207.25,19542-67-7,free base,"IκB/IKK,E2 conjugating","BAY 11-7082 is a NF-κB inhibitor, inhibits TNFα-induced IκBα phosphorylation with IC50 of 10 μM.",C1(S(/C=C/C#N)(=O)=O)C=CC(=CC=1)C,197,http://www.selleckchem.com/products/bay-11-7082-bay-11-7821.html,NF-κB,K02645b,H3,L1200-4,0187172066,5353431
349,S5002,Fingolimod (FTY720) HCl,,,343.9,162359-56-0,hydrochloride,S1P Receptor,Fingolimod (FTY720) is a S1P antagonist with IC50 of 0.033 nM.,C1(=CC=C(C=C1)CCCCCCCC)CCC(CO)(N)CO.Cl,200,http://www.selleckchem.com/products/FTY720.html,GPCR & G Protein,K06391a,H4,L1200-4,0187172067,107969
350,S7035,XL388,,,455.5,1251156-08-7,free base,mTOR,"XL388 is a highly potent, selective, ATP-competitive inhibitor of  mTOR with IC50 of 9.9 nM, 1000-fold selectivity over the closely related PI3K kinases.",C1(=NC=C(C=C1)C2=CC=C3C(=C2)CN(CCO3)C(=O)C4=CC=C(C(=C4C)F)S(C)(=O)=O)N,50,http://www.selleckchem.com/products/xl388.html,PI3K/Akt/mTOR,K06475a,H5,L1200-4,0187172068,59604787
351,S7102,VE-822,,,463.55,1232416-25-9,free base,ATM/ATR,VE-822 is an ATR inhibitor with IC50 of 19 nM.,N1=CC(=NC(=C1N)C2=CC(=NO2)C3=CC=C(C=C3)CNC)C4=CC=C(C=C4)S(=O)(=O)C(C)C,77,http://www.selleckchem.com/products/ve-822.html,PI3K/Akt/mTOR,K06487a,H6,L1200-4,0187172069,59472121
352,S7167,SSR128129E,Yes,,346.31,848318-25-2,free base,FGFR,"SSR128129E is an orally-active and allosteric FGFR1 inhibitor with IC50 of 1.9 μM, while not affecting other related RTKs.",C1=CC2N(C(=C(C=2OC)C)C(=O)C3=CC=C(C(=C3)C(O[Na])=O)N)C=C1,199,http://www.selleckchem.com/products/ssr128129e.html,Angiogenesis,K06481a,H7,L1200-4,0187172070,68853159
353,S7253,AZD2858,,,453.52,486424-20-8,free base,GSK-3,"AZD2858 is a selective GSK-3 inhibitor with an IC50 of 68 nM, activating Wnt signaling, increases bone mass in rats.",C1=C(N=C(C(=N1)N)C(=O)NC2=CN=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N4CCN(CC4)C,15,http://www.selleckchem.com/products/azd2858.html,PI3K/Akt/mTOR,K06471a,H8,L1200-4,0187172071,10138980
354,S7397,Sorafenib,Yes,,464.82,284461-73-0,free base,Raf,"Sorafenib is a multikinase inhibitor of Raf-1, B-Raf and VEGFR-2 with IC50 of 6 nM, 22 nM and 90 nM, respectively.",C1(C(F)(F)F)C(=CC=C(NC(NC2C=CC(OC3C=C(C(=O)NC)N=CC=3)=CC=2)=O)C=1)Cl,200,http://www.selleckchem.com/products/sorafenib.html,MAPK,K00597c,H9,L1200-4,0187169937,216239
